Conference PaperPDF Available

Vertigo Awareness In University Students

Authors:

Abstract

Introduction and Aim: Vertigo, a symptom, is quite common worldwide. Anamnesis is important in understanding the cause and planning the appropriate treatment. For a successful anamnesis, it is necessary to describe the sensation experienced by the patients fully. Therefore, knowledge and awareness of vertigo are very important. This study aims to investigate the awareness of vertigo in university students. Materials and Methods: This descriptive cross-sectional study was conducted on university students. We collected the data in a self-administered survey using google surveys. Five hundred forty-two students were included in the study. A vertigo awareness questionnaire was applied to these students. Findings are presented with descriptive statistics. Results: Of the 542 individuals included in the study, 442 (81.5%) were female, and 100 (18.5%) were male. Students mostly answered "I don't know" to 9 (50%) questions of the 18-question VFA. In one question, they confused other types of dizziness with vertigo. However, for the remaining eight questions, most students demonstrated a good level of knowledge, albeit the overall rate still remained relatively low. Notably, 50% of the students expressed the belief that social media could be utilized as a means to enhance knowledge and awareness of vertigo. Conclusion: Our study findings revealed a low level of vertigo knowledge and awareness among university students. This could be attributed to the fact that all forms of dizziness in Turkey are commonly referred to as "vertigo," which is perceived as a disease. To address this issue, utilizing educational platforms like social media can play a crucial role in enhancing vertigo knowledge and awareness. Thus, it can be easier to understand the cause of vertigo with healthier information during the anamnesis.
1
2. 
Kongresi
2nd International Eurasia Health Science Congre
15 - 16 Haziran / June 2023
(IEHSC 2023)

Online
TRABZON
Bildiri 
Conference Abstracts Book
2
TURKEY
https://iehsc.avrasya.edu.tr

ISBN: 978-625-99642-0-1

KONGRE ADI

2nd International Eurasia Health Science Congre

15- 16 Haziran /June 2023
Online
TRABZON

 



ADRES: 
TEL: (0462) 335 50 00
3
KURULLAR / BOARDS
ONUR KURULU / EXECUTIVE COMMITTEE
Honorary President of the Congress
, Avrasya University Rector
Congress President
, Avrasya University
MEMBERS OF SCIENTIFIC COMMITTEE
 Avrasya University, Turkiye
 Avrasya University, Turkiye
Prof. Dr. Aytap SEZER, Avrasya University, Turkiye
 Avrasya University, Turkiye
Prof. Dr. Cemal BIYIK, Avrasya University, Turkiye
 Avrasya University, Turkiye
 Biruni University, Turkiye
 
 Antalya Bilim University, Turkiye
 Hacettepe University, Turkiye
Prof. Dr. Bahittin KAHVE Karadeniz Teknik University, Turkiye
 Karadeniz Teknik University, Turkiye
 Trabzon University, Turkiye
Prof. Dr. Fatma Deniz SAYINER 
 Lokman Hekim University, Turkiye
 Karadeniz Teknik University, Turkiye
Prof. Dr. Feza Korkusuz Hacettepe University, Turkiye
 
 Antalya Bilim University, Turkiye
 
 Hacettepe University, Turkiye
 
 Karadeniz Teknik University, Turkiye
 Karadeniz Teknik University, Turkiye
 Ankara City Hospital, Turkiye
4
 Mersin University, Turkiye
Prof. Dr. Sevgi KIZILCI, 
 
Prof. Dr. Erkan VURALKAN, Avrasya University, Turkiye
Prof. Dr. Zeynep Yezdan FIRAT, 
 Avrasya University, Turkiye
Assoc. Prof. Seda FANDAKLI, Avrasya University, Turkiye
Assoc. Prof. Birsen ALTAY, 
Assoc. Prof. Emine CANYILMAZ, Karadeniz Teknik University, Turkiye
 
 Trabzon University, Turkiye
 Karadeniz Teknik University, Turkiye
Assoc. Prof. Nazan KARAHAN 
 Avrasya University, Turkiye
 Giresun University, Turkiye
 
 Avrasya University, Turkiye
 Avrasya University, Turkiye
Asst. Prof. Emin AKSOY, 
Asst. Prof. Emine ATICI, 
 Avrasya University, Turkiye
Asst. Prof. Fatih CESUR, Avrasya University, Turkiye
 Avrasya University, Turkiye
 Avrasya University, Turkiye
 Avrasya University, Turkiye
 Biruni University, Turkiye
Asst. Prof. Mehmet YILDIZLAR, Avrasya University, Turkiye
 Avrasya University, Turkiye
 Karadeniz Teknik University, Turkiye
 
Asst. Prof. Ramazan SARI, Avrasya University, Turkiye
Asst. Prof. Sadiye USTA, Avrasya University, Turkiye
 e
 Avrasya University, Turkiye
5
 Avrasya University, Turkiye
 
 University of Craviova, Romania
 University, Turkiye
Dr. Issofou Adamou ELHADJI Abdou Moumouni University, Niger
 Avrasya University, Turkiye
Iris MEYENBURG ALTWARG RN, Dipl. Pflegewirtin, Germany
Rosana Svetic CISIC, RN Bsn Msn, Ph.D., Croatia
 
Yogesh Sharda, Personal Development Trainer and Workshop Facilitator
 Trabzon Nursing Home Elderly Care and Rehabilitation, Turkiye
 University of Surhrey, England
 O
KONGRE SEKRETERYASI / CONGRESS SECRETARIAT
Lect. , Avrasya University, Turkiye
Lect. Ezgi ALBAYRAK, Avrasya University, Turkiye
Lect. Arif AKSOY, Avrasya University, Turkiye
, Avrasya University, Turkiye

, Avrasya University, Turkiye
6

 .........8
Afetlerde Psikososyal Destek



..

..63
..68
.74




D V





Klinik 



.166
...178

Probiyotiklerin Antioksidan Etkileri
Deprem Bilincini


7



Analizi 
 
8

123KUZAN4
56
1 Harran , 0000-0002-0417-3588, brckara86@hotmail.com
2 Harran       , 0000-0001-9564-2214,
ibrahimkoruk@yahoo.com
3 Harran       , 0000-0002-3026-5822,
dr.ahmetgunduzalp@gmail.com
4 Harran 0000-0002-5284-0525, kuzanrustem@gmail.com
5 Harran , 0000-0002-2870-710X, sulehur@gmail.com
6 , muratoglu637@gmail.com
       
biri olarak belirtmektedir. [1]         
        
(MKL).      cilt   KL formudur. [2] KL
Afganistan, Cezayir, Brezilya, Kolombiya, Irak, Pakistan, Peru,
 [6]
  
1990- 
 [5]
     -boyun, kol, bacak gibi yerlerinde

olabilir. [9]

  (10, 16).   
h         



1. Tedaviyi 
2. Tedaviyi terk etme nedenlerini belirlemektir.


9
   
           

     -     
             

 
incelendi ve tedavisini tamamlamayan 370 l    
tedavisini tamamlamayan hasta        

. 
        de sekiz dozu
tamamlamayanlar .

 Veri anal

        
ebeveynleri
Bulgular

 (Tablo 1).
Tablo 1
Tedavi Tamamlama Durumu


Tedaviyi tamamlayanlar
183
49,5
Tedaviyi terk edenler
187
50,5

terk edenler
102
54,6

gelmeyenler
73
39

12
6.4
 tamamlamadan
terk edenler
6
3.2

gelmeyenler
6
3.2
Toplam
370
100,0
          


10
    

 ).
Tablo 2. -

         
-19 pandemisi nedeniyle temas etmek istememe


(%1,1) izlemektedir (Tablo 3).



Cinsiyet

95
50,8
Erkek
92
49,2


114
61,0
21-44 
52
27,8

21
11,2


27
14,4
Okuryazar
9
4,8
 

41
21,9

54
28,9
Ortaokul
40
21,4

16
8,6

Evet
34
18,2

40
21,4

113
60,4


30
16,0

84
44,9

73
39,0
  
Durumu
Evet
65
34,8

122
65,2

Evet
91
48,7

96
51,3
Toplam
187
100,0
11
Tablo 3
Tedaviyi Terk Nedenleri


54
28,9

51
27,3

50
26,7
Covid-19 pandemisi
19
10,2

11
5,9
Gebelik
2
1,1
Toplam
187
100,0


         
        
 (15).

-  

 (22, 23, 24).
KL ve Visseral Leishmaniasis (VL)    

). 

         ; tedaviye
         
esinde en

            

kendilerini daha iyi hi).
        
         ektedir.

Covid-
12

          
25

sosyo-



         

        
           
       
        

Kaynaklar
1. World Health Organization (2020). Neglected tropical diseases [online]. Website
https://www.who.int/data/gho/data/themes/neglected-tropical-diseases [accessed 15
December 2020].
2. World Health Organization (2020). Leishmaniasis [online]. Website
2.https://www.who.int/news-room/fact-sheets/detail/leishmaniasis [accessed 15
December 2020].
3. World Health Organization (2010). Control of the leishmaniases: report of a meeting of
the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22-26 March
2010 [online]. Website https://apps.who.int/iris/handle/10665/44412 [accessed 15
December 2020].
4. Centers for Disease Control and Prevention (2020). Parasites - Leishmaniasis [online].
Website
https://www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html#tx
[accessed 15 December 2020].
5. 

(in Turkish)
6. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
7. Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Medicine and
Infectious Disease 2007;5:150-8. doi: 10.1016/j.tmaid.2006.09.004.
8. Blum J, Desjeux P, Schwartz E, et al. Treatment of cutaneous leishmaniasis among
travellers. Journal of Antimicrobial Chemotherapy 2004;53(2):158-66. doi:
10.1093/jac/dkh058.
9. 

10. Hodiamont CJ, Kager PA, Bart A, de Vries HJ, van Thiel PP, et al. Species-directed
therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS
13
Neglected Tropical Diseases 2014 May 1;8(5):e2832. doi:
10.1371/journal.pntd.0002832.
11. Yanik M, Gurel MS, Simsek Z, et al. The psychological impact of cutaneous
leishmaniasis. Clinical and Experimental Dermatology 2004;29:464-7. doi:
10.1111/j.1365-2230.2004.01605.x.
12. Anthroponotic Cutaneous Leishmaniasis: Knowledge, Attitudes, Practices, and Risk
Factors among residents in endemic Communities in Kerman City in the Southeast of
Iran. Authorea May 14, 2020. doi: 10.22541/au.158948952.21626095
13. Irum S, Aftab M, Khan A, Naz S, Simsek S, et al. Cutaneous Leishmaniasis (CL): A
Cross-Sectional Community Based Survey on Knowledge, Attitude and Practices in a
Highly Endemic Area of Waziristan (KPK Province), Pakistan. Acta Tropica 2021
Jan;213:105746. doi: 10.1016/j.actatropica.2020.105746.
14. Uzun S, Durdu M, Culha G, Allahverdiyev AM, Memisoglu HR. Clinical features,
epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous
leishmaniasis: recent experience in Turkey. The Journal of Parasitology 2004
Aug;90(4):853-9. doi: 10.1645/GE-185
15. 


16.  -
Related Awareness Regarding Cutaneous Leishmaniasis Cases in Sanliurfa, Delay
Level in Treatment and Reasons for Delay. Saudi Journal of Medicine (SJM) 2020,P:
292-299. doi: 10.36348/sjm.2020.v05i09.002.
17. Surendra Uranw, Bart Ostyn, Thomas P.C. Dorlo, Epco Hasker, Bruno Dujardin, et al.
Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions
in Nepal. Tropical Medicine and International Health 2013;18(2):179-87.
doi:10.1111/tmi.12025
18. Pontello Junior R, Gon Ados S, Ogama A. American cutaneous leishmaniasis:
epidemiological profile of patients treated in Londrina from 1998 to 2009. Anais
Brasileiros de Dermatologia 2013 Sep-Oct;88(5):748-53. doi: 10.1590/abd1806-
4841.20132168
19. Kansal S, Chakravarty J, Kumar A, Malaviya P, Boelaert M, et al. Risk Factors
associated with defaulting from visceral leishmaniasis treatment: analysis under routine
programme conditions in Bihar, India. Tropical Medicine and International Health
2017 Aug;22(8):1037-1042. doi: 10.1111/tmi.12906.
20. Bernard N Muture 1, Margaret N Keraka , Peter K Kimuu , Ephantus W Kabiru ,
Victor Ombeka , et al. Factors associated with default from treatment among
tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public
Health 2011;11:696. doi: 10.1186/1471-2458-11-696.
21. Garrido Mda S, Penna ML, Perez-Porcuna TM, de Souza AB, Marreiro Lda S et al.
Factors associated with tuberculosis treatment default in an endemic area of the
Brazilian Amazon: a case control-study. PLoS One 2012;7(6):e39134. doi:
10.1371/journal.pone.0039134.
22. Bennis I, Belaid L, De Brouwere V, Filali H, Sahibi H, et al. The mosquitoes that
destroy your face. Social impact of Cutaneous Leishmaniasis in South-eastern
14
Morocco, A qualitative study. PLoS One. 2017 Dec 20;12(12):e0189906. doi:
10.1371/journal.pone.0189906.
23. Garapati P, Pal B, Siddiqui NA, Bimal S, Das P, et al. Knowledge, stigma, health
seeking behaviour and its determinants among patients with post kalaazar dermal
leishmaniasis, Bihar, India. PloS one 2018;13(9):e0203407. doi:
10.1371/journal.pone.0203407.
24. Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of
localised cutaneous Leishmaniasis: a scoping review. BMC Public Health 2018 Mar
15;18(1):358. doi: 10.1186/s12889-018-5260-9.
25. Shimels T, Asrat Kassu R, Bogale G, Bekele M, Getnet M, et al. Magnitude and
associated factors of poor medication adherence among diabetic and hypertensive
patients visiting public health facilities in Ethiopia during the COVID-19 pandemic.
PLoS One 2021 Apr 6;16(4):e0249222. doi: 10.1371/journal.pone.0249222.
26. Koyuncu T, Metintas S, Ayhan E, Oz F, Bugrul N, et al. Evaluation of reproductive
health criteria in seasonal agricultural workers: a sample from Eskisehir, Turkey. Rural
Remote Health 2016 Oct-Dec;16(4):3489. doi:10.22605/RRH3489
27. 
1;38(0):8-12. doi: 10.7705/biomedica.v38i3.4034.
15
Afetlerde Psikososyal Destek
Psychosocial Support in Disasters
12
1         Gaziantep,
, b.caki@hotmail.com, 0000-0002-3592-5121
2      Gaziantep,
 gungormusz@yahoo.co.uk, 0000-0002-3761-8184
  ve          
          

         
 Bu derleme, afet

Afetlerde Psikososya




         

         

Anahtar Kelimeler: 
16
ABSTRACT
Introduction and Aim: Disasters are events that cause physical, economic, and social
destructions and losses for people, and stop or interrupt everyday life and human activities.
Psychosocial support practices are needed in order to protect and improve the mental health and
psychosocial well-being of individuals in the face of events/incidents, to ensure the
reorganization of society, and to support the transition to the ordinary period. This study is a
review of psychosocial support practices that should be done in disasters.
Psychosocial Support in Disasters: It is the process of supporting the elimination of
psychosocial problems and the normalization of society. Psychosocial support is carried out in
line with basic principles and methods. In the process of psychosocial support, first of all, the
reactions of individuals to the process should be evaluated and interventions should be planned
accordingly. Planned psychosocial interventions vary according to the disaster period.
Conclusion: Effective implementation of the psychosocial support plan may increase
the flexibility and resilience of society against disasters. Nurses, who are the pioneers of
healthcare professionals, also need to contribute to psychosocial support practices regarding
disasters that completely change the lives of individuals and societies.
Keywords: Disasters, Psychosocial intervention, Public Health, Nursing
1. 
          


          

etirilmesi, etkilenen
     
         
          



2. 
    
        
        
          

         
olm
     
insan, toplum, mal,
    
(4).
17


          
          
        
          
Epidemiology of Disasters -CRED) CRED, 2000-2019 yılları arasında 
 7348  
             



            

          
idir. Deprem, heyelan
   6



 8          



3. 

         
            
          

          
          

            
         
 (1,2).
Zarar Azaltma:    

          

         

 

18
 

4. 
 



            
aha etkili bir
         

           
         

1).
Birincil Korunma:         
          



idir (1).
 



       
         
    



5. 
AFAD psikososyal 
   
         
         


          
 


19
Fiziksel Tepkiler:      


   
biriyle ta

        
 




         


          
         
 
           

         
           
          

- 
          

    
  

         
          

-  
olumsuz psikolojik etkilerinden korunabilecek bireyleri temsil eder. Afet ve acil durumlarda

 
         
          
        

20
- 
           
          
           


- 
         


    


Afet ve acil durumlardan sonra uyg






      







            

           

       enin afet ve acil



yer 
21


            
        

          

5.2. 
         

   

Gereksinim ve Kaynak Tespiti: 


ve kurumla


psikososy         
          
       ini



edilebilir. Tedav
        


     




yerdir (2,12).
Afet ve acil durumlarda etkilenen bir toplumun, ortak

          plumu
          
          
       

22
 
psikososyal uygulamalardan biridir. Bu projeler, etkilenen bireylerin, ailelerin ve toplumun
i         

       ri ve

       
        
  
         



          
durumlarda yar       
        


       
         
Psikososy

          yandan da

5.3. 

          

        
d
 

Zar




 

23
 
          


          

          
        







aneler gibi) ve toplum merkezleri gibi kaynaklar
belirlenmelidir.

        

     




          


         


     Etkilenenlerin normal


         
verilme

24
   
elidir.
          

         
       


psikososyal etkileri, 





6. 
         

         


         
hizmeti verebilme          

      
6).
7. 

         


         osyal
          

       
        

gerekmektedir.
8. 
25
1. Halk sağlığı
hemşireliği -
2. Afet ve acil durumlarda
psikososyal destek hizmetleri. Saha çalışanları için el rehberi. Ankara. 05 Mart 2023 tarihinde
https://toroslarram.meb.k12.tr/meb_iys_dosyalar/33/14/768185/dosyalar/2023_02/08143115_
Afet-Acil-Durumlarda-Psikososyal-Destek-PSS_Handbook_tr_080419-
1.pdf?CHK=1927eabadc6c4f18823cd38740b9cdc4 
3. TAçıklamalı afet
yönetimi terimleri sözlüğü. 12 Mart 2023 tarihinde https://www.afad.gov.tr/aciklamali-afet-
yonetimi-terimleri-sozlugu 
4. Afet Yönetimi beklenilmeyeni
beklemek, en kötüsünü yönetmek 

5.  
İlk ve acil yardım teknikerliği paramedik içinde (s:826-

6. 
  Paramedik ve Acil Sağlık Hizmetleri Dergisi, 1(1), 28-40.
7. Türkiye ve dünyada en
sık görülen doğal afetler. 16 Ocak 2023 tarihinde https://tatd.org.tr/afet/afet-yazi-
dizisi/2020de-turkiye-ve-dunyada-en-sik-gorulen-dogal-afetler/ 
8.  
(2021). 2020 yılı meteorolojik afetler değerlendirmesi. Ankara. 16 Mart 2023 tarihinde
https://mgm.gov.tr/FILES/genel/raporlar/2020MeteorolojikAfetlerDegerlendirmesi.pd
f 
9. 2023 Kahramanmaraş depremleri. (2023). In Wikipedia.
https://tr.wikipedia.org/wiki/2023_Kahramanmara%C5%9F_depremleri
10. Gormon, L.M., Sultan, D.F. (2014). Psikosoyal hemşirelik genel hasta bakımı içinde.

11. 

12. Afetlerde psikososyal destek uygulama rehberi. 
. 01 Mart 2023 tarihinde
https://www.kizilay.org.tr/Upload/Dokuman/Dosya/20725363_afetlerde-psikososyal-destek-
uygulama-rehberi.pdf 
13. , &
Aker, T. (ed). APHB psikososyal uygulamalar eğitimi el kitabı -169). Ankara:

14. Afet yönetimi I. 

https://acikders.ankara.edu.tr/pluginfile.php/165619/mod_resource/content/1/1.%20HAFTA.p
df 
26

Vertigo Awareness In University Students
1
1emresylmz28@gmail.com, 0000-0002-7554-3048

           
i
          
          
      

  :       
         

sunuldu.
Bulgular:     
         
           
sekiz 
    

 
  killerinin


a

Anahtar Kalimeler: 
27
ABSTRACT
Introduction and Aim: Vertigo, a symptom, is quite common worldwide. Anamnesis is
important in understanding the cause and planning the appropriate treatment. For a successful
anamnesis, it is necessary to describe the sensation experienced by the patients fully. Therefore,
knowledge and awareness of vertigo are very important. This study aims to investigate the
awareness of vertigo in university students.
Materials and Methods: This descriptive cross-sectional study was conducted on university
students. We collected the data in a self-administered survey using google surveys. Five
hundred forty-two students were included in the study. A vertigo awareness questionnaire was
applied to these students. Findings are presented with descriptive statistics.
Results: Of the 542 individuals included in the study, 442 (81.5%) were female, and 100
(18.5%) were male. Students mostly answered "I don't know" to 9 (50%) questions of the 18-
question VFA. In one question, they confused other types of dizziness with vertigo. However,
for the remaining eight questions, most students demonstrated a good level of knowledge, albeit
the overall rate still remained relatively low. Notably, 50% of the students expressed the belief
that social media could be utilized as a means to enhance knowledge and awareness of vertigo.
Conclusion: Our study findings revealed a low level of vertigo knowledge and awareness
among university students. This could be attributed to the fact that all forms of dizziness in
Turkey are commonly referred to as "vertigo," which is perceived as a disease. To address this
issue, utilizing educational platforms like social media can play a crucial role in enhancing
vertigo knowledge and awareness. Thus, it can be easier to understand the cause of vertigo with
healthier information during the anamnesis.
Keywords: vertigo, dizziness, student, awareness, anamnesis
Introduction
Dizziness is traditionally categorized into four subgroups: vertigo (a spinning sensation),
disequilibrium (a feeling of imbalance), light-headedness (a sensation of giddiness), and
presyncope (a sensation of feeling faint). Among these subgroups, vertigo is the most prevalent,
accounting for approximately 54% of all dizziness cases (Cranfield et al., 2010). Vertigo can
further be classified into two types: central and peripheral, based on the location of the
underlying pathology within the vestibular system (Kuo et al., 2008). Peripheral vertigo arises
from pathologies affecting the end organs in the inner ear and the vestibular nerve. The most
common cause of peripheral vertigo is benign paroxysmal positional vertigo (BPPV) (Kim et
al., 2021), followed by Meniere's disease and vestibular neuritis. While peripheral vertigo does
not pose a life-threatening risk, it significantly impacts the quality of life of affected individuals.
Balance is maintained through the integration of visual, vestibular, and proprioceptive inputs
within the central nervous system. Any abnormalities or disruptions in these systems or the
central nervous system itself can lead to sensations of imbalance or dizziness. Certain
conditions such as cerebrovascular diseases (SVAs), tumours, and central nervous system
disorders like multiple sclerosis (MS) are considered emergencies in the context of vertigo. In
such cases, it is crucial to differentiate vertigo from other non-spinning forms of dizziness (Kim
et a., 2021).
Patients who present with complaints of dizziness often struggle to accurately describe their
symptoms. This difficulty is compounded by the fact that all forms of dizziness are commonly
28
referred to as "vertigo," particularly in Turkish language usage. Another challenge is the
perception of vertigo as a disease itself. These factors have a detrimental impact on the
anamnesis process, which is a crucial stage in identifying the underlying cause of vertigo.
Therefore, enhancing knowledge and awareness about vertigo becomes a critical issue in
improving the accuracy and effectiveness of the anamnesis stage.
This study aims to investigate the awareness of vertigo in university students.
Materials and Methods
This descriptive cross-sectional study was conducted on university students. We collected the
data in a self-administered survey using Google surveys. The study did not include the data of
the participants who did not complete the questionnaire. We asked all participants included in
the study to consent to the Google survey, and we obtained permission from the university's
ethics committee for the study (2023/02 decision no:30)
Five hundred forty-two students were included in the study. A vertigo awareness questionnaire
(VAQ) was applied to these students. The basis of VAQ is based on the BPPV awareness
questionnaire used by Mohammed et al., (2022). We adapted these questions to general vertigo.
The original questionnaire consists of 5 parts. Section 1 is the study consent part. Section 2
includes sociodemographic information. Section 3 consists of yes or no questions about BPPV.
Section 4 consists of yes/no/don't know questions about BPPV. The last part was a suggestion
question to increase awareness of the disease. We conducted a pilot study before collecting data
to ensure the questions' clarity, content and face validity. The pilot study was conducted on 15
participants and asked for comments on the questions. After the pilot study, the questions were
reviewed and reorganized. Pilot study data were not included in the study.
Results
Of the 542 individuals included in the study, 442 (81.5%) were female, and 100 (18.5%) were
-
3.40 (18-38). The age and gender status of the individuals are presented in Table 1.
Table 1. Age and gender status of individuals.





















Most participants did not have a chronic disease, did not go to an audiologist, did not experience
vertigo, did not know the types of dizziness, and did not experience otitis media. However, the
majority stated that they knew about vertigo. The chronic disease status of the participants, the
status of applying to an audiologist, whether they have experienced vertigo and otitis media,
and their knowledge of the types of dizziness and vertigo are presented in Table 2.
29
Table 2. The chronic disease status of the participants, their status of applying to an audiologist,
whether they experienced vertigo and otitis media, and their knowledge of the types of dizziness
and vertigo.













































In the 18-item vertigo awareness survey, participants mostly responded with "I don't know" to
9 questions. When asked if other types of dizziness like lightheadedness or disequilibrium are
considered vertigo, the majority answered "yes" incorrectly. However, for the remaining 8
questions, the majority provided correct responses. They acknowledged that vertigo is a
symptom, can be common, may indicate a serious condition, can be caused by head trauma and
vitamin deficiency, can last from seconds to days, and that auditory symptoms and eye
movements (nystagmus) are important for diagnosis. They also correctly identified which clinic
to visit, the importance of clinical examination, and that treatment involves more than just
physicians. The responses given by participants in the VAQ are presented in Table 3.
Table 3. Responses of the participants to the Vertigo awareness questionnaire.






























30





































































 









































        







31
We also asked the participants how awareness of vertigo could be increased. 50% of the
participants stated that social media, and 21% said television could be beneficial. The platforms
suggested by the participants to increase their awareness of vertigo are presented in Table 4.
Figure 1. Platforms suggested by participants to increase awareness of vertigo.
Discussion
This study aims to investigate the awareness of vertigo in university students. At the end of our
study, it was determined that most university students had limited knowledge about vertigo.
In our study, the number of students with chronic disease was 3%. In a study conducted in Taif,
Saudi Arabia, investigating BPPV awareness, the rate of chronic disease was reported to be
14% (Mohammed et al., 2022). This rate is similar in other studies (Alotaibi et al., 2020). The
fact that the rate of chronic diseases in our study was lower than in other studies may be related
to the age of the participants. Since the individuals in our study were university students, they
were younger than those in other studies. Similarly, the lower rate of vertigo and otitis media
in our study compared to other studies (Mohammed et al., 2022)can be explained by age.
The most interesting finding in our study was that the students stated, 'I know what vertigo is',
with a rate of 78.2% (Table 2). On the other hand, in Table 3, it was observed that other types
of dizziness were confused with vertigo, with 64.9% of the students. This confirms that all types
of dizziness are named vertigo due to its usage in Turkish. Similarly, one-third of the
participants stated vertigo as a symptom, while the others stated that it was a disease or gave
the answer I don't know. Therefore, vertigo is still confused in our country.
The literature has reported that the lifetime prevalence of dizziness is 23.2% (Kroenke et al.,
1993). 45.8% of the individuals in our study stated that they had experienced vertigo before,
and this rate is higher than in the literature. This may be because the individuals in our study
did not know the types of dizziness and described some simple events as vertigo. Our study
may indicate that even those who study vertigo are not fully understood.
Students mostly answered "I don't know" to 9 (50%) questions of the 18-question VFA. In one
question, they confused other types of dizziness with vertigo. This rate is an indication that
vertigo is still unknown in Turkish society. Vertigo's knowledge and awareness level can be
increased with the social media platform, as stated mainly by the students who participated in
the survey.
On the other hand, students stated that auditory symptoms are determinant in individuals with
vertigo complaints, and they know which polyclinic they should go to if they experience
Social media
50%
Raising
awareness in
schools
17%
Television
21%
Newspaper
12%
32
vertigo. This is an indication that the students know that the ears are not only responsible for
hearing and that I am also responsible for the balance.
Finally, in our study, 52.8% of the students stated that vertigo was diagnosed clinically.
However, when going into more detail, it was understood that the students did not know which
diagnostic tests were used and which methods were used in the treatment.
Conclusion and Suggestions
Our study determined that the level of vertigo knowledge and awareness was low in university
students. This situation may be because all dizziness types in Turkey are called vertigo, which
is known as a disease. Using platforms such as social media for educational purposes can
increase vertigo knowledge and awareness. Thus, it can be easier to understand the cause of
vertigo with healthier information during the anamnesis.
References
1. Cranfield, S., Mackenzie, I., Gabbay, M. (2020). Can GPs diagnose benign paroxysmal
positional vertigo and does the Epley manoeuvre work in primary care? British Journal of
General Practise, 60(578):698-9.
2. Kuo, C.H., Pang, L., Chang, R. (2008). Vertigo Part 1 Assessment in general practice.
Australian Family Physician, 37(5):34147.
3. Kim, H.J., Park, J., Kim, J.S. (2021). Update on benign paroxysmal positional vertigo.
Journal of Neurology, 268(5):1995-2000.
4. Dommaraju. S., Perera, E. (2016). An approach to vertigo in general practice. Australian
Family Physician. 45(4):190-4.
5. Mohammed, A., Basurrah, et al. (2022) Awareness of benign paroxysmal positional vertigo
among the population of Taif city. World Family Medicine, 20(9): 105-109.
6. Alotaibi, S.S., Alshbiny, M.T., Alsehali, S.A., Hayat, M., Aladhyani, A.N., Aboud, S.
(2020). Knowledge and awareness of benign paroxysmal positional vertigo among Saudi
population: a cross-sectional study. International Journal of Medicine in Developing
Countries, 4(8): 1184- 1190.
7. Kroenke, K., Price, R.K. (1993). Symptoms in the community. Prevalence, classification,
and psychiatric comorbidity. Archive of International Medicine, 8;153(21):2474-80.
33

Etkisinin Belirlenmesi
1 2
1            
esraunal2428@gmail.com
2         -   


 
         

      rolapsus Semptom Skoru ve Prolapsus


Bulgular:        
           
   

          

Organ Prolapsus         

 

 
34
Determining the Effect of Prolapse Stages on Quality of Life
ABSTRACT
Aim: The research was in order to determine the effect of prolapse stages on quality of life.
Methods: A cross-
Outpatient Clinic. The sample of the study consisted of 120 women diagnosed with urogenital
prolapse. Data were collected using questionnaire form, Pelvic Organ Prolapse Symptom Score
and Prolapse Life Quality Scale. Data were evaluated using number, percentage, mean, standard

Results: It was found that the average age of women participating in the research is 53.69 
The area most affected by prolapse quality of life was found to be the domain of general health.
The feeling of something coming down from the vagina was found to be the most disturbing
symptom. The difference between the age, education level, employment status of the women and
the mean scores of Pelvic Organ Prolapse Symptom Score and Prolapse Life Quality Scale were
statistically significant (p <0.05). In the study, as the prolapse stage increased, the score of the
Pelvic Organ Prolapse Symptom Score and Prolapse Quality of Life Scale mean scores increased
statistically (p <0.05).
Conclusion: In the study, it was found that the increase of the prolapse stage increases the
prolapse symptoms and negatively affects the quality of life.
Keywords: Prolapse, women, stages, quality life

     



       

        
    
re 2-


tedir (8).
         
    
     -       

        
 
        

  

  
35

(12-15).
          
         

         
tomlar nedeniyle s

anlamda izole etmektedirler (19).      
   

         
 
        


         belirlemek

- 

00-


 
            
           



Okuma yazma bilen
.

-2), Pelvik Organ
Prolapsus Semptom Skoru (POP-SS) (EK-  -YK) (EK-4)



           
  

36
Prolapsus -
          
            
             




etkilemiyor (1), Hafif etkiliyor (2)
           
-
  

Pelvik Organ Prolapsusu Semptom Skoru (POP-SS)
          
        -   

          

           0.86

- 


dakikada dolduruldu.

          
        testi, One Way Anova ve



etik onay (2019/9-2) (Ek-        izin (Ek-



sadece bu gruba
.
BULGULAR

--
-

37
           
 


     

          



   -     
POP-
 -      - 
         

           
skorun         
          
n ortalama
           

    -SS ve P-    
0.001). -SS ve
P-

        

vermektedir (R=.889, R2
ev       
        
Evresinin,   

38
Tablo 1.     -  
(S=120)
*S=30

Tablo 2.         


Ortalama
Min-Max
POP-SS Toplam
13.88
1-24
P-

74.71
30-100
Prolapsusun Etkisi
53.04
22-88

47.50
20-80

47.00
20-80

47.16
20-80
Evre 1
Evre 2
Evre 3
Evre 4
Toplam
S* (%)
S* (%)
S* (%)
S* (%)
S (%)

26-46
17(56.7)
9(30.0)
11(36.7)
5(16.7)
42(35.0)
47-67
13(43.3)
17(56.7)
14(46.7)
12(40.0)
56(46.7)

0(0.0)
4(13.3)
5(16.6)
13(43.3)
22(18.3)

Okuryazar
0(0.0)
4(13.3)
9(30.0)
19(63.3)
32(26.7)

9(30.0)
11(36.7)
11(36.7)
4(13.3)
35(29.2)
Ortaokul
9(30.0)
8(26.7)
4(13.3)
3(10.0)
24(20.0)
Lise
11(36.7)
6(20.0)
5(16.7)
4(13.3)
26(21.7)

1 (3.3)
1(3.3)
1(3.3)
0(0.0)
3(2.5)


8(26.7)
7(23.3)
5(16.7)
0(0.0)
20(16.7)

22(73.3)
23(76.7)
25(83.3)
30(100.0)
100(83.3)
Gelir Durumu
Gelir giderden az
15(50.0)
10(33.3)
12(40.0)
16(53.3)
53(44.2)
Gelir gidere denk
14(46.7)
20(66.7)
18(60.0)
14(46.7)
66(55.0)
Gelir giderden fazla
1(3.3)
0(0.0)
0(0.0)
0(0.0)
1(0.8)
39

48.50
20-80

58.77
20-80
Uyku/Enerji
37.91
20-80

37.25
20-80
P-
54.60
30.9-81.8
Tablo 3.     -SS ve P-  


POP-SS Toplam Puan
P-

Test ve


Test ve

Prolapsus Evresi
1. Evre


2. Evre


3. Evre

F=103.990

F=72.557
4. Evre

p=0.000

p=0.000
F: One Way Anova test
Tablo 4.        


B
Standart
Hata
Beta
t
p
Sabit
-1.724
0.312
-5.7520
0.000

0.008
0.218
0.089
0.035
0.972

0.024
0.005
0.326
40.505
0.000
Prolapsusun Etkisi
0.013
0.070
0.120
0.181
0.857

-0.007
0.019
-0.115
-0.338
0.736
Fiziksel 
0.000
0.041
0.004
0.006
0.995

0.107
0.274
0.140
0.391
0.696

-0.001
0.030
-0.030
-0.047
0.962

0.007
0.031
0.099
0.233
0.817
40
Uyku/Enerji
0.006
0.021
0.087
0.289
0.773

0.030
0.041
0.403
0.728
0.468
R=.889 R2=.790 F(9,110)=46.020 p=.000

   
         
         



POP---
  
         olan bir grupta POP-SS puan

POP-    -     
       -   
   
a

         
-54.60

 -          
            -YK

            
.
          

            



  ). 

          
         

        

 

             
          
41




         


 
Rzepka

           
            
           



          

       




         ilen
.

1) . Turkiye Klinikleri
Anesthesiology Reanimation-Special Topics. 2018 11(1): 8-17.
2)           
-
30.
3) 
 Turk J Obstet Gyencol. 2014, 11 (3):
176-180.
4)           
Florence Nightingale Hemşirelik Dergisi. 2012, 20(1): 69-79
5) Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M,
Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN,
Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F,
Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG,
Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers
TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng
AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A,
Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey
ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar
42
F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK,
Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell
D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell
BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA,
Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F,
Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London
S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks
R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R,
Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D,
Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB,
Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J,
Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao
M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C,
Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon
JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K,
Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K,
nen R, van
Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA,
Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf
AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA, Memish
ZA. A comparative risk assessment of burden of disease and injury attributable to 67
risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet. 2012, 15;380(9859):2224-60
6) Masenga GG, Shayo BC, Rasch V.Prevalence and risk factors for pelvic organ prolapse
in Kilimanjaro, Tanzania:A population based study in Tanzanian ruralcommunity. PLoS
One. 2018, 13(4): e0195910
7) mlarla
     

8) Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor
disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009, 114(6):1278-83.
9)         
Semptomatoloji. Kafkas J Med Sci. 2017, 7(2):10710.
10) Akter F, Gartoulla P, Oldroyd J, Islam RM. Prevalence of, and risk factors for,
symptomatic pelvic organ prolapse in Rural Bangladesh: a cross-sectional survey study.
Int Urogynecol J. 2016, 27(11): 1753-9.
11) Friedman T, Eslick GD, Dietz HP. Risk factors for prolapse recurrence: systematic
review and meta-analysis. Int Urogynecol J. 2018, 29(1):13-21
12)   

-233.
13) Doaee M, Moradi-Lakeh M, Nourmohammadi A, Razavi-Ratki SK, Nojomi M.
Management of pelvic organ prolapse and quality of life: a systematic review and meta-
analysis. Int Urogynecol J. 2014, 25(2):153-63.
14) Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S. P-QOL: a validated
questionnaire to assess the symptoms and quality of life of women with
urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2005, 16(3):176-81
43
15) Mao M, Ai F, Zhang Y, Kang J, Liang S, Xu T, Zhu L. Changes in the symptoms
and quality of life of women with symptomatic pelvic organ prolapse fitted with
a ring with supportpessary. Maturitas. 2018, 117:51-6.
16) Albayrak A. Kan       
   Journal of Faculty of Theology, Sakarya
University/Sakarya Üniversitesi Ilahiyat Fakültesi Dergisi. 2019, 21(40): 349-76.
17) Panzini RG, Mosqueiro BP, Zimpel RR, Bandeira DR, Rocha NS, Fleck MP. Quality-
of-life and spirituality. Int Rev Psychiatry. 2017, 29(3):263-82.
18)          
 

19) 
         
Kitabevi,2019: 651-60.
20) Cam C, Sakalli M, Ay P, Aran T, Cam M, Karateke A. Validation of the prolapse quality
of life questionnaire (P-QOL) in a Turkish population. Eur J Obstet Gynecol Reprod
Biol. 2007,135(1):132-5.
21) Seven M, 
 TAF Prev Med Bull. 2008, 7(4): 31722.
22) Hagen S, Glazener C, Sinclair L, Stark D, Bugge C. Psychometric properties of the
pelvic organ prolapse symptom score. BJOG. 2009, 116(1): 25-31.
23)     
adaptation of the Pelvic Organ Prolapse Symptom Score and its validity and
reliability. Int Urogynecol J
24) Kudish BI, Iglesia CB, Gutman RE, Sokol AI, Rodgers AK, Gass M O'Sullivan MJ,
Larson J, Abu-Sitta M, Howard BV. Risk factors for prolapse development in white,
black, and Hispanic women. Female Pelvic Med Reconstr Surg. 2011,17(2):80-90
25) Sun Y, Chen H, Liu Y, Jiao R, Yuan J, Zhang X, Liu Z. Conservative interventions for
the treatment of pelvic organ prolapse: A systematic review protocol. Medicine
(Baltimore). 2019, 98(47):e18116.
26) 
 

27) Flores-Espinoza C, Araya AX, Pizarro-Berdichevsky J, Santos V, Ferrer M, Garin O,
Swift Digesu AG. Validation of the Spanish-language version of the Prolapse Quality
of Life questionnaire in Chilean women. Int Urogynecol J. 2015, 26(1): 123-30.
28) Frota IPR, Rocha ABO, Neto JAV, Vasconcelos CTM, De Magalhaes TF, Karbage
SAL, Augusto KL, Nascimento SLD, Haddad JM, Bezerra LRPS. Pelvic floor muscle
function and quality of life in postmenopausal women with and without pelvic floor
dysfunction. Acta Obstet Gynecol Scand. 2018, 97(5): 552-9
29) Shrestha B, Onta S, Choulagai B, Poudyal A, Pahari DP, Uprety A, Petzold M, Krettek
     -seeking practices in relation to uterine
prolapse in a hill district of Nepal. BMC Womens Health. 2014, 14: 20.
44
30)             
reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL)in a
Brazilian population. Int Urogynecol J. 2011, 22(6):751-5.
31) 


32) Lowenstein L, Gamble T, Sanses TV, et al. Sexual function is related to body image
perception in women with pelvic organ prolapse. J Sex Med. 2009;6(8):2286-2291.
doi:10.1111/j.1743-6109.2009.01329.x
33) Rzepka J, Zalewski K, Stefanowicz A, Khullar V, Swift S, Digesu GA. Validation of
the polish version of P-QoL questionnaire. Ginekol Pol. 2016;87:47783.
34) 34) Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Genet T. Validation of the
Amharic version of the Pelvic Organ Prolapse Symptom Score (POP-SS). Int
Urogynecol J. 2019;30(1):149-156. doi:10.1007/s00192-018-3825-x
35) Manchana T, Bunyavejchevin S. Validation of the prolapse quality of life (P-QOL)
questionnaire in Thai version. Int Urogynecol J. 2010;21:98593
45

Psychosocial Adaptation To Pregnancy and The Roles Of The Midwifery
1 2
1sukran.basgol@omu.edu.tr, 0000-0001-
9451-4544
2
yagmurbiray5833@gmail.com, ORCID NO:0009-0008-9968-6781

         
         
        
        Bu derlemede, 
psikososyal uyum ve ebenin rolleri 
     dinamik     
           
         m



     

        
    



Anahtar Kelimeler: 
ABSTRACT
During pregnancy, from implantation to birth, various anatomical, biochemical, physiological
and psychological changes occur in the female body. The basis of these changes is based on the
preparation of the mother for birth and meeting the . Indeed, pregnancy is a process
of adaptation. In this review, psychosocial adjustment to pregnancy and the role of the midwife
are discussed in the light of the literature.
Adaptation in pregnancy is a dynamic concept with no clear boundaries. The woman
interacts with the developing and changing events during the pregnancy. For a healthy
pregnancy, birth and postpartum period, it is very important for the pregnant/family to adapt to
the changes in their lives. While some women easily adapt to the changes that occur due to
pregnancy, some women have difficulty adapting to pregnancy; may experience mild, moderate
and severe affective disorders. As a matter of fact, every woman's feelings and reactions are
different. Even when pregnancy and childbirth are planned; Depending on different variables
such as the healthy development of the baby, the birth phenomenon, coping with the baby, and
new roles, women often experience anxiety and anxiety. The emotions experienced by women
46
can change and develop according to the trimesters. Therefore, midwives who care for pregnant
women should evaluate compliance with pregnant women with validity and reliability scales,
supportive institution protocols should be developed, pregnant women should be given training
on the subject, and appropriate environments should be provided for evidence-based
interventions.
Keywords: Pregnancy, psychosocial adjustment, midwife, care


        -40 hafta olan gebelik


 
   
         


ve ark., 2014).
         


          
        
 

          

 

        
uyumun gel    Davis & Narayan, 2020; Simo ve ark.,

-
          
belirsizlik ve ambivalan duygular   




Potansiyel ev problemleri,

  -kusma, yorgunluk, meme hassasiyeti gibi fiziksel

 gebe olup

          
47
 edilmesidir. Bu trimester sonunda
"Ben gebeyim" (Arslan ve ark., 2019).



usu




 2021).
-

         

          
           
          




Lederman & Wels, 2020).
esterde Gebel-
      


          
 (







Sosyal destek


48

-ekonomik 
         

  

rilmektedir. Sosyal
         
          
      r. Kukreti ve ark. (2022)
 


         

korkusunu azal
-Paternal Adaptasyon
        
            

         

       olarak ifade etmesi uyumu
Lederman & Wels, 2020, Yurdakul ve ark., 2020).

Gebe ve ailesinde psikososyal uyumu etkile  
          

  
         


2019).
        
      - 

      
         


      
 

  

vb) .
49
Kaynaklar

 , 6(1), 179-192.
         

-246.

 gisi, 11(1), 170-182.
          

Ankara.
Choi, W. H., Lee, G. L., Chan, C. H., Cheung, R. Y., Lee, I. L., & Chan, C. L. (2012). The
    
psychosocial adaptation. Journal of Advanced Nursing, 68(12), 2633-2645.
Coskun, A. M., Arslan, S., & Okcu, G. (2020). An Analysis of Pregnancy Perception of
Pregnant Women in Terms of Stress, Demographic and Obstetric Characteristics. Journal
of Education and Research in Nursing, 17(1), 1-9.
           
 -40.
Davis, E. P., & Narayan, A. J. (2020). Pregnancy as a period of risk, adaptation, and resilience
for mothers and infants. Development and Psychopathology, 32(5), 1625-1639.

Factors Associated With Adaptation. Journal of Marmara University Institute of Health
Sciences, 4(4), 200-206.
zeyinin Distres, Depresyon ve
  5(3), 450-9.
Kukreti, P., Ransing, R., Raghuveer, P., Mahdevaiah, M., Deshpande, S. N., Kataria, D., ... &
Garg, B. (2022). Stepped care model for developing pathways of screening, referral, and
brief intervention for depression in pregnancy: A mixed-method study from development
phase. Indian journal of social psychiatry, 38(1), 12.
Lederman, R.P., Wels, K. (2020). Psychosocial adaptation to pregnancy: seven dimensions of
maternal role development. In: Psychosocial Adaptation to Pregnancy. 4th ed. New York:
Springer.
 
rgisi, 8(1), 61-68.
            
-Dergisi, 2(3), 33-42.
               
anxiety and psychosocial adaptation to pregnancy. Archives of women's mental
health, 22, 511-518.
50


             
       
, 17(3), 258-266.
51

1 2
1 sukran.basgol@omu.edu.tr, ORCID NO:
0000-0001-9451-4544
2 
yagmurbiray5833@gmail.com, ORCID NO:0009-0008-9968-6781

Giriş ve Amaç:
            



 
   W   Google F k 201
           
    
SPSS 22,         
,
Bulgular:       %82, 
          kez depremi
 ,       
tir. %80,ise  
     ,,31 olarak bulu   
  ,,
16,,11 ve Sosyal Destek Arama alt boyutu 15,,
 
             

birinci derece          
          
         

Anahtar Kelimeler: 
ABSTRACT
Introduction and Aim: Earthquake is a natural disaster that has multidimensional negative
effects in terms of environmental, economic, physical and social as well as loss of life. It
negatively affects the psychological state of individuals with the stress it causes. In this study,
it was aimed to determine the coping strategies of women of reproductive age with earthquake
stress and the factors affecting it.
Method: This research was designed as descriptive and cross-sectional. Snowball sampling
method was used and 201 women were reached by using Google form over Whatsapp
application. In the study, 'Personal Information Form,' and 'Strategies for Coping with
Earthquake Stress Scale' were used as data collection tools. The obtained data were analyzed
52
using the statistical program SPSS 22,0 (Statistical Package for the Social Sciences). Statistical
significance level was accepted as p < 0,05.
Findings: The mean age of women is 24,,77 (min:18, max:53). Education level of 82,6%
of them is university and above. 66,7% of the participants experienced an earthquake at least
once in their lifetime. 73,6% stated that they did not know whether the building they lived in
was earthquake resistant or not, and 80,6% were found to experience earthquake-related stress.
Strategies for Coping with Earthquake Stress Scale mean score was found to be 44,,31.
The scores for the three sub-dimensions of the scale were found to be 14,,31 for Religious
Coping, 16,,11 for Positive Re-evaluation, and 15,,99 for Seeking Social Support.
Conclusion and Suggestions: In this study, it was determined that almost all of the women
experienced earthquake-related stress, had high levels of coping strategies with earthquake
stress, and had the highest level of positive re-evaluation. In particular, it was found that women
who lost their lives in their first degree relatives due to the earthquake had more strategies to
cope with earthquake stress. Accordingly, it is recommended that all individuals who have not
experienced the post-earthquake period should be spiritually strengthened, supported, and
strategies for coping with stress should be taught.
Keywords: Woman, earthquake, stress, coping

-



de 
         
        
         
 
olumsuzluklardan daha fazla etkilenebilmektedir (Demirci & Avcu, 2021).
         
    
       





        

puanlar

 , uykusuzluk , anksiyete reli psikososyal
         

 
ark., 2021).
53


          
       
          
          

           


).
           


 
        Google F 
WhatsAF
          
WhatsApp kull- 
 
minumum 
1 

kullanmak, okuma-


      istical Package for the Social Sciences)

ortalama ve standart sapma (𝑋 - 
ewness-
           

          
          

        
 
 depreme 
Deprem Stresi  Deprem Stresi 
    
-8-9-
10--12-13-14-15-16/6 Madde), Sosyal Destek
Arama (1-3-4-6-7 / 5 Madd
  
           
kendime sa         
         
54
 
Olumlu 
            
         
        ,85  ,  ,74
   
,79 ,,tur.
BULGULAR
,
,,,
, 
 ,       
   ,     
   deprem nedeniyle b   can
   %80,      
           
deprem nedeniyle birinci derece
           
,05) (Tablo 1).
  


n (%)



F=0,83
p=0,43

6 (3,0)
45,,53
Lise
29 (14,4)
45,,63

166 (82,6)
43,,66
Meslek
F=1,071
p=0,34

25 (12,4)
45,,82

53 (14,9)
44,,56

123 (61,2)
43,,76
Medeni durum
t=-4,027
p=0,087
Bekar
157 (78,1)
43,,85
Evli
44 (21,9)
46,,81

t=0,614
p=0,680
Evet
134 (66,7)
44,,27

67 (33,3)
43,,29
55
   
olma durumu
t=1,073
p=0,637
Evet
100 (49,8)
44,,23

101 (50,2)
43,,30

olma durumu
F=1,932
p=0,148
Evet
30 (14,9)
42,,13

23 (11,4)
42,,37
Bilmiyorum
148 (73,6)
44,,05
Deprem nedeniyle birinci derece
  
t=1,195
p=0,033*
Evet
10 (5,0)
46,,97

191 (95)
44,,15

t=0,108
p=0,572
Evet
162 (80,6)
44,,11

39 (19,4)
44,,96

          olarak
      








14,,31
5-20

16,,11
9-22
Sosyal Destek Arama
15,,99
9-21

44,,31
25-57

         
          
 genel de ise
56
        
           
.
          
       
,depremzedelerle ilgili



        
         

   
   

        
destek arama ve 
           
          
,


         




         


birinci derece          
          
         


KAYNAKLAR
            
differences in psychological effect of the August 1999 earthquake in Turkey. Nordic journal of
psychiatry, 60(5), 387-391.
Alkan, N. U. (1999). 1995 Dinar Depremi. -60.
Bradshaw, S. (2004). Socio-economic impacts of natural disasters: a gender analysis. CEPAL,
32, 10-49.
            
    -
105.
57
 Sosyal
Bilimler Akademi Dergisi, 3(2), 88-103.


Dergisi, 2(25), 10-17.
Li, S., Gillani, A. H., Ibrahim, M. M. I. M., Omer, S., & Fang, Y. (2022). Should we focus more
on teaching and training disaster management in health-care colleges? An insight into the
students' knowledge, attitude, and readiness to practice. Journal of pharmacy and bioallied
sciences, 14(3), 147-156.
Mamun, M. A., Huq, N., Papia, Z. F., Tasfina, S., & Gozal, D. (2019). Prevalence of depression
among Bangladeshi village women subsequent to a natural disaster: a pilot study. Psychiatry
research, 276, 124-128.
Kula, N. 
234-255.
Udomratn, P. (2008). Mental health and the psychosocial consequences of natural disasters in
Asia. International review of psychiatry, 20(5), 441-444.

Stres        
rk Psikiyatri Dergisi,
32(4).
58
 
The Place And Importance Of Spiritual Approach In Nursing
Serpil Tonkal1,Tuba Karabey2
1         
-0002-9469-6007
2         
-0002-2334-6560


 



       




         



ABSTRACT
The concept of spiritualism, which is defined as understanding life, analyzing relations with
oneself and other people, evaluating oneself, and finding the best one, by integrating all of
these within oneself, comes to the fore in many areas today. Therefore, this concept is of great
importance in nursing. With the existence of nursing from the past to the present, the concept
of spiritualism is like the nursing profession. Applications of the concept of spirituality are
used in many areas of nursing practice. Spiritual practices have many mental and mental
contributions to people. It increases the rate of benefit from the care received by the person
and enables the person to overcome the disease process with the least damage. Diseases often
increase spiritual needs in addition to emotional, mental, and physical symptoms. Hope, trust,
love, forgiveness, the need to find the meaning of life, experience, communication,
consolation, religious rituals, prayer, and worship can be defined as spiritual needs. These
requirements are of great importance in nursing care. The purpose of this review is to discuss

Keywords: Spirituality, Nursing care, Spiritual care
59
THE PLACE AND IMPORTANCE OF SPIRITUAL APPROACH IN NURSING
Introduction
The main purpose of nursing is to improve the health status of patients who need help, whose
health status is deteriorated, and whose condition is getting worse, and to ensure that they can
continue their lives (Lotfi et al., 2019; Karaman,2016). In addition to these, not only the
physical health of the patient but also the mental health and needs of the patient should be taken
into consideration (Grover et al., 2020). Looking at nursing care from a holistic perspective, the
concept of wellness in health should also include spiritual well-being (Seaward and Lissard,
2020). Because when a person looks at his structure in general, he has requirements for every
size. Therefore, it is not enough just to correct the disease, that is, it must also be psychologically
good. At the same time, without interfering with the personal life of the person; that is, the
treatment should be completed by preserving the individual's culture, development, life
experience, and beliefs (Miller and Thoresen, 2003; Karaman,2016). The nurse who cares
should not see the practices she does by paying attention to these details as a plus job. Because
a nurse should listen to the spiritual thoughts and concerns of a patient with spiritual feelings
and should see the patient's thoughts as -
Navarro et al., 2021). However, when he/she does this, he/she gives health care to the patient
    
patient independent in meeting basic needs and these needs consist of physiological,
psychological, sociological, spiritual, and intellectual areas. In other words, spiritual care is the
most important part of holistic nursing care and nursing care will be incomplete if these are not
taken into account(Quinn,2002).
Spiritual Approach To Nursing
Spirituality is a concept that does not have a Turkish equivalent but can be defined with the
word spirituality, which is an Arabic word. The definition of spirituality, which is accepted as
the broadest definition, is in the form of inspiration, respect, and submission, deeper than
religious commitment, which seeks meaning and purpose, including those who do not believe
in god (Ledger, 2005). Spiritualism, defined as the unifying force, is the interaction between
the body and the soul. This concept, which is generally known as a religion from past to present,
actually includes religion (Connell MeehanT,2012), Although it does not mean the same as a
religion by definition, it is known that the relationship between them cannot be ignored and it
is beneficial in terms of preventing diseases, speed of recovery, and providing peace for
individuals who are sick. For example, the concept of prayer in religion in accepting and
defeating a disease increases the hope of the patient and plays a major role in the recovery of
the patients we talk more specifically about these, the importance of the health-spiritual
relationship provides great benefits for individuals to prioritize their spiritual values as
consolation and support during the treatment process, to determine the spiritual values in the
interventions to be made and to cope with and overcome stress during the treatment process
(Uygur, 2016).
Spirituality is defined by what we do rather than what we are, and its Latin meaning is to

with life-threatening illnesses forms the basis of their well-being. So here we need to pay more
attention to the importance of holistic care. When we approach the patient in this way, the
patient's acceptance of the disease, acceptance of death, etc. It's easier to go through the stages
(Khorshid and Arslan,2006).
Diseases often increase spiritual needs in addition to emotional, mental, and physical
60

meaning of life, experience, communication, consolation, religious rituals, prayer, and worship
can be defined as spiritual needs. These requirements are of great importance in nursing care
(McEwen, 2005), If the nurse does not take these needs into account in the care process, unmet
spiritual needs will have negative consequences on the patient's well-being. These results
include an increased risk of depression, reduced quality of life, and decreased perceptions of
spiritual well-
During the nursing care process, the patient's personal life, preferences, and habits should
be cared f
these are paid attention to, a solid bond is established between the patient and the nurse. Dec.
Before the care is given, the patient's religious orientations, what he is motivated by, what
creates a bad effect, etc. information should be taken from the patient. When these are known,

The Use Of Spiritual Care In Nursing Practice
After nurses collect the data on values related to the spiritual needs of individuals, they
interpret, analyze and interpret what they have achieved using critical thinking skills. It
determines the nursing diagnosis of the patient in light of the results it finds.
Spirituality-related diagnoses have been on many diagnosis lists since time immemorial.

by the American Nurses Association (ANA) since 1994, as well as in the nursing codes of the
International Nurses Association (ICN). (Accessen and Sivrikaya, 2017). Nurse some questions
may be asked for spiritual diagnostics, for example, what are the reasons that make you strong
and hopeful here, what are the spiritual practices that are important to you, does your location
interfere with your spiritual practices, etc. they are questions. After these questions are asked,
the patient's spiritual needs should be determined and an appropriate care plan should be made
for them. At these stages, it is very important to listen to the patient well, to make eye contact,

patient's self-confidence is broken, hesitates to talk about himself and his beliefs, as a result, it
becomes even more difficult for us to provide holistic care to the patient. While diagnosing the
patient, it is necessary to observe him and analyze his reactions well(Quinn,2002).
There are points to be considered in spiritual nursing care while planning the applications to be
made. These should be done by considering the spiritual needs of the person, the individual
should be supported to use the spiritual resources actively, when the situations that make the
individual uneasy arise, the patient's differences should be understood and respected, and the
individual should be helped to overcome this situation without feeling alone. These should be

The basis of the spiritual care practice is the bond between the patient and the nurse who cares.
Factors that make up this bond include good communication skills, trust, empathy, awareness,
and acceptance of the broad definition of spirituality. The goals of the nurse in meeting their
spiritual care needs are to rest the patient spiritually, to reduce their fears, to reduce their
anxiety, to facilitate their compliance with the treatment, and to make their life meaningful.
(Connell Meehan,2012). Nursing initiatives are very important in meeting the spiritual needs
of individuals. In this process, the symptoms and expressions of distress regarding the spiritual
dimension of the individual should be evaluated, and the patient should be told that emotional
or behavioral reactions such as denial, questioning the cause of suffering, anxiety, uncertainty,
anger, weakness, shame, and guilt, which may occur in the event of a crisis, are normal.
Judgmental attitudes arising from the behavior of the individual should not be exhibited, an
61
empathic approach should be taken, the individual should be encouraged to express his or her
mental state, and therapeutic communication techniques should be used (Meehan,2012). The
individual's spiritual experiences and coping techniques should be looked at in the story of the
individual, an environment that will relax the patient and meet his spiritual needs should be
provided, and he should be supported in this regard. The individual's sources of support should
be determined and it should be ensured that he receives support from them, the hope of the
patient's survival should be maintained, and in this respect, the patient should always be
accessible. Regardless of their religion, the nurse should respect the patient's religion and
support them to live according 
Although the evaluation of the applications made after the nursing attempts are completed and
the conclusion of a conclusion does not sustain the patient's life, it has a great impact. When a
good evaluation is made and the patient is directed in the right way, both successful nursing

the spiritual care she gave during the evaluation phase was effective; he can understand the
results such as confirming that the patient's spiritual needs have been met, accepting the
situation and events the patient is in, stating that he feels better psychologically, increasing his
compliance with treatment. If he concludes that he is not providing effective care, he should
continue nursing care with a different spiritual diagnosis (Erol, 2020).
Conclusion
Spiritual care has a very important place in nursing care and its benefits to nursing care cannot
be ignored, so this area needs to be developed. The most important thing to do in ensuring the
advent of the spiritual approach in nursing is to increase education on this subject, preparation,
and training for spiritual care for experienced nurses should be developed and encouraged,
nurses should observe people experienced in spiritual care and have opportunities to practice
providing spiritual care, managers should review policies related to spiritual care. and should
consider this issue and make evaluation updates.
References
Arslan, H., 
comfort according to the concept development process of Meleis. Maltepe University Journal
of Nursing Science and Art, 2(1), 51-58.
      damentals: science and principles of nursing]
Nursing principles: nursing science and principles. Istanbul: Academy Printing and Publishing;
1136-37.
Cetinkaya, B., Altungag, S., & Azak, A. (2007). Spiritual care and nursing .
Cinar, F., & Eti Aslan, F. (2017). Spiritualism and nursing: The importance of spiritual care in
intensive care patients. Journal of Nursing Academic Research, 3(1), 37-42.
Cinar, F., & Eti Aslan, F. (2017). Spiritualism and nursing: The importance of spiritual care in
intensive care patients. Journal of Nursing Academic Research, 3(1), 37-42.
Connell Meehan, T. (2012). Spirituality and spiritual care from a careful nursing perspective.
Journal of Nursing Management, 20(8), 990-1001.
             
perception of spirituality and spiritual care and some affecting factors. Hacettepe University
Faculty of Nursing Journal, 1(3), 1-12.
           hane University
Journal of Health Sciences, 6(3), 184-190.
-Navarro, E. B., Medina-
at the end of lifeis it necessary? A qualitative approach to the protagonists. International
62
Journal of Environmental Research and Public Health, 19(1), 227.
Grover, S., Dua, D., Sahoo, S., Mehra, A., Nehra, R., & Chakrabarti, S. (2020). Why all
COVID-19 hospitals should have mental health professionals: The importance of mental health
in a worldwide crisis! Asian journal of psychiatry, 51, 102147.
            
spiritual care competencies of nurse academicians. Journal of Health Sciences and Professions,
6(2), 380-389.
Kavak,                
spiritual care. Annals of Health Sciences Research, 3(1), 21-24.
Khorshid, L., & Arslan, G. G. (2006). Nursing And Spiritual Care. Journal of Ege University
Faculty of Nursing, 22(1), 233-243.
Lotfi, M., Zamanzadeh, V., Valizadeh, L., & Khajehgoodari, M. (2019). Assessment of nurse
patient communication and patient satisfaction from nursing care. Nursing open, 6(3), 1189-
1196.
McEwen, M. (2005). Spiritual nursing care: state of the art. Holistic Nursing Practice, 19(4),
161-168.
Miller, W. R., & Thoresen, C. E. (2003). Spirituality, religion, and health: An emerging research
field. American psychologist, 58(1), 24.
Narayanasamy A. (2002) Spiritual Coping Mechanisms in Chronically Ill Patients. British
Journal of Nursing 11(22):1462
Ozer, D., & Pasinlioglu, T. (2022). Spirituality in the Conceptual Framework of Nursing.
Proceedings Book, 118-124.
Seaward, B. L., & Lissard, C. (2020). A spiritual well-being model for the healing arts. Journal
of Holistic Nursing, 38(1), 102-106.

Health Sciences, (3), 187-191.
Uygur, D. (2016). Determining the nurses' perception of spirituality and spiritual care and
examining the relationship between them and job satisfaction (Master's thesis, Institute of
Health Sciences).
Erol, F (2020) Spiritual minister reflected in the nursing process JOINIHP. 1(1) 30-39
Meehan, T. C. (2012). The Careful Nursing philosophy and professional practice model.
Journal of Clinical Nursing, 21(19pt20), 2905-2916.
63

Sarcopenia and Exercise in the Elderly
1,2
1,2 Uzman Fizyoterapist, 
, semahisen@gmail.com , 0000-0001-9434-7627




    

biyoelektrik impedans
          

        


ile kombine ed      
           
in

          

gerekmektedir.      

Anahtar kelimeler: 
ABSTRACT
Today, the elderly population is increasing. With aging, changes occur in the muscle
structure of the individual. The changes that occur with aging affect the activities of daily living
of the elderly and reduce the quality of life. Sarcopenia is one of the common geriatric
syndromes in the elderly. Deceleration in movements and decline in cognitive functions are
observed due to the decrease in muscle mass of the individual with aging. Different methods
are used to diagnose sarcopenia. These include bioelectrical impedance analysis and muscle
strength and physical activity assessment. It is seen that the presence of sarcopenia in elderly
individuals is between 9.0% and 40.4%. Many risk factors (gender, physical inactivity,
malnutrition, hormones, etc.) have been identified for the development of sarcopenia. There is
no basic treatment method for sarcopenia. One of the most important options to prevent
sarcopenia in the elderly is physical activity and exercise. Exercise programs combined with
adequate nutrition have a great role in preventing sarcopenia. Especially aerobic and resistance
exercises have great importance in improving resistance to sarcopenia by increasing muscle
strength and mass. Therefore, it should be aimed to increase the resistance of elderly individuals
against sarcopenia with appropriate exercise programs.
In conclusion, sarcopenia is a global problem that progresses with aging. In the diagnosis of
sarcopenia, muscle strength, mass and performance should be evaluated with appropriate
64
methods. Awareness should be raised that the implementation of exercises in elderly individuals
is important for improvements in quality of life.
Keywords: aging, sarcopenia, aerobic exercise, resistance exercises

        
          -iskelet
.
nde

.

Sarkopeni de bunlardan bir tanesidir (Distefano & Goodpaster, 2018).
Sarkopeni

(Cruz-
Jentoft et al., 2019)       

         
 (Abellan van Kan, 2009)       

          
 (Janssen et al., 2002)       
        
(Cruz-Jentoft et al., 2010).
          
i yoktur.

.
           

          
 beklenmektedir(Cruz-Jentoft et al., 2010) (Martone et al., 2020).
          

(Simsek et al., 2019).

           
(Morley, 2016).
     
(Frankel et al., 2006).
65

           
        
(Kwon et al., 2019).
 3,5 olan 21
            
           
       
(Huang et al., 2022).


(Frontera et al., 1988).
Pre-
         
(Vikberg et al., 2019).

        

           
(Beaudart et al., 2017).
-
         
        
          
(Lu et al.,
2021).

         
(Cruz-Jentoft et al.,
2014).

        alitesini,

            


          

      
         

         


66
KAYNAKLAR
Abellan van Kan, G. (2009). Epidemiology and consequences of sarcopenia. JNHA-The
Journal of Nutrition, Health and Aging, 13, 708-712.
Beaudart, C., Dawson, A., Shaw, S. C., Harvey, N. C., Kanis, J. A., Binkley, N., Reginster, J.
oli, R., Cooper, C., & Dennison, E. M.
(2017). Nutrition and physical activity in the prevention and treatment of sarcopenia:
systematic review. Osteoporos Int, 28(6), 1817-1833. https://doi.org/10.1007/s00198-
017-3980-9
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin,
F. C., Michel, J.-P., Rolland, Y., & Schneider, S. M. (2010). Sarcopenia: European
consensus on definition and diagnosisReport of the European Working Group on
Sarcopenia in Older PeopleA. J. Cruz-Gentoft et al. Age and ageing, 39(4), 412-423.
Cruz-
Landi, F., Rolland, Y., & Sayer, A. A. (2019). Writing Group for the European Working
Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for
EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age
Ageing, 48(1), 16-31.
Cruz-Jentoft, A. J., L
Fielding, R. A., Martin, F. C., Michel, J. P., Sieber, C., Stout, J. R., Studenski, S. A.,
Vellas, B., Woo, J., Zamboni, M., & Cederholm, T. (2014). Prevalence of and
interventions for sarcopenia in ageing adults: a systematic review. Report of the
International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing, 43(6), 748-759.
https://doi.org/10.1093/ageing/afu115
Distefano, G., & Goodpaster, B. H. (2018). Effects of exercise and aging on skeletal muscle.
Cold Spring Harbor perspectives in medicine, 8(3), a029785.
Frankel, J. E., Bean, J. F., & Frontera, W. R. (2006). Exercise in the elderly: research and
clinical practice. Clinics in geriatric medicine, 22(2), 239-256.
Frontera, W. R., Meredith, C. N., O'Reilly, K. P., Knuttgen, H. G., & Evans, W. J. (1988).
Strength conditioning in older men: skeletal muscle hypertrophy and improved function.
Journal of applied physiology, 64(3), 1038-1044.
Huang, Y., Han, J., Gu, Q., Cai, Y., Li, J., Wang, S., Wang, S., Wang, R., & Liu, X. (2022).
Effect of Yijinjing combined with elastic band exercise on muscle mass and function in
middle-aged and elderly patients with prediabetes: A randomized controlled trial. Front
Med (Lausanne), 9, 990100. https://doi.org/10.3389/fmed.2022.990100
Janssen, I., Heymsfield, S. B., & Ross, R. (2002). Low relative skeletal muscle mass
(sarcopenia) in older persons is associated with functional impairment and physical
disability. Journal of the american geriatrics society, 50(5), 889-896.


. (2005). Sağlıklı Yaşlanma ve Egzersiz, Hacettepe Üniversitesi Fizik Tedavi
ve Rehabilitasyon Yüksekokuluti.
  Turk Kardiyol Dern Ars,
45(5), 1-4.
Kwon, I., Kim, J. S., Shin, C. H., Park, Y., & Kim, J. H. (2019). Associations Between Skeletal
Muscle Mass, Grip Strength, and Physical and Cognitive Functions in Elderly Women:
Effect of Exercise with Resistive Theraband. J Exerc Nutrition Biochem, 23(3), 50-55.
https://doi.org/10.20463/jenb.2019.0023
Lu, L., Mao, L., Feng, Y., Ainsworth, B. E., Liu, Y., & Chen, N. (2021). Effects of different
exercise training modes on muscle strength and physical performance in older people
67
with sarcopenia: a systematic review and meta-analysis. BMC Geriatr, 21(1), 708.
https://doi.org/10.1186/s12877-021-02642-8
Martone, A. M., Marzetti, E., Salini, S., Zazzara, M. B., Santoro, L., Tosato, M., Picca, A.,
Calvani, R., & Landi, F. (2020). Sarcopenia identified according to the EWGSOP2
definition in community-living people: prevalence and clinical features. Journal of the
American Medical Directors Association, 21(10), 1470-1474.
Morley, J. E. (2016). Frailty and sarcopenia in elderly. Wiener klinische Wochenschrift, 128,
439-445.

       Türk Geriatri
Dergisi, 8(2), 84-88.
Simsek, H., Meseri, R., Sahin, S., Kilavuz, A., Bicakli, D. H., Uyar, M., Savas, S., Sarac, F., &
Akcicek, F. (2019). Prevalence of sarcopenia and related factors in community-dwelling
elderly individuals. Saudi medical journal, 40(6), 568.
Vikberg, S., S
(2019). Effects of Resistance Training on Functional Strength and Muscle Mass in 70-
Year-Old Individuals With Pre-sarcopenia: A Randomized Controlled Trial. J Am Med
Dir Assoc, 20(1), 28-34. https://doi.org/10.1016/j.jamda.2018.09.011
68

1
1

         
  
 

          
 Bu anlamda  


Anahtar kelimeler: yoga, 
ABSTRACT
Coronavirus is a large family of viruses that are common in nature and start as mild infections
similar to the common cold in humans, causing damage to the lungs and leading to respiratory
failure, leading to fatal diseases. Yoga is an approach that affects the mental, mental and
emotional well-being of individuals as well as physical development, reduces inflammatory
markers and affects markers of virus-specific immune response. In this sense, our study is
important in terms of expressing the importance of yoga, which is a simple and useful home-
based practice for the prevention of coronavirus transmission and post-recovery management.
Keywords: yoga, coronavirus, immune system
Covid-

       -MERS ve Acute
Respiratory Syndrome-         

-

           
           






etkeni olan SARS-COV-       

   
           
  -CoV-      bilinmektedir. Fakat
69



          

        
-inflamatuar
    -   
-


      lde pro-inflamatuar ACE1 sistem etkilenimine
sebebiyet vermektedir [4, 5].
          
   




           
  
          
  

           

ruhsal, zihinsel ve duygusal iyilik halleri ile de ilgilenir [8].

          

        
gelmesini i         


          
          
        

        
kayropraktik

-
          
           
   

70

         

 





         


  
          5 adet Hatha yoga
pozunu 
          

Asana-
kardiyorespi        
            

        
       
        
12]. Pranayama ve meditasyon pratiklerinin bireylerin depresyon ve anksiyete
         

fizy
-diastolik kan
          


            
        
        
    


         
          -

boyunc-pranayama uygulanan
-
          
uy         

71
-beden terapileri, akut
ve kronik stres etkenleri, sempatik sinir sistemi ve Hipotalamus-hipofiz-

          


Covid-19 ve Yoga

y


             
-

 
           
 Nitrik oksitin      
-     
solunum ve nitrik oksidin SARS-CoV-      
          
    -    

           
         
      
           
-

        
      -  



    
Yoga terapisinin, s-RII ve IL-1RA ve stresle
 
edir.
KAYNAKLAR
1.          -19 ve Fiziksel

143-146 . Retrieved from https://dergipark.org.tr/tr/pub/ikcusbfd/issue/55773/742615
2. Hoffmann, M., Kleine-
 C., &
-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and
Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271280.e8.
https://doi.org/10.1016/j.cell.2020.02.052
72
3. Henry, B. M., Vikse, J., Benoit, S., Favaloro, E. J., & Lippi, G. (2020).
Hyperinflammation and derangement of renin-angiotensinaldosterone system in
COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and
microvascular immunothrombosis. Clinica Chimica Acta, 507, 167-173
4. 9). Nefesten Solunuma

5. Kenyon, C. (2020). The Forrest Gump approach to preventing severe COVID-19
reverse the predisposing pro-inflammatory state with exercise. Microbes and infection.
6. Karunaratne, H. K. B. M. S. Yoga Therapy for Immunomodulation (Prevent & Cure) of
COVID-19.
7. Basavaraddi, DI, (tarih yok), Yoga: Its Origin, History and Development.
8. -153.
9. ki Asana, Pranayama ve Meditasyonun Beyin

53(2).
10. Chanavirut, R., Khaidjapho, K., Jaree, P., & Pongnaratorn, P. (2006). Yoga exercise
increases chest wall expansion and lung volumes in young healthy Thais. Thai J Physiol
Sci, 19(1), 1-7.
11. Harinath, K., Malhotra, A. S., Pal, K., Prasad, R., Kumar, R., Kain, T. C., Rai, L., &
Sawhney, R. C. (2004). Effects of Hatha yoga and Omkar meditation on
cardiorespiratory performance, psychologic profile, and melatonin secretion. Journal of
alternative and complementary medicine (New York, N.Y.), 10(2), 261268.
https://doi.org/10.1089/107555304323062257
12. Girodo M. Yoga meditation and flooding in the treatment of anxiety neurosis. J Behav
Ther Exp Psychiatry. 1974; 5(2):157-60.
13. Kozasa, E. H., Santos, R. F., Rueda, A. D., Benedito-Silva, A. A., De Ornellas, F. L., &
Leite, J. R. (2008). Evaluation of Siddha Samadhi Yoga for anxiety and depression
symptoms: a preliminary study. Psychological reports, 103(1), 271274.
https://doi.org/10.2466/pr0.103.1.271-274
14.              
         
    ri Dergisi , 12 (1) , 25-32 . Retrieved from
https://dergipark.org.tr/tr/pub/gbesbd/issue/28036/298384
15. Trakroo, M., Bhavanani, A. B., Pal, G. K., Udupa, K., & Krishnamurthy, N. (2013). A
comparative study of the effects of asan, pranayama and asan-pranayama training on
neurological and neuromuscular functions of Pondicherry police trainees. International
journal of yoga, 6(2), 96103. https://doi.org/10.4103/0973-6131.113398
16. Purdy, J. (2013). Chronic physical illness: A psychophysiological approach for chronic
physical illness. Yale Journal of Biological Medicine, 86, 1528
17. Morgan, N., Irwin, M. R., Chung, M., & Wang, C. (2014). The effects of mind-body
therapies on the immune system: meta-analysis. PloS one, 9(7), e100903.
https://doi.org/10.1371/journal.pone.0100903
18. Riley, K. E., & Park, C. L. (2015). How does yoga reduce stress? A systematic review
of mechanisms of change and guide to future inquiry. Health Psychology Review, 9,
379396.
19. Karunaratne, H. K. B. M. S. Yoga Therapy for Immunomodulation (Prevent & Cure) of
COVID-19.
73
20. Shah, K., Adhikari, C., Saha, S., & Saxena, D. (2022). Yoga, immunity and COVID-
19: A scoping review. Journal of family medicine and primary care, 11(5), 16831701.
https://doi.org/10.4103/jfmpc.jfmpc_2182_21
21. Nagarathna, R., Nagendra, H. R., & Majumdar, V. (2020). A perspective on yoga as a
preventive strategy for coronavirus disease 2019. International Journal of Yoga, 13(2),
89.
22. Bushell, W., Castle, R., Williams, M. A., Brouwer, K. C., Tanzi, R. E., Chopra, D., &
Mills, P. J. (2020). Meditation and yoga practices as potential adjunctive treatment of
SARS-CoV-2 infection and COVID-19: a brief overview of key subjects. The Journal
of Alternative and Complementary Medicine, 26(7), 547-556.
74
Psikolojik 
1
1-0002-1546-5340

      
       

Rousseau, 2004

   
         
           

         
         


bozuldu

Anahtar Kelimeler: 

        
        
       
  
           
  
          
         
i informal
         
          
          
   


Psikolojik szleme, rgtle      
            
szlemedir.
75
Psikolojik Szlemenin zellikleri
         


re de
rgtle birey ar
Biimsellikten ziyade, informel ve ilikisel zellie sahiptir.
z konudur ve zamanla deiime u
ok duygusal beklentiler ve ykmllkler ierir.

         




        
        
       


        




belirtebilir.
       

        
        



y

          
           
         

İşlemsel Sözleşme: rgtsel amaekletirilmesi, rgtsel hedeflere ula
iin gerekli olan ilemlerin yrtlmesine fiziksel, bili     
gerekleri ile szlemeden doan ykmllkleri yerine getirmesi ilemsel szlemenin
gere         
getirmeleri beklenir. belirlenen ileri yapmakdurumdan vazife rtmamak
76
ve iletmenin uzun dnem geleceine deil      ten
nce haber verme, rakipleri desteklememe, bilgilerini iletmeden saklamama ve
belli bir sre t etmeyi kapsar.
İlişkisel Sözleşme: rgte kar Biz duygusurgt-
ye ama benzerliimesleki gelime ve iletiimde adalet nemlidir. Yksek
performans iin aba gsterme, rglastermeyi kapsar.
Psikolojik szleme kar zlerden
dnmeleri ve kar  zle
verilir. Daha ok , iletmenin ilemsel szle  
durumlarda ortaya        
ortaya u dnlr. Uyumsuzluznden dnme
dali bir ekilde de ortaya  olabilir.
Psikolojik Szleme hlali
        
          
         
        



ieri , parasal d grl 
         






          












Argyris,C. (1960), Understanding organizational behavior, Homewood, IL: Dorsey Press.
     
        Sosyal
77
Bilmler Enstitüsü, Turizm İşletmeciliği ve Otelcilik Anabilm Dalı, Doktora Tezi,
Erzurum.
Örgütlerde Yönetsel Yaklaşımlar, 
Levinson H., Price, C., Munden, K., Mandl, H. Ve Solley, C.(1962), Men, management and
mental health, Cmabridge, MA., Harward University Press.
Mao, H.; Liu,X. Ve Ge, H. (2008), Evading tactics of psychological contract violations, Asian
Social Science, 4(11).
Morrison, E.W. ve Robinson, S.L. (1997), When employees feel betrayed: A model of how
psychological contract violation develops, Academy of Management Review, 22(1).
Robinson, S.L. ve Morrison E.W.(2000), The development of psychological contract breach
and violation: A longitudinal study, Journal of Organizational Behaviour, 21(5)
Rousseau, D.M. (2004), Psychological contracts in the work place:Understanding the ties that
motivate, Academy of management executive, 18(1).
Schein, E.H. (1965), Organizational psychology, Englewood Cliff, NJ.Prentice Hall.
78

1
10000-0002-1546-5340

           
          
 
 


           
         

         
    

Anahtar Kelimeler: 

        
       
         abet
          



        
, 2005: 517).
        

       

   


    
  


         

79


         
          
 
       


   
        lan
       
         
       
o

         

          
olabilmektedir.
        

        

  
       


 
 

             
ola

-25) en



        
 
        
       
        
        

          

80


         
      
de         
        

         
        
          
          





Sosyal Ekonomik Araştırmalar Dergisi, 12(23).
Garrow, V., (2016) Presenteeism, A rewiev of current thinking, Institute for Employment
Studies, Report no:507. Brighton, United Kingdom.
Higginbottom, K. (2018), The price of presenteeism, Forbes.
International Journal of Social Sciences and Humanity Studies, 6(1).
Meerding, W.J. , Ijzelenberg, W. Koopmanschap, M. A., Severens, J.L. ve Burdorf, A.(2005),
Health problems lead to considerable productivity loss at work among workers with
high physical load jobs. Journal of clinical epidemiology, 58(5).
        Effects Of Presenteeism Syndrome On
Employees. Burnout Levels.
81

1
10000-0002-1546-5340

          
        
         
 
        

          


        

          
          
etkileyebilirler.
Anahtar Kelimeler: 

         

erisine giren
          
         

    

        

         
   

       
           j,

  
        
k         
          
         
82
           
  
           





herhang
         

Di Battista, 1996; Jermier, 1988). Faaliyetlere za


   

          

        
         
         
    

-Kelley vd., 1996; Baron vd.,
- 568), misilleme
(Skarlicki ve Folger, 1997: 434-ess, 2000),
a-- Kelley, 1998), sabotaj (Taylor ve Walton, 1971;
Dubois, 1979; Giacalone ve Rosenfeld, 1987; Crino, 1989-1994; Di Battista, 1991-1996;


          



          
    

          



almaz.

        

83
Güce Sahip Olmama; 
             
          
sahip 
Battista, 1991).
Hayal Kırıklığı;        
       

ve Spector, 1987; Taylor ve Walton,1971).
İşleri Kolaylaştırma Düşüncesi; 
       
            

Sıkıntı ve Eğlence Düşüncesi; bire


(Crino, 1994: 317).
Adaletsizlik Algısı;       
         
        ik bir gayret

Crino ve Leap, 1989; Di Battista, 1996; Neuman ve Baron, 1998; Skarlicki ve Folger,1997;
meyen, terfi durumu ihmal edilen,
 
           


          
          

         
         
    
          
         


           


          

          
        
84
       


           
             

       

 

     
etmeye daha fazla 


 
        
 
     


         

          
         
        

       
        
       


 
Journal of Management, 24(3), 391419.
H.Ü.
İktisadi ve İdari Bilimler Fakültesi Dergisi, 27(1).
Analoui, F. (1995). Workplace sabotage: its styles, motives, and management. Journal of
Management Development, 14,48-65.
Baron, R. A., J. H. Neuman and D. Geddes (1999) Social and Personal Determinants of
Workplace Aggression: Evidence for the Impact of Perceived Injustice and the type A
Behavior Pattern, Aggressive Behavior, 25(4),
Chen P.Y. and P.E. Spector(1992) relationship of work stressors with aggression, withdrawal,
theft and substance use: an exploratory study, Journal of Occupational and
Organizational Psychology, 65(3), 177184.
85
Crino, M. D. (1994). Employee Sabotage: A Random or Preventable Phenomenon? Journal of
Managerial Issues, 6.
Crino, M. D. ve Leap, T. L. (1989). What hr managers must know about employee sabotage.
Personnel, 66(5), 31-38.
DiBattista, R. A. (1996). Forecasting sabotage events in the workplace. Public Personnel
Management, 25, 41-52.
Dubois, P. (1979). Sabotage In Industry. Harmondsworth, Middlesex, UK.: Pelican. 224.
Greenberg, J. (1982) Approaching equity and avoiding inequity in groups and organizations.
ın j. greenberg & r. l. cohen (eds), equity and justice in social behavior. New York:
Academic Press. 389-435.
Greenberg, J. (1986). Determinants of perceived faimess of performance evaluations. Journal
of Applied Psychology, 71, 340-342.
Greenberg, J. (1990a). Employee theft as a reaction to under
of pay cuts, Journal of Applied Psychology, 75,
Greenberg, J. (1993b). The Social Side of Faimess: Interpersonal and Informational Classes of
Organizational Justice, in R. Cropanzano (ed.), Justice in The Workplace: Approaching
Faimess in Human Resource Management, Englewood Cliffs, NJ: Erlbaum, 79-103.
Greenberg, J. ve Baron, R.A. (2003). Behavior in organizations: understanding and managing
the human side ofwork. 18th Edition, Prentice-Hall, Upper Saddle River. 691.
Greenberg, J., ve Alge, B. J. (1998). Aggressive reactions to workplace injustice. In R. W.
  -Kelly, & J. M. Collins (Eds.), Dysfunctional behavior in
organizations, Part A: Violent and deviant behavior. London: JAI Press. 83-117.
Robinson, S.L. and A.M. O' Leary-
  Academy of Management
Journal, 41(6).
            ja
Ömer Halisdemir Üniversitesi İktisadi ve
İdari Büimler Fakültesi Dergisi, 12 (2), 252-263.
86
a
1
1-0002-1546-5340
 
Muhtar Kent



uyumunu ele a


           

            
  

Anahtar Kelimeler: 


            
         
        

          

       
           
normlar ve    
    
          
    
          
2012).
         

           


         

87





            


          
         
Genel anlamda
          


       
mesafeleri 

          


 


          

        
        


b
  


     
benzeri negatif etkilerini azalt       
            

          
          
  nlamda daha



         
        

88
         

          

   

           
  
t-

          belirli bir grubun
         

Maznevski, 2000).

        

          
 
            sel

          




           
ktir.
         




         
.Christopher Earley


 



            
         
89
   


 



           

           


   

 
          



   
          
          


davranma ye
          
       ek gibi


           
 

           




         




90
 
           
         

         
          

 yerine,


          





 

          ,


Uyumlu (The Chameleon) Tipler: 
         

           
halktan daha iyi 
olarak bilgi ve becerilerinin sonucudur.
           
         


         
 

         
yeten
           




91
         
         
          

         







          
        
 





Alon, I,. ve Higgins, J. M.(2005). Global leadership success through emotional and cultural
intelligences, Business Horizons, 48: 501-512.
Ang, S. Dyne, L. V., Koh, C., ve Chandrasekar, N. A. ( 2007). Cultural Intelligence: Its
Measurement and Effects on Cultural Judgment and Decision Making, Cultural
Adaptation, and Task Performance, Management and Organization Review, 3, (3): 335-
371.
         

Earley, P. C., ve Mosakowski, E. (2004). , Harvard Business Review.
Gardner, H. (1983). Frames of Mind: Theory of multiple intelligences. Fontana Press,
Gottfredson, L. S.(1997). Mainstream science on intelligence: An editorial with 52 signatories,
history, and bibliography. Intelligence, 24,(1):1323.
Harris, M.M. (2006). Cultural skill: an emerging construct for the 21st century, Global Forum,
43, (3).

Legg, S,.ve Hutter, M.,A. (2007). Collection of Definitions of Intelligence,Technical Report,
29.
Maznevski, M. (2006). Leading with cultural intelligence,
http://www.ft.com/cms/s/0/eb76e076-d93f-11db-
9b4a000b5df10621,dwp_uuid=5bd47902-91db-11db-
Tarihi: 06.06.20023).
92
Sternberg, R. J. (1997). Sucesfull intelligence. New York: Plume.
Thomas, D. C., ve Inkson, K. (2005). Cultural Intelligence: people skills for a global workplace.
Consulting to Management, 16, (1).
Tan, J.S., (2004). Issues & observations: cultural intelligence and the global economy,
Leadership in Action, 24,(5): 19-21.
Triandis, H. C. (2006). Cultural intelligence in organisations, Group& Organisations
Management, 31, (1)
        competent organization, Ivey
Business Journal Feature Article.
            
(2), :147 168
93

1Necibe Damla 
1-0002-1546-5340


          
          


  olumsuz durumları ifşa etme eylemi   
      




Anahtar Kelimeler: 

           

mewood,
          



kimi zaman ispiyoncu, muhbir gibi olumsuz kavramlarla nitelendirilebilmektedir
         




         
olumsuz etkilemektedir (Bowen, Call ve Rajgopal,2010).
         
          


   


          

94
          
a susmak yerine
              
          
           
            
         
         

           
        
            
edilmektedir.
       

         
-
 
        

sorun bildirm    

      
           

-Whistleblowing-
          



            
          Lai,
2014).

  

 








eylemdir.
95
      



          



a





 
             
 
   
-- 


          


     
etkisinin bulund          
           

     
         fark eder, keşfeder,

   a bir değerlendirmede   karar  
tepki 

        
           
         
ola          

(Jubb, 1999: 3-10).
         
           
hi ve
Newdick,2009: 39; Nam ve Lemak, 2007: 40-
          


96
   




ar verebilecek ahlaki
             
          
         

           
         


        
  
          


vermektedirler.
eyen nadir kurumsal
mekanizmalardan biridir (Biegelman ve Bartow, 2006: 254-255). Sorun bildirme

            
          
Cooper-WorldCom, Coleen Rowley-FBI ve Sherron Watkins-  

   
    -      
pozisyonu ile; Sims ve Keenan (1998) cinsiyet ile; Tava  

  




   
        



proak           

       ya da kesin olmayan
          

        
     
97

etme) ancak ilgililerin        
 
           
Atalay, 2010)

            

          

-whistleblowing- kavra
            

ma olumsuz
 -whistleblowing-       

 
         
   




Mercek Dergisi,
Appelbaum, S., Iaconi, Giulio, D. ve Matousek, A. (2007), Positive and negative deviant
workplace behaviors: causes, ımpacts, and solutions, corporate governance, 7:5.
          Anadolu
Üniversitesi Sosyal Bilimler Dergisi, 2(2).
Dünyada ve türkiye’de iş etiği ve etik yönetimi


exploring the role of       
Journal of Occupational and Organizational Psychology, 83.
-Journal of Business Ethics, 81(3).
le-blowing: target firm characteristics and
The Accounting Review, ,4

study of mainland chinese mba students, Managerial Auditing Journal, 17:9,
Endüstri İlişkileri ve İnsan Kaynakları Dergisi,
16(2)
98

    İstanbul Üniversitesi İşletme Fakültesi Dergisi,
43(1).
İş Ahlakı Dergisi, 5 (2).
         
Dokuz Eylül Üniversitesi Sosyal Bilimler Enstitüsü Dergisi,14 (2).
Madencilik Dergisi,44 (4).
Hersh, M.A. (2002), Whistleblowers-     
responsibility for ethical behaviour, Annual Reviews in Control, 26, s.243-262.
İş dünyası sözlüğü
 Journal of
Business Ethics, 21(1).
Lacayo, R. ve Ripley, A. (2002), Persons of the year 2002: The whistleblowers, Time, 30.
Landman, W. (2005) whistle-blowing program best practice some policy considerations for
the global fund, Ethics Institute of South Africa Publications, 3.
Lewis, D. 
british and south african legislation, Managerial Law, 3.

results of a survey of prEducation and the
Law, 13 (3)
            etik
Eskişehir Osmangazi Üniversitesi Sosyal Bilimler Dergisi, 11(2).
, A. ve Ulu, S. (20102), Çalışma yaşamında sorun bildirme sistemi, çalışma
yaşamında davranış: güncel yaklaşımlar     

The Influence of Organizational Justice on Accountant Whistleblowing, Accounting,
Organizations and Society, 35, s.707-717.
Tavakoli, A., Keenan, J. P. ve Karanovic, B. (2003), Culture and whistleblowing: an empirical
study of croatian and united states ma
Journal of Business Ethics, 43, s.49-64.
99

Eda AKKAYA*, Fatma Sena AKPOLAT**
          

0009-0003-8708-7558, 0009-0008-9510-3999, 0009-0003-5651-6882, 0000-0002-0294-6380

 D 

         e
        
          

         

   
        
        
gerekmektedir.
Anahtar Kelimeler: Depresyon, D vitami
ABSTRACT
Introduction and Objective: Vitamin D is a fat-soluble vitamin synthesized in the skin
through sunlight exposure and has multiple functions in the human body. Recently, low levels
of vitamin D have been associated with schizophrenia, depression, psychotic symptoms, and
alcohol use in adults, and with attention deficit hyperactivity disorder (ADHD) in children. The
aim of this review is to examine the relationship between vitamin D and depression in light of
current literature. Within the scope of this review, 34 articles focusing on the association
between vitamin D and depression were examined. The literature presents conflicting results
regarding the relationship between vitamin D deficiency and depression. While there are studies
suggesting that vitamin D supplementation may lead to a decrease in depression symptoms and
have a therapeutic effect in antidepressant treatments, there are also studies that fail to provide
evidence for these effects. To clarify the controversial points, further randomized controlled
trials with large sample sizes are necessary.
Keywords: Depression, vitamin D, serum vitamin D levels, vitamin D deficiency
100

          

     
 


-10
-
        
gastrektomi, 25-hidroksilasyon defekti, kro   
   

bireyler, D vitamin       
2019).
           
        


   
         

         


         
  
(Oliveira ve ark., 2018)
D Vitamini Nedir?
           

- 

2 ve D3 2 bitkisel
3 
2017).

          

vitamini takviyesi ve UVB radyasyonuna maruz kalma yoluyla elde edilebilir. (Grant ve ark.,
2015).
       -   
              
vitamini ta
101

           

 
2022)


1 Adet yumurta (50 g)
25 IU
 margarin
20 IU

20 IU

500-1000 IU

100-250 IU

100 IU

-

   3     
  2  

 17). D vitamini sentezinin




   
           
   



-
           



  -hidroksilasyon defekti), kronik
        
102
     - 
            
        
      
           

            
    Osteomalazisi

  
           


   
  


-
     (DSM-V, 2013     
          

 

         
  
        

 
-
l, 2011).
Depresyonun Etiyolojisi
          
       
 

          
         

            
          


         


          

103

Depresyon 
        

        


  

-


           

           

         
  







.


          


          

         
         


Kaynaklar
Alexopoulos, G. S. (2005). Depression in the elderly. The lancet, 365(9475), 1961-1970.
Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in
adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100-7. doi:
10.1192/bjp.bp.111.106666. PMID: 23377209.
104
A. P. Association. (2013). Diagnostic And Statistical Manual Of Mental Disorders Dsm-5.


-47.
      esyon ve D Vitamini, Bes Diy Derg,
2015:43(2):160-165.
Black, L. J., Jacoby, P., Allen, K. L., Trapp, G. S., Hart, P. H., Byrne, S. M., ... & Oddy, W.
H. (2014). Low vitamin D levels are associated with symptoms of depression in young adult
males. Australian & New Zealand Journal of Psychiatry, 48(5), 464-471.

Family Physician, 10(1), 35-42.
de Oliveira, C., Hirani, V., & Biddulph, J. P. (2018). Associations between vitamin D levels
and depressive symptoms in later life: evidence from the English Longitudinal Study of
Ageing (ELSA). The Journals of Gerontology: Series A, 73(10), 1377-1382.
de Koning, E. J., Lips, P., Penninx, B. W., Elders, P. J., Heijboer, A. C., den Heijer, M., ...
& van Schoor, N. M. (2019). Vitamin D supplementation for the prevention of depression
and poor physical function in older persons: the D-Vitaal study, a randomized clinical trial.
The American journal of clinical nutrition, 110(5), 1119-1130.
Ersoy, N., & Ersoy, G. Vitamin D deficiency and Depression: What Can We Do?. Hacettepe
University Faculty of Health Sciences Journal, 4(3), 1-14.
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of
the     -hydroxylase in human brain. Journal of chemical
neuroanatomy, 29(1), 21-30.
   
-7.
          

          
Epidemiyolojisi, Journal Of Con-66.
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and
prevention. Rev Endocr Metab Disord 2017;18:153-65.
Hoogendijk, W., Beekman, A., Deeg, D., Lips, P., & Penninx, B. (2009). Depression is
associated with decreased 25-hydroxyvitamin-D and increased parathyroid hormone levels
in old age. European Psychiatry, 24(S1), 1-1.
105
          
-58.
Jaddou HY, Batieha AM, Khader YS, Kanaan SH, El-Khateeb MS, Ajlouni KM. (2012).
Depression is associated with low levels of 25-hydroxy vitamin D among Jordanian adults:
results from a national population survey. Eur Arch Psychiatry Clin Neurosci, 262(4):3217.

-74.
Koenigs, M., & Grafman, J. (2009). The functional neuroanatomy of depression: distinct
roles for ventromedial and dorsolateral prefrontal cortex. Behavioural brain research,
201(2), 239-243.
Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM,
Beekman AT, Smit JH, Penninx BW. The association between low vitamin D and
depressive disorders. Mol Psychiatry. 2014 Apr;19(4):444-51. doi: 10.1038/mp.2013.36.
Epub 2013 Apr 9. PMID: 23568194.
Moore, J. D., & Bona, J. R. (2001). Depression and dysthymia. Medical Clinics of North
America, 85(3), 631-644.
Moyad MA. Vitamin D: A Rapid Review. Urol Nurs. 2008;28(5):343-349.
          
  
2005.

-288.
        
 2022
      
https://psikiyatri.org.tr/halka-yonelik/23/depresyon
Yalamanchili, V., & Gallagher, J. C. (2018). Dose ranging effects of vitamin D3 on the
geriatric depression score: A clinical trial. The Journal of steroid biochemistry and
molecular biology, 178, 60-64.

-63.
106
Polikistik Over Send
Polycystic Ovary Syndrome and Unsaturated Fatty Acids
12
1        dytkubrakaraa@gmail.com, 0000-
0002-4770-1328
2        mine@yurttagul.com, 0000-0001-
5170-0523

        

           
yeniliklerle birlikte tedavi, beslenme ve     
 
          
          
-
         


Anahtar Kelimeler: -
ABSTRACT
Polycystic ovary syndrome (PCOS); It is a common endocrine disease that affects women in
the reproductive period, which is caused by environmental and many genetic factors, and is
usually manifested by anovulation and hyperandrogenism. Along with the innovations achieved
in the diagnosis and treatment of PCOS, treatment should be supported by dietary and lifestyle
changes. In the medical nutrition treatment of PCOS, reducing the intake of simple sugar and
refined carbohydrates, consuming foods with a low glycemic index, limiting the intake of trans
fat and saturated fat, and diets containing adequate and balanced unsaturated fatty acids are
recommended. It is stated that increasing omega-3 fatty acids, one of the unsaturated fatty acids,
in the treatment of PCOS affects the treatment positively by reducing insulin resistance and
androgen production. The aim of this study is to examine the effectiveness of unsaturated fatty
acids in the treatment of PCOS in the light of current studies in the literature.
Keywords: Polycystic ovary syndrome, Unsaturated fatty acids, Omega-3 fatty acids
107

         
         
       (Azziz vd., 2004). Metabolik

           
        
(Bozdag & Yildiz, 2013; Ecklund & Usadi, 2015; Keskin vd., 2016)


       lkaya, 2021)   
asitlerinden (MUFA) zengin badem ve n-3/n-     
i ve androjenleri
          
          

(Kalgaonkar vd., 2011).


        
(Barrea vd.,
2019).

1.1 
    

       

          
 -uterin fetal

      (Dumesic vd.,
2007).
1.2 
         
         
   (Moran vd.,
2013). 16 g 

          e
     (Douglas vd., 2006)   
          
glisemik indeksli karbonhidratlardan gelece    

108
  (Lydic & Juturu, 2008)
%15-          

-
daha az
.
    -   
-
      -obezite ve anti-inflamatuar etkiler,

-
dislipidemi, hiperandrojenizm ve metabolik fonksiyonlarda   
(Salek vd., 2019).

 
        
(LA) (18:2 n- -linolenik asit (ALA) (18:3 n-  

        
-3), dokosapentaenoik asit (DPA;
22:5 n-3) ve DHA (22:6 n-3) sentezlenebilmektedir. Elzem 
(Simopoulos, 2016).
(Yang vd., 2018).
        
asitleri
109
-6 ve n-
          
         
  (Saini & Keum, 2018).     
             

(Albracht-Schulte vd., 2018).
         


-
(Saini & Keum, 2018).
- 
 
        
(Baysal, 2017).
2.2 Diyetteki Omega-6 ve Omega-
-6 ve n-in
       
          
       
        
          
-4 (LT-
TXA3 ve LT-(Saini & Keum, 2018)

bu eikosanoidler pro-  
ise anti-inf       -6/n- 
         
(Simopoulos, 2016)-6/n--2(Saini & Keum,
2018). Lifli besinlerden fakir v-
-6/n-(Albracht-Schulte vd., 2018)-
3/n-        
    -3/n-     
         
         

      -3/n-  
          (Ma vd.,
2019).
110

        

           


          

(Yahay vd., 2021)

           

(Emami vd., 2020)        -3 geni
        
--3 genindeki mutasyonlar
TGF-     
-
 -       n
       (D Prabhu & Valsala
Gopalakrishnan, 2021). Polak ve ark. (Polak vd., 2020) 
    


PKOS'lu hastalarda omega-
     ematik inceleme ve meta-analiz
 -3 takviyesinin C-reaktif proteini azaltarak ve adiponektin seviyesini
       
(Tosatti vd., 2021). Omega-
        - 
omega-           
 (Yang vd., 2018). Omega-
         

        -3 alan grubun LH seviyeleri

(Nadjarzadeh vd.,
2015). Diyete omega-       -40 ya
         

          
--reaktif protein (hs-

(Mirmasoumi vd., 2018). Komal ve
ark. (Komal vd., 2020)  -    
omega-
          
-
111
       
          

   -        


Polikistik over

  


        


biri olan omega-3 P

      mevcuttur.
Ancak omega-6 ve omega-      
    

KAYNAKLAR
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-
McComb, J., & Moustaid-Moussa, N. (2018). Omega-3 fatty acids in obesity and metabolic
syndrome: A mechanistic update. The Journal of Nutritional Biochemistry, 58, 1-16.
https://doi.org/10.1016/j.jnutbio.2018.02.012
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004).
The prevalence and features of the polycystic ovary syndrome in an unselected population. The
Journal of Clinical Endocrinology and Metabolism, 89(6), 2745-2749.
https://doi.org/10.1210/jc.2003-032046
Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese,
G., Colao, A., & Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns
and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11(10),
2278. https://doi.org/10.3390/nu11102278
Baysal. (2017). Beslenme
Bozdag, G., & Yildiz, B. O. (2013). Interventions for the metabolic dysfunction in polycystic
ovary syndrome. Steroids, 78(8), 777-781. https://doi.org/10.1016/j.steroids.2013.04.008
D Prabhu, Y., & Valsala Gopalakrishnan, A. (2021). Can polyunsaturated fatty acids regulate
Polycystic Ovary Syndrome via TGF-  Life Sciences, 276, 119416.
https://doi.org/10.1016/j.lfs.2021.119416
112
Douglas, C. C., Gower, B. A., Darnell, B. E., Ovalle, F., Oster, R. A., & Azziz, R. (2006). Role
of diet in the treatment of polycystic ovary syndrome. Fertility and Sterility, 85(3), 679-688.
https://doi.org/10.1016/j.fertnstert.2005.08.045
Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007). Polycystic ovary syndrome and its
developmental origins. Reviews in Endocrine & Metabolic Disorders, 8(2), 127-141.
https://doi.org/10.1007/s11154-007-9046-0
Ecklund, L. C., & Usadi, R. S. (2015). Endocrine and reproductive effects of polycystic ovarian
syndrome. Obstetrics and Gynecology Clinics of North America, 42(1), 55-65.
https://doi.org/10.1016/j.ogc.2014.09.003
Emami, N., Alizadeh, A., Moini, A., Yaghmaei, P., & Shahhosseini, M. (2020). Differences in
fatty acid profiles and desaturation indices of abdominal subcutaneous adipose tissue between
pregnant women with and without PCOS. Adipocyte, 9(1), 16-23.
https://doi.org/10.1080/21623945.2019.1710021
Kalgaonkar, S., Almario, R. U., Gurusinghe, D., Garamendi, E. M., Buchan, W., Kim, K., &
Karakas, S. E. (2011). Differential effects of walnuts vs almonds on improving metabolic and
endocrine parameters in PCOS. European Journal of Clinical Nutrition, 65(3), 386-393.
https://doi.org/10.1038/ejcn.2010.266

             
Turkish Journal of Clinics
and Laboratory, 34-38. https://doi.org/10.18663/tjcl.79713
Komal, F., Khan, M. K., Imran, M., Ahmad, M. H., Anwar, H., Ashfaq, U. A., Ahmad, N.,
Masroor, A., Ahmad, R. S., Nadeem, M., & Nisa, M. U. (2020). Impact of different omega-3
fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages
profile in PCOS rat model. Journal of Translational Medicine, 18(1), 349.
https://doi.org/10.1186/s12967-020-02519-1
Lydic, M., & Juturu, V. (2008). Dietary Approaches and Alternative Therapies for Polycystic
Ovary Syndrome. Current Nutrition & Food Science, 4(4), 265-281.
Ma, X., Weng, X., Hu, X., Wang, Q., Tian, Y., Ding, Y., & Zhang, C. (2019). Roles of different
n-3/n-6 PUFA ratios in ovarian cell development and steroidogenesis in PCOS rats. Food &
Function, 10(11), 7397-7406. https://doi.org/10.1039/c9fo01730e
Mirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh,
M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z. (2018). The Effects of Flaxseed
Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic
Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Experimental and
Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and]
German Diabetes Association, 126(4), 222-228. https://doi.org/10.1055/s-0043-119751
Moran, L. J., Ko, H., Misso, M., Marsh, K., Noakes, M., Talbot, M., Frearson, M., Thondan,
M., Stepto, N., & Teede, H. J. (2013). Dietary composition in the treatment of polycystic ovary
syndrome: A systematic review to inform evidence-based guidelines. Journal of the Academy
of Nutrition and Dietetics, 113(4), 520-545. https://doi.org/10.1016/j.jand.2012.11.018
113
Nadjarzadeh, A., Dehghani-Firouzabadi, R., Daneshbodi, H., Lotfi, M. H., Vaziri, N., &
Mozaffari-Khosravi, H. (2015). Effect of Omega-3 Supplementation on Visfatin, Adiponectin,
and Anthropometric Indices in Women with Polycystic Ovarian Syndrome. Journal of
Reproduction & Infertility, 16(4), 212-220.
Polak, A. M., Krentowska        -
             
Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese
Women with Polycystic Ovary Syndrome. Nutrients, 12(9), 2753.
https://doi.org/10.3390/nu12092753
Saini, R. K., & Keum, Y.-S. (2018). Omega-3 and omega-6 polyunsaturated fatty acids: Dietary
sources, metabolism, and significance - A review. Life Sciences, 203, 255-267.
https://doi.org/10.1016/j.lfs.2018.04.049
Salek, M., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019). N-3 fatty acids as
preventive and therapeutic agents in attenuating PCOS complications. EXCLI Journal, 18, 558-
575. https://doi.org/10.17179/excli2019-1534
 lkaya, B. (2021). The Role of Dietary Supplements and Lifestyle Changes in
Reducing Polycystic Ovary Syndrome Complications. Hacettepe University Faculty of Health
Sciences Journal, 8(3), Article 3. https://doi.org/10.21020/husbfd.842922
Simopoulos, A. P. (2016). An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases
the Risk for Obesity. Nutrients, 8(3), 128. https://doi.org/10.3390/nu8030128
k Over Sendromu ve Beslenme. Beslenme ve
Diyet Dergisi, 41(3), 253-257.
 
(2021). Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress
markers in patients with polycystic ovary syndrome: A systematic review and meta-analysis.
The British Journal of Nutrition, 125(6), 657-668.
https://doi.org/10.1017/S0007114520003207
Yahay, M., Heidari, Z., Allameh, Z., & Amani, R. (2021). The effects of canola and olive oils
consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with
polycystic ovarian syndrome: A randomized controlled trial. Lipids in Health and Disease,
20(1), 7. https://doi.org/10.1186/s12944-021-01433-9
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018). Effectiveness of Omega-3 fatty acid for polycystic
ovary syndrome: A systematic review and meta-analysis. Reproductive Biology and
Endocrinology: RB&E, 16(1), 27. https://doi.org/10.1186/s12958-018-0346-x
114

The Relationship Between Ulcerative Colitis and Vitamin D
12
1        dytkubrakaraa@gmail.com, 0000-
0002-4770-1328
2        mine@yurttagul.com, 0000-0001-
5170-0523

D vit           
          

         

          

     
           
  

Anahtar Kelimeler: 
THE RELATIONSHIP BETWEEN ULCERATIVE COLITIS AND VITAMIN D
ABSTRACT
Vitamin D is a type of fat-soluble sterol that performs hormone-like functions. The main target
tissues of vitamin D are the intestine, kidneys and bone. It also provides support for immunity
by increasing antimicrobial substances in the intestinal lumen. Therefore, vitamin D is thought
to be one of the dietary factors that play a role in the occurrence of inflammatory bowel diseases.
des Crohn's disease (CH) and ulcerative colitis (UC),
which are associated with impaired mucosal response in hereditarily predisposed individuals.
Studies show that vitamin D deficiency is common in individuals with IBD and that deficiency
is both a predisposing factor in the occurrence of the disease and may be associated with an
increase in the severity of the disease. The aim of this study is to examine the relationship
between ulcerative colitis and vitamin D in line with current data.
Keywords: Ulcerative colitis, vitamin D, Inflammatory bowel disease
115

      
-      

    
          ol
           
 

           
    
         

         
         




--
          
sentezlenmektedir. D3 vitamininden, biyolojik olarak aktif kalsitriol sentezi yapabil
290-
         -hidroksilaz
-hidroksilaz ile biyolojik olarak aktif
-hidroksilaz, parathormon (PTH)

          
          
          
vitaminine benzer yollarla 




           
-dehidrokolesterol 



116
          
(Razzaque, 2018). D vitamini; bitkisel besinlerde az miktarda ergokalsiferol (D2 vitamini),

    
           
     
         

         
           
        
 
vd., 2018).



         





    


vd., 2014).
     



         

           


117
          



     
ranskripsiyonu

         
         
    -  
   
 
          
          



           
    
           
kalitesinin           

(Dash

-hidroksi D vitamini (25-OHD)
seviyesi, toplam antioksidan kapasitesi (TAC) ve Toplam Oksidan Durumu (TOS), inflamatuar
  -   
-OHD seviyeleri
  

-
 


D vitam-
          


               

-
            
grupta D vitamini sevi

          -reaktif
prot

  olarak, 40 ng/mL D

     
118

           


        
        
-erini

          
 90 hafif ila orta dereceli

         
vitamininin serum TNF -  -       

   

  
         
    

            
    

         
etkilerini inceleyen sistematik bir derleme ve meta-  

C-
         

         
         
           








           
(Sutherland vd., 1987).

        

    


119
mevcuttur. Ancak D vita

KAYNAKLAR
Abrams, G. D., Feldman, D., & Safran, M. R. (2018). Effects of Vitamin D on Skeletal Muscle
and Athletic Performance. The Journal of the American Academy of Orthopaedic Surgeons,
26(8), 278-285. https://doi.org/10.5435/JAAOS-D-16-00464
Ahamed Z, R., Dutta, U., Sharma, V., Prasad, K. K., Popli, P., Kalsi, D., Vaishnavi, C., Arora,
S., & Kochhar, R. (2019). Oral Nano Vitamin D Supplementation Reduces Disease Activity in
Ulcerative Colitis: A Double-Blind Randomized Parallel Group Placebo-controlled Trial.
Journal of Clinical Gastroenterology, 53(10), e409-e415.
https://doi.org/10.1097/MCG.0000000000001233
Ardesia, M., Ferlazzo, G., & Fries, W. (2015). Vitamin D and inflammatory bowel disease.
BioMed Research International, 2015, 470805. https://doi.org/10.1155/2015/470805
Arihiro, S., Nakashima, A., Matsuoka, M., Suto, S., Uchiyama, K., Kato, T., Mitobe, J.,
Komoike, N., Itagaki, M., Miyakawa, Y., Koido, S., Hokari, A., Saruta, M., Tajiri, H.,
Matsuura, T., & Urashima, M. (2019). Randomized Trial of Vitamin D Supplementation to
Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory
Bowel Disease. Inflammatory Bowel Diseases, 25(6), 1088-1095.
https://doi.org/10.1093/ibd/izy346
Battistini, C., Ballan, R., Herkenhoff, M. E., Saad, S. M. I., & Sun, J. (2020). Vitamin D
Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. International Journal of
Molecular Sciences, 22(1), 362. https://doi.org/10.3390/ijms22010362
Bulut T. (2003). İnflamatuar bağırsak hastalıklarında medikal ve cerrahi tedavi prensipleri.
17(4), 365-370.
Cantorna, M. T., Yu, S., & Bruce, D. (2008). The paradoxical effects of vitamin D on type 1
mediated immunity. Molecular Aspects of Medicine, 29(6), 369-375.
https://doi.org/10.1016/j.mam.2008.04.004
Chetcuti Zammit, S., Schembri, J., Pisani, A., Vella, S., Azzopardi, M., Skamnelos, A.,
Christodoulou, D. K., Katsanos, K. H., & Ellul, P. (2019). Vitamin D and Ulcerative Colitis: Is
There a Relationship with Disease Extent? Digestive Diseases (Basel, Switzerland), 37(3), 208-
213. https://doi.org/10.1159/000494439
120
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016). Vitamin D:
Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiological Reviews,
96(1), 365-408. https://doi.org/10.1152/physrev.00014.2015
Cosnes, J., Gower-Rousseau, C., Seksik, P., & Cortot, A. (2011). Epidemiology and natural
history of inflammatory bowel diseases. Gastroenterology, 140(6), 1785-1794.
https://doi.org/10.1053/j.gastro.2011.01.055
Dash, K. R., Panda, C., Das, H. S., Mishra, D., Behera, S. K., Parida, P. K., & Mohapatra, D.
(2021). Association of Vitamin D Level With Disease Severity and Quality of Life in Newly
Diagnosed Patients of Ulcerative Colitis: A Cross-Sectional Analysis. Cureus, 13(7), e16481.
https://doi.org/10.7759/cureus.16481
Garcia, M., Seelaender, M., Sotiropoulos, A., Coletti, D., & Lancha, A. H. (2019). Vitamin D,
muscle recovery, sarcopenia, cachexia, and muscle atrophy. Nutrition (Burbank, Los Angeles
County, Calif.), 60, 66-69. https://doi.org/10.1016/j.nut.2018.09.031
Garg, M., Hendy, P., Ding, J. N., Shaw, S., Hold, G., & Hart, A. (2018). The Effect of Vitamin
D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis. Journal
of Crohn’s & Colitis, 12(8), 963-972. https://doi.org/10.1093/ecco-jcc/jjy052
Glickman, J. N., & Odze, R. D. (2008). Does rectal sparing ever occur in ulcerative colitis?
Inflammatory Bowel Diseases, 14 Suppl 2, S166-167. https://doi.org/10.1002/ibd.20592
Guan, Y., Hao, Y., Guan, Y., Bu, H., & Wang, H. (2022). Effects of vitamin D supplementation
on blood markers in ulcerative colitis patients: A systematic review and meta-analysis.
European Journal of Nutrition, 61(1), 23-35. https://doi.org/10.1007/s00394-021-02603-2
Gubatan, J., & Moss, A. C. (2018). Vitamin D in inflammatory bowel disease: More than just
a supplement. Current Opinion in Gastroenterology, 34(4), 217-225.
https://doi.org/10.1097/MOG.0000000000000449
Guyton, A., & Hal  

Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357(3),
266-281. https://doi.org/10.1056/NEJMra070553
121
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney,
R. P., Murad, M. H., Weaver, C. M., & Endocrine Society. (2011). Evaluation, treatment, and
prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. The
Journal of Clinical Endocrinology and Metabolism, 96(7), 1911-1930.
https://doi.org/10.1210/jc.2011-0385
Holick, M. F., & Chen, T. C. (2008). Vitamin D deficiency: A worldwide problem with health
consequences. The American Journal of Clinical Nutrition, 87(4), 1080S-6S.
https://doi.org/10.1093/ajcn/87.4.1080S
     

Karimi, S., Tabataba-Vakili, S., Yari, Z., Alborzi, F., Hedayati, M., Ebrahimi-Daryani, N., &
Hekmatdoost, A. (2019). The effects of two vitamin D regimens on ulcerative colitis activity
index, quality of life and oxidant/anti-oxidant status. Nutrition Journal, 18(1), 16.
https://doi.org/10.1186/s12937-019-0441-7
Kennel, K. A., Drake, M. T., & Hurley, D. L. (2010). Vitamin D deficiency in adults: When to
test and how to treat. Mayo Clinic Proceedings, 85(8), 752-757; quiz 757-758.
https://doi.org/10.4065/mcp.2010.0138
Koundourakis, N. E., Avgoustinaki, P. D., Malliaraki, N., & Margioris, A. N. (2016). Muscular
effects of vitamin D in young athletes and non-athletes and in the elderly. Hormones (Athens,
Greece), 15(4), 471-488. https://doi.org/10.14310/horm.2002.1705
Law, A. D., Dutta, U., Kochhar, R., Vaishnavi, C., Kumar, S., Noor, T., Bhadada, S., & Singh,
K. (2019). Vitamin D deficiency in adult patients with ulcerative colitis: Prevalence and
relationship with disease severity, extent, and duration. Indian Journal of Gastroenterology:
Official Journal of the Indian Society of Gastroenterology, 38(1), 6-14.
https://doi.org/10.1007/s12664-019-00932-z
Lin, R. (2016). Crosstalk between Vitamin D Metabolism, VDR Signalling, and Innate
Immunity. BioMed Research International, 2016, 1375858.
https://doi.org/10.1155/2016/1375858

Pludowski, P., Hiligsmann, M., Trummer, C., Schwetz, V., Lerchbaum, E., Pandis, M.,

Zittermann, A. (2018). Rationale and Plan for Vitamin D Food Fortification: A Review and
Guidance Paper. Frontiers in Endocrinology, 9, 373. https://doi.org/10.3389/fendo.2018.00373
122
Pludowski, P., Holick, M. F., Grant, W. B., Konstantynowicz, J., Mascarenhas, M. R., Haq, A.,
Povoroznyuk, V., Balatska, N., Barbosa, A. P., Karonova, T., Rudenka, E., Misiorowski, W.,
  ska- 
Abramowicz, P., Bhattoa, H. P., & Wimalawansa, S. J. (2018). Vitamin D supplementation
guidelines. The Journal of Steroid Biochemistry and Molecular Biology, 175, 125-135.
https://doi.org/10.1016/j.jsbmb.2017.01.021
Razzaque, M. S. (2018). Can adverse effects of excessive vitamin D supplementation occur
without developing hypervitaminosis D? The Journal of Steroid Biochemistry and Molecular
Biology, 180, 81-86. https://doi.org/10.1016/j.jsbmb.2017.07.006
Sharifi, A., Vahedi, H., Nedjat, S., Rafiei, H., & Hosseinzadeh-Attar, M. J. (2019). Effect of
single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: A
randomized placebo-controlled trial. APMIS: Acta Pathologica, Microbiologica, et
Immunologica Scandinavica, 127(10), 681-687. https://doi.org/10.1111/apm.12982
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T.,
Sparr, J., Prokipchuk, E., & Borgen, L. (1987). 5-Aminosalicylic acid enema in the treatment
of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology, 92(6), 1894-
1898. https://doi.org/10.1016/0016-5085(87)90621-4


Walsh, A. J., Ghosh, A., Brain, A. O., Buchel, O., Burger, D., Thomas, S., White, L., Collins,
G. S., Keshav, S., & Travis, S. P. L. (2014). Comparing disease activity indices in ulcerative
colitis. Journal of Crohn’s & Colitis, 8(4), 318-325.
https://doi.org/10.1016/j.crohns.2013.09.010
Zhou, Z., Zhou, R., Zhang, Z., & Li, K. (2019). The Association Between Vitamin D Status,
         
Review and Meta-Analysis. Medical Science Monitor: International Medical Journal of
Experimental and Clinical Research, 25, 666-674. https://doi.org/10.12659/MSM.912840
123
Cannabis sativa
1 2
1          
izelkavak@gmail.com, 0000-0002-6990-3625
2ferhat.sirinyildiz@adu.edu.tr, 0000-
0001-8800-9787

Cannabis sativa         
          
      Cannabis sativa 
         
         


    Cannabis sativa    
            
Cannabis
sativa

     

 Cannabis sativa 

Bulgular: 



antikarsinojen, diyabet, Alzheimer, Parkinson gibi ha

Cannabis sativa 
 
       
         


Anahtar Kelimeler: Cannabis sativa, Kenevir, Marihuana, Cannabis sativa 
Abstract
Cannabis sativa, BC It has been used in important food and textile sources since the 4000s. Its
use as a medicine by the Chinese also made it take place in the oldest pharmacopoeia. With
centuries of workCannabis sativaThe variety, derivatives and functions of . Cannabis-derived
drugs have shown therapeutic potential for many medical conditions, including neurological
and psychiatric disorders, including epilepsy, Parkinson's, Alzheimer's, inflammation, diabetes,
colitis, anorexia, MS, pain, and cancer.
124
In recent years, foods have been the focus of research not only for nutritional purposes but also
as beneficial effects in the field of health.Cannabis sativa from its fibers and seeds for thousands
of years; It is the first cultivated plant used in many fields such as construction, textile, food,
paper, medicine. Limited due to its euphoric effect and commercial concern.Cannabis sativa;
It has updated its existence and became the focus again as it has been proven by scientific
studies that it does not have this effect in the form of oil, and its effects in medical and industrial
fields. In this study, 90 scientific studies on the subject were read and scanned with speed
reading and 81 scientific articles were included in the compilation study.
Materials and Methods: In this studyCannabis sativa The use, history and scientific studies
of the seed oil in the field of health have been compiled.
Conclusion and Discussion:Cannabis sativa In recent years, it has become the focus of the
scientific world and has become the most studied plant. What makes it so popular is;
phytochemical content. The phytochemical content has been defined by hundreds of
compounds from different chemical classes. It is rich in vitamin E derivatives and has antiviral,
anti-inflammatory, antifungal, antihyperlipidemic properties. It is not superfluous for it to be a
focal point in the scientific world to reveal the potential effects of cannabis, which has such a
high therapeutic potential, and to conduct advanced clinical studies.
Keywords: Cannabis sativa, Cannabis, Marijuana, Cannabis sativa oil
1. 
Cannabis sativa         


y    -       

  er. 8-
(Jickells & Negrusz, 2008) 
   
           jik,
Cannabis sativa
Cannabis sativa’
      (Thomas & ElSohly, 2015). Bu
derlemenin amacı Cannabis sativa        
 .
1.1.Cannabis sativa
Cannabis sativa    

   -  -    

(Abel, 1980).

   (Saleh, 2019)       
kullan(Epstein, 2010)

  (Butrica, 2002)-i
(Sina, 2014)
         

125
   
(Couch et al., 2018).
  
olan Cannabis sativa      haricen egzama ve sedef
(Anwar et al., 2006;
Jeong et al., 2014)
Cannabis sativa’nın        (Epstein, 2010;
Scurlock & Andersen, 2005)
(Mercuri et
al., 2002; Merlin, 2017)         
(Carod-Artal, 2013).
1.2. Kannabinoidlerin Farmakolojisi
         



         
mevcuttur (Fraguas--)


bildiri (Booth et al., 2017)     
(Fraguas--.
1.3. Cannabis sativa Tohumu Yağı

(Farag &
Kayser, 2017).
(Jia
et al., 2013)de apoptozisi
  (Souto-Maior et al., 2017)     
        
(Callaway, 2004)--25 protein, %20-
30 karbonhidrat, % 10-

bitkidir (Tambe et al., 1996)
         sitleri olan


antiinflamatuar, antitrombotik, kalp-  ucu, antiosteoporotik, antialerjik,

             
        
(Leizer et al., 2000)
          
  

      (Mendeloff, 1988). Bu tespit,
126
          (Fraguas-
-.
2. 
           

           



yan etkili bir ajan old
3. 
           Cannabis
sativa, Cannabis sativa   

4. BULGULAR
4.1. Cannabis sativa Multiple Skleroz (MS)
         
   
  -      
            
(Jean-Gilles
et al., 2009)

Cannabis
sativa         
(Killestein et al., 2002) bunun yerine 7.5
(Ungerleider et al., 1988, p. 9).
4.2. Cannabis sativa- Epilepsi
          


 
            
  
          

        
ko(Wallace et al., 2003).
Cannabis sativa ekstr
(Hussain et al., 2015; Porter
et al., 2008).
4.3. Cannabis sativa- Parkinson
        
         
(Basavarajappa et al., 2017; Stampanoni Bassi et al., 2017). Pa 

(Hurley et al., 2003).
         

(Hurley et al., 2003).
127
Rotenon ile         
(El Banoua et al., 2004).
4.4. Cannabis sativa Alzheimer
  


(Benito et al., 2003).
4.5. Cannabis sativa 
         
         
  
.
4.6. Cannabis sativa- Kanser

          
(Fraguas-2018)
           
(Sredni et al., 2016; Wu et al.,
2012).
       -  

nilen prostat kanseri derecesini belirleyen skorlamaya etki
(Chung et al., 2009; Cipriano et al., 2013; Orellana-Serradell et al., 2015;
Sarfaraz et al., 2005).
4.7. Cannabis sativa- Anoreksiya
 
. Scherma v
-THC ve hem
    

(Scherma et al., 2017).
4.8. Cannabis sativa- Diyabet
           
        
 (Weiss et al., 2006). Bundan d   

        

          
(Comelli et al., 2008).
4.9. Cannabis sativa- Kolit
Cannabis sativa        
    (Couch et al., 2018). Kannobikromen (CBC),
        
      
rapo(Hasenoehrl et al., 2017; Naftali et al., 2014; Pagano et al., 2016). Nallathambi

 (Nallathambi et al., 2017).
4.10. Cannabis sativa- 
128
          
         
enerasyona neden
(Coyle & Puttfarcken, 1993).

CB1-        
ktedirler (Cabral et al., 1995).
          
Alzheimer, travma gibi has
(Mechoulam, 2002).
5. 
       
          
   id ise

(DeMorrow et al., 2008; Frampton et al., 2010). Sivri fare
         
        
   (Darmani, 2001). 1975   
   
(Sallan et al., 1975)
           

         (Mackie & Stella,
2006)
         
(Costa et al., 2004)
        

        (Wong & Baum,
2019)           
  
.
6. 
    
           



   


         

          
129
 

7. 
Abel, E. L. (1980). Marijuana the first twelve thousand years Plenum Press. New York, New
York, USA.
Anwar, F., Latif, S., & Ashraf, M. (2006). Analytical characterization of hemp (Cannabis
sativa) seed oil from different agro-ecological zones of Pakistan. Journal of the American Oil
329.
 Journal
of Faculty of Pharmacy of Ankara University, 45(3), 631651.
Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017). Endocannabinoid
system in neurodegenerative disorders. Journal of Neurochemistry, 142(5), 624648.
Benito, C.,  
(2003). Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively
overexpressed in neuritic plaque-       
Neuroscience, 23(35), 1113611141.
Booth, J. K., Page, J. E., & Bohlmann, J. (2017). Terpene synthases from Cannabis sativa. Plos
One, 12(3), e0173911.
Butrica, J. L. (2002). The medical use of cannabis among the Greeks and Romans. Journal of
Cannabis Therapeutics, 2(2), 5170.
Cabral, G. A., Toney, D. M., Fischer-Stenger, K., Harrison, M. P., & Marciano-Cabral, F.
(1995). Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive
cells. Life Sciences, 56(2324), 20652072.
Callaway, J. C. (2004). Hempseed as a nutritional resource: An overview. Euphytica, 140, 65
72.
Carod-Artal, F. J. (2013). Psychoactive plants in ancient Greece. Neurosciences and History,
1(1), 2838.
Chung, S. C., Hammarsten, P., Josefsson, A., Stattin, P., Granfors, T., Egevad, L., Mancini, G.,
Lutz, B., Bergh, A., & Fowler, C. J. (2009). A high cannabinoid CB1 receptor immunoreactivity
is associated with disease severity and outcome in prostate cancer. European Journal of Cancer,
45(1), 174182.
    
cannabinoid CB1 receptor expression and Akt signalling in prostate cancer. PLoS One, 8(6),
e65798.
Comelli, F., Giagnoni, G., Bettoni, I., Colleoni, M., & Costa, B. (2008). Antihyperalgesic effect
of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved.
Phytotherapy Research, 22(8), 10171024.
Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., & Giagnoni, G.
(2004). Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of
cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn-
Archives of Pharmacology, 369, 294299.
130
llivan, S. E. (2018). The use of
cannabinoids in colitis: A systematic review and meta-analysis. Inflammatory Bowel Diseases,
24(4), 680697.
Coyle, J. T., & Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative
disorders. Science, 262(5134), 689695.
-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis
produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A.
Neuropsychopharmacology, 24(2), 198203.
DeMorrow, S., Francis, H., Gaudio, E., Venter, J., Franchitto, A., Kopriva, S., Onori, P.,
Mancinelli, R., Frampton, G., & Coufal, M. (2008). The endocannabinoid anandamide inhibits
cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.
American Journal of Physiology-Gastrointestinal and Liver Physiology, 295(6), G1150
G1158.
El Banoua, F., Caraballo, I., Flores, J. A., Galan-Rodriguez, B., & Fernandez-Espejo, E. (2004).
Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors
           
Neurobiology of Disease, 16(2), 377385.
Epstein, H. A. (2010). A natural approach to soothing atopic skin. Skinmed, 8(2), 9597.
Farag, S., & Kayser, O. (2017). The cannabis plant: Botanical aspects. In Handbook of cannabis
and related pathologies (pp. 312). Elsevier.
Fraguas--Sabroso, C., & Torres-  
effects of the endocannabinoid system in cancer: A review. British Journal of Pharmacology,
175(13), 25662580.
Fraguas-- 
78(16), 16651703.
Frampton, G., Coufal, M., Li, H., Ramirez, J., & DeMorrow, S. (2010). Opposing actions of
endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch
signaling. Experimental Cell Research, 316(9), 14651478.
Hasenoehrl, C., Storr, M., & Schicho, R. (2017). Cannabinoids for treating inflammatory bowel
diseases: Where are we and where do we go? Expert Review of Gastroenterology &
Hepatology, 11(4), 329337.
   -A., Radbruch, L., & Petzke, F. (2017). Cannabinoids in pain
management and palliative medicine: An overview of systematic reviews and prospective

Hurley, M. J., Mash, D. C., & Jenner, P. (2003). Expression of cannabinoid CB 1 receptor
mRNA in basal ganglia of normal and parkinsonian human brain. Journal of Neural
Transmission, 110, 12791288.
Hussain, S. A., Zhou, R., Jacobson, C., Weng, J., Cheng, E., Lay, J., Hung, P., Lerner, J. T., &
Sankar, R. (2015). Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment
of pediatric epilepsy: A potential role for infantile spasms and LennoxGastaut syndrome.
Epilepsy & Behavior, 47, 138141.
131
Jean-Gilles, L., Feng, S., Tench, C. R., Chapman, V., Kendall, D. A., Barrett, D. A., &
Constantinescu, C. S. (2009). Plasma endocannabinoid levels in multiple sclerosis. Journal of
the Neurological Sciences, 287(12), 212215.
Jeong, M., Cho, J., Shin, J.-I., Jeon, Y.-J., Kim, J.-H., Lee, S.-J., Kim, E.-S., & Lee, K. (2014).
Hempseed oil induces reactive oxygen species-and C/EBP homologous protein-mediated
apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells. Journal of
Ethnopharmacology, 154(3), 745752.
Jia, S.-S., Xi, G.-P., Zhang, M., Chen, Y.-B., Lei, B., Dong, X.-S., & Yang, Y.-M. (2013).
Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human
colon cancer cells. Oncology Reports, 29(1), 349354.
           
Toxicologie Analytique, 20(4), 233234.
Killestein, J., Hoogervorst, E. L. J., Reif, M., Kalkers, N. F., Van Loenen, A. C., Staats, P. G.
M., Gorter, R. W., Uitdehaag, B. M. J., & Polman, C. H. (2002). Safety, tolerability, and
efficacy of orally administered cannabinoids in MS. Neurology, 58(9), 14041407.
Leizer, C., Ribnicky, D., Poulev, A., Dushenkov, S., & Raskin, I. (2000). The composition of
hemp seed oil and its potential as an important source of nutrition. Journal of Nutraceuticals,
Functional & Medical Foods, 2(4), 3553.
Mackie, K., & Stella, N. (2006). Cannabinoid receptors and endocannabinoids: Evidence for
new players. The AAPS Journal, 8, E298E306.
Mechoulam, R. (2002). Discovery of endocannabinoids and some random thoughts on their
possible roles in neuroprotection and aggression. Prostaglandins, Leukotrienes and Essential
Fatty Acids (PLEFA), 66(23), 9399.
Mendeloff, A. I. (1988). The epidemiology of idiopathic inflammatory bowel disease.
Inflammatory Bowel Disease., 334.
Mercuri, A. M., Accorsi, C. A., & Bandini Mazzanti, M. (2002). The long history of Cannabis
and its cultivation by the Romans in central Italy, shown by pollen records from Lago Albano
and Lago di Nemi. Vegetation History and Archaeobotany, 11, 263276.
Merlin, M. (2017). Cannabis: A Complete Guide. JSTOR.
Naftali, T., Mechulam, R., Lev, L. B., & Konikoff, F. M. (2014). Cannabis for inflammatory
bowel disease. Digestive Diseases, 32(4), 468474.
Nallathambi, R., Mazuz, M., Ion, A., Selvaraj, G., Weininger, S., Fridlender, M., Nasser, A.,
Sagee, O., Kumari, P., & Nemichenizer, D. (2017). Anti-inflammatory activity in colon models
   -tetrahydrocannabinolic acid that interacts with additional compounds in
cannabis extracts. Cannabis and Cannabinoid Research, 2(1), 167182.
Orellana-egos, I., Huidobro, C.,
Llanos, M. N., & Contreras, H. R. (2015). Proapoptotic effect of endocannabinoids in prostate
cancer cells. Oncology Reports, 33(4), 15991608.
Pagano, E., Capasso, R., Piscitelli, F., Romano, B., Parisi, O. A., Finizio, S., Lauritano, A.,
Marzo, V. D., Izzo, A. A., & Borrelli, F. (2016). An orally active cannabis extract with high
content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility
in the mouse. Frontiers in Pharmacology, 7, 341.
132
Porter, C. K., Tribble, D. R., Aliaga, P. A., Halvorson, H. A., & Riddle, M. S. (2008). Infectious
gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology, 135(3),
781786. https://doi.org/10.1053/j.gastro.2008.05.081
Saleh, M. E. A. (201      
       

Sallan, S. E., Zinberg, N. E., & Frei III, E. (1975). Antiemetic effect of delta-9-
tetrahydrocannabinol in patients receiving cancer chemotherapy. New England Journal of
Medicine, 293(16), 795797.
Sarfaraz, S., Afaq, F., Adhami, V. M., & Mukhtar, H. (2005). Cannabinoid receptor as a novel
target for the treatment of prostate cancer. Cancer Research, 65(5), 16351641.
Scherma, M., Satta, V., Collu, R., Boi, M. F., Usai, P., Fratta, W., & Fadda, P. (2017).
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat
model of activity-based anorexia. British Journal of Pharmacology, 174(16), 26822695.
Scurlock, J. A., & Andersen, B. (2005). Diagnoses in Assyrian and Babylonian medicine:
Ancient sources, translations, and modern medical analyses. University of Illinois Press.
-Ka-
Souto-
de Almeida, R. N. (2017). Antinociceptive and anticonvulsant effects of the monoterpene
linalool oxide. Pharmaceutical Biology, 55(1), 6367.
Sredni, S. T., Huang, C.-C., Suzuki, M., Pundy, T., Chou, P., & Tomita, T. (2016). Spontaneous
involution of pediatric low-grade gliomas: High expression of cannabinoid receptor 1 (CNR1)
at the time of diagnosis may i      
Nervous System, 32, 20612067.
Stampanoni Bassi, M., Sancesario, A., Morace, R., Centonze, D., & Iezzi, E. (2017).
29.
Tambe, Y., Tsujiuchi, H., Honda, G., Ikeshiro, Y., & Tanaka, S. (1996). Gastric cytoprotection
of the non-steroidal anti--caryophyllene. Planta Medica, 62(05),
469470.
Thomas, B. F., & ElSohly, M. A. (2015). The analytical chemistry of cannabis: Quality
assessment, assurance, and regulation of medicinal marijuana and cannabinoid preparations.
Elsevier.
-
Special Topics, 6(1), 15.
Ulu
Ungerleider, J. T., Andyrsiak, T., Fairbanks, L., Ellison, G. W., & Myers, L. W. (1988). Delta-
9-THC in the treatment of spasticity associated with multiple sclerosis. Advances in Alcohol &
Substance Abuse, 7(1), 3950.
Wallace, M. J., Blair, R. E., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2003). The
endogenous cannabinoid system regulates seizure frequency and duration in a model of
temporal lobe epilepsy. Journal of Pharmacology and Experimental Therapeutics, 307(1), 129
137.
133
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2006).
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity, 39(2),
143151.
Wong, K. U., & Baum, C. R. (2019). Acute cannabis toxicity. Pediatric Emergency Care,
35(11), 799804.
Wu, X., Han, L., Zhang, X., Li, L., Jiang, C., Qiu, Y., Huang, R., Xie, B., Lin, Z., & Ren, J.
(2012). Alteration of endocannabinoid system in human gliomas. Journal of Neurochemistry,
120(5), 842849.

134

1, 2
1
ferrganat@gmail.com, 0000-0002-7275-4843
2            
0000-0001-6769-1326
          

          






  -kalp ve   gibi hayati sorunlara neden






           

 rabdomiyoliz sonucunda


Anahtar Kelimeler; crush sendromu, sendrom, rabdomiyoliz, afet, ezilme
ABSTRACT
Disaster, caused by a sudden event that harms people, causes injuries and results in
serious death rates.
Among the natural disasters that have occurred in the world and resulted in serious loss
of life are hurricanes, storms, tornadoes, tsunamis, avalanches, and earthquakes. Earthquakes,
considered one of the unpredictable disasters, are referred to as the natural disaster with the
highest death toll and mortality rate due to the debris. Earthquakes are a natural phenomenon
that demonstrates that people can safely step on the ground and the structures above them can
be damaged and collapse. Emotional, physical, mental, and social effects are observed in people
after experiencing natural disasters. Most disaster victims experience fear, anxiety, anger,
pessimism, panic, helplessness, shock response, nausea, vomiting, chest pain, weakness due to
thirst and hunger under the debris, heart attacks due to intense stress, and severe fractures and
135
injuries throughout their bodies. In addition, complications such as lacerations, abrasions,
avulsions, rhabdomyolysis, and crush syndrome can also be seen in many of those trapped
under debris.
Crush syndrome is a disease picture that causes life-threatening problems such as acute
renal failure, shock, kidney-heart and respiratory failure due to the partial or
complete crushing of body tissues, the formation of edema, and pressure exposure. This
condition entered our health agenda permanently after the Marmara earthquake on August 17,
1999. This earthquake, with its epicenter in Golcuk and a magnitude of 7.4, is one of the
heaviest disasters in the history of the Republic and has caused the death of 17,480 people and
the injury of 43,953 people according to the Crisis Management Center data of the Prime
Ministry. In addition, the epidemic of renal failure that emerged after this earthquake has
become the largest documented nephrological disaster in medical history, and the awareness of
Turkey being an "earthquake country" has been realized. Crush syndrome, which is a picture
that mostly results from rhabdomyolysis caused by trauma and results in many medical and
surgical negative situations that can lead to death, is one of the most important issues in the care
of these patients. The most important points in the care of crush syndrome are to provide rapid
and loading fluid therapy, eliminate the factors that cause trauma, and eliminate unwanted
situations.
Keywords; crush syndrome, syndrome, rhabdomyolysis, disaster, crush


        
           


1.


         

   

         
crush (ezilme) sendromu gibi komplikasyonlar da g
          
       2. Messina

         

         

136
-
Hanshin-Awaji (Japonya) depremleridir1,3.
          


Crush Sendromu
  -kalp ve   gibi hayati sorunlara neden
4.
  
          


Merkezi         

           olma

5.
        
           

Rabdomiyoliz          
        Rabdomiyoliz

sebep olur.
Miyoglobin; kas dokusunda bulunan demir ve oksijen  Kan miyoglobin
  
  

6.
-

          
7   

137
1. Klinik Bulgular
 

fazla beklenmektedir.



         
        
         
Hipovolemi           
       15  

   30 mmHg      
olarak 68 saat sonra kas-8.
o yorgunluk,
o 
o Kaslarda kuvvetsizlik ve sertlik,
o 
o Kompartman Sendromu
o 
o Hipotansiyon,
o 
o - Kusma
o Susuzluk hissi
o 
o Asendan paralizi
o Parestezi
o 
o Miyalji,
o 
o 
o Hiperpotasemi
o Hipoksi sonucu doku nekrozu,
o 
o 
o Asistoli
o Metabolik asidoz
o 

           
138
         dem
           

Kompartman sendromu:        

durumudur. Bu sebeple kompartman sendromunda cerrahi olarak fasiyotomi yapmak
gerekebilmektedir.
2. Laboratuvar 
 

2.1. 

ahverengi veya siyah) olarak
9.
         
9,10.

2.2. Kan Tahlili:

       

     Hiperpotasemi; kan potasyum
        
 

          


Orta derece hiperkalemi serum potasyumunu
139


kalsiyum-hipokalsemi 

        12 saat sonra

          120
         

   
alenin aminotrans

         
getirir11.


       hiperfosfatemi ye sebep olur.
        
-kemik-
  -kusma ve

 da anemi      
  trombositopeni     
         
enfeksiyonlara sebep olurken, tr     

 metabolik asidoz ortaya

Kan pH
PCO2 


       
kardiyak aritmiler gelmektedir.

140
   6      

 

 
zeyi -ST-T dalga

 
        


3. 
          
        nmeyen


         

         

        

        



Fizik        




12.
  -20 ml/saat 

potasyum veya laktat 
13.
          

         
 

141
 -
         
verilmelidir.

50 ml %20 mannitol-
    mannitol-alkali   



KAYNAKLAR
1. 
2. Better OS. History of the Crush Syndrome: From the earthquakes of Messina, Sicily
1909 to Spitak, Armenia 1988. Am J Nephrol 1997; 17:392
3. Van Holder R, Sever MS, Erek E, Lameire N. Acute Renal Failure Related to Crush
Syndrome: Towards an Era of Seismo-nephrology. Nephrol Dial Transplant 2000;
15:151
4. h Sendromu Bilim ve Teknik 310:86
5.         
Ankara, 2000: 3-15.
6. Huerta--to-bedside review: 2015;9(2):158:69.
7. Umke.org MYOLOGIA CRUSH SENDROMU -12
8. Better OS, Stein JH: Early management of shock and prophylaxis of acute renal failure
in traumatic rhabdomyolysis. N Engl J Med 2012;322:825-829
9. Huerta-Alardin HL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis- an
overview for clinicians. Crit Care 2005; 9:158-169. http://dx.doi.org/10.1186/cc2978
10. Turk Neph Dial Transpl 1999;
4:163-166.
11. ldemir M. Crush sendromu. Tıp Araştırma
Dergisi 2006; 4:31-38.
12. Sever MS, Vanholder R. RDRTF of ISN Work Group on Recommendations for the
Management of Crush Victims in Mass Disasters. Recommendation for management of
crush victims in mass disasters. Nephrol Dial Transplant 2012;27(Suppl 1):1-67.
http://dx.doi.org/10.1093/ndt/gfs040
13. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 2009; 67:272-283.
142
 

1, 2
1 hilalcangi95@hotmail.com /
21280884@omu.edu.tr , https://orcid.org/0009-0003-7551-328
2 
senay1981@yahoo.com / senay.arli@omu.edu.tr, https://orcid.org/0000-0002-8231-3857

   
         
          
        
         
   


          

        
         
 
     bakteriyel kolonizasyonunun cilt

          
(NICE), 
          
         

Anahtar Kelimeler: 

143
Clinical Evidence For The Relationship Between Preoperative Hair Removal and
Surgical Site Infection
1 2
1         hilalcangi95@hotmail.com /
21280884@omu.edu.tr , https://orcid.org/0009-0003-7551-3281
2            
senay1981@yahoo.com / senay.arli@omu.edu.tr, https://orcid.org/0000-0002-8231-3857
Abstract
Healthcare-associated surgical site infections are preventable infections affecting hundreds of
millions worldwide each year. This review aims to present clinical evidence for the relationship
between preoperative hair removal and surgical site infection. Preoperative skin preparation
aims to reduce the number of microorganisms in the operation area and prevent infection. There
are concerns that hair in the preoperative surgical site will limit access or view to the operative
field, interfere with skin marking, impair skin antisepsis, interfere with the placement or
subsequent removal of sutures or incision site dressings, and pose an increased risk. In addition,
there is clinical evidence for the relationship between preoperative hair removal methods and
postoperative surgical site infections. Guidelines of the World Health Organization(WHO) and
Center for Disease Control and Prevention(CDC) recommend that hair should not be removed
unless surgical intervention is contraindicated, and if it is to be removed, preferably with electric
clippers (clippers) just before the surgery. After shaving with a razor, microscopically small
lesions may form on the skin and bacterial colonization increases the risk of surgical site
infections by multiplying in surgical incisions after skin microorganisms penetrate these
lesions. For this reason, the National Institute for Health and Care Excellence(NICE), the
American Society for Healthcare Epidemiology(SHEA), and the Infectious Diseases Society of
America(IDSA) recommend not using razor shaving as it increases the risk of surgical site
infections, and if hair removal is required, use a disposable clipper head on the day of surgery.
Keywords: Hair removal before surgery; surgical site infection; hair removal methods.



]. C
           
maliyetlidir[Kusachi ve ark,. 2012  
  Badia ve ark,. 2020     
      Dakshinamoorthy, 2018].
          
siyon olmaya devam etmektedir[Kothari ve ark,. 2016].
144
        
Magill
ve ark,. 2018; CDC, 2023]. 
        
Alexander ve ark,. 1983     
        
           
        
McIntyre & McCloy, 1994    

         
Wangensteen ve ark,. 1980     

  
.
Hallstrom & Beck, 1993Kothari ve
ark,. 2016].
  
         
        
  Lefebvre,
2015].         
         
Healthcare Epidemiology of America(SHEA) cerrahi s
         

Mangram ve ark,. 2019; Anderson ve ark,. 2014; Ban ve
ark,. 2016; Calvet ve ark,. 2016; AORN, 2019].     

        
2015].
1. 

          
 
            
         
           



145
         
       

Yazar
Tarih

Ameliyat


Takip
Edile
n

r

Adeleye &
Olowookere
2008

Kranial
Cerrahisi
A: Jilet
B
C: Epilasyon
Yok
7-21-
30
A: 1/65
B: 3/65
C: 1/65
Adisa ve ark,.
2011
Nijerya
Genel
Cerrahi
A: Jilet
B

En Az

Hafta
A: 11/86
B: 2/79
Bekar ve ark,.
2001

Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
30
A: 12/980
B:
13/1038

2007

Omurga
Cerrahisi
A: Jilet
B: Epilasyon
Yok
Net

A: 4/371
B: 1/418
Dhamnaskar ve
ark,.
2022
Hindista
n
Abdomina
l Cerrahi
A: Jilet
B: Epilasyon
Yok
7-14-
30
A: 22/232
B: 20/232
Dakshinamoort
hy
2018
Hindista
n
Genel
Cerrahi
A: Jilet
B
3-15
A: 5/50
B: 1/50
Iwami ve ark.
2006
Japonya
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
30
A: 5/82
B: 7/82
Faheem ve
ark,.
2011
Suudi
Arabista
n
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
7-30
A: 17/ 319
B: 5/108
Grober ve ark,.
2013
Kanada

Cerrahi
A: Jilet
B
30-60
A: 2/108
B: 2/107
Jacob ve ark,.
2018
Hindista
n
Kulak
Cerrahisi
A: Jilet
B
14
A: 2/33
B: 0/31
Kattipattanapo
ng ve ark,.
2012
Tayland
Kulak ve
Meme
Cerrahisi
A: Jilet
B: Epilasyon
Yok
30
A: 3/66
B: 2/70
Kattipattanapo
ng ve ark,.
2013
Tayland
Kulak
Cerrahisi
A: Jilet
B: Epilasyon
Yok
30
A:3/60
B:2/76
146
Kothari ve
ark,.
2016
USA
Genel
Cerrahi
A
B: Epilasyon
Yok
30
A: 47/768
B: 49/775
Kovavisarach
ve ark,.
2005
Tayland

A: Jilet
B: 
14
21
A: 24/231
B: 16/227
Liu ve ark.
2008

Genel
Cerrahi
A: Jilet
B: Epilasyon
Yok
1-30
A: 38/600
B: 31/600
Li
2011

Ortopedik
Cerrahi
A: Jilet
B: 

1-30
A: 3/130
B: 5/130
Lu ve ark.
2002


Cerrahisi
A: Jilet
B: Epilasyon
Yok
1-7-
30
A: 1/30
B: 2/30
Mahanth ve
ark,.
2017
Hindista
n
Genel
Cerrahi
A: Jilet
B

C
7-14-
30
A:9 /74
B: 4/82
C: 2/71
Marul &

2005


Cerrahi
A: Jilet
B
15
A: 15/78
B: 13/78
Mehdi ve ark.
2009

Kranial
Cerrahi
A: Jilet
B
C: Epilasyon
Yok
1-30
A: 1/65
B: 3/65
C: 1/65

ark,.
2004


Cerrahi
A: Jilet
B: Epilasyon
yok
Net

A: 29/149
B: 25/151
Miller ve ark,.
2001
USA
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
7-14
A: 6/100
B: 11/150
Okoli ve ark,.
2020
Nijerya
Abdomina
l Cerrahi
A: Jilet
B

30
A: 11/50
B:6/50
Omolabake &
Ozoila
2020
Nijerya
Genel
Cerrahi
A: Jilet
B
Net

A: 7/76
B: 2/65
Ratanalert ve
ark,.
2005
Tayland
Abdomina
l Cerrahi
A: Jilet
B: Epilasyon
yok
Net

A: 12/83
B: 2/36
Suat & Ayhan
2007

Spinal
Cerrahi
A: Jilet
B: Epilasyon
Yok
1-30
A: 4/371
B: 1/418
Sun & Kou
2014

Kolesistek
tomi
A: Jilet
B: Epilasyon
Yok
1-30
A: 3/96
B: 2/110
147
Suvera ve ark,.
2013
Hindista
n
Genel
Cerrahi
A: Jilet
B

7-14-
30
A:15/112
B: 3/103
Taylor &
Tanner
2005


Cerrahi
A: Jilet
B
15
A: 15/78
B: 13/78
Walia ve ark,.
2021
Hindista
n
Genel
Cerrahi
A: Jilet
B: Epilasyon
Yok
7-14
A:9/50
B:4/50
Woraya ve ark.
2013
Tayland
Meme
Cerrahisi
A: Jilet
B: Epilasyon
Yok
1-30
A: 3/66
B: 2/70


        
  

    
 

        Adeleye &
Olowookere, 2008; Bekar ve ark,. 2001; Dhamnaskar ve ark., 2022; Iwami ve ark,. 2006;
Kattipattana, 2013; Kothari ve ark,. 2016; Liu, 2008; Lu, 2002; Mehdi ve ark,. 2009; Miller ve


 
        

Yazar
Tarih

Ameliyat


Takip
Edilen


Adeleye &
Olowookere
2009

Beyin
Cerrahisi
A: Jilet
B
C: Epilasyon
Yok
7-21-30
A: 1/65
B: 3/65
C: 1/65
Bekar ve ark,.
2001

Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
30
A: 12/980
B:
13/1038

2007

Omurga
Cerrahisi
A: Jilet
B: Epilasyon
Yok
Net

A: 4/371
B: 1/418
152
Dhamnaskar ve
ark,.
2022
Hindista
n
Abdomina
l Cerrahi
A: Jilet
B: Epilasyon
yok
7-14-30
A: 22/232
B:20/232
Iwami ve ark,.
2006
Japonya
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
30
A: 5/82
B: 7/82
Faheem ve ark,.
2011
Suudi
Arabista
n
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
7-30
A: 17/ 319
B: 5/108
Kattipattanapo
ng ve ark,.
2012
Tayland
Kulak ve
Meme
Cerrahisi
A: Jilet
B: Epilasyon
Yok
30
A: 3/66
B: 2/70
Kattipattanapo
ng ve ark,.
2013
Tayland
Kulak
Cerrahisi
A: Jilet
B: Epilasyon
Yok
30
A: 3/60
B: 2/76
Kothari ve ark,.
2016
USA
Genel
Cerrahi
A
B: Epilasyon
Yok
30
A: 47/768
B: 49/775
Liu ve ark.
2008

Genel
Cerrahi
A: Jilet
B: Epilasyon
Yok
1-30
A: 38/600
B: 31/600
Lu ve ark
2002


Cerrahisi
A: Jilet
B: Epilasyon
Yok
1-7-30
A: 1/30
B: 2/30
Mehdi ve ark.
2009

Kranial
Cerrahi
A: Jilet
B
C: Epilasyon
Yok
1-30
A: 1/65
B: 3/65
C: 1/65

ark.
2004

Endoskopi

Cerrahi
A: Jilet
B: Epilasyon
yok
Net

A: 29/149
B: 25/151
Miller ve ark,.
2001
USA
Kranial
Cerrahi
A: Jilet
B: Epilasyon
yok
7-14
A: 6/100
B: 11/150
Ratanalert ve
ark,.
2005
Tayland

Abdomina
l Cerrahi
A: Jilet
B: Epilasyon
yok
Net

A: 12/83
B: 2/36
Suat & Ayhan
2007

Spinal
Cerrahi
A: Jilet
B: Epilasyon
Yok
1-30
A: 4/371
B: 1/418
Sun & Kou
2014

Kolesistek
tomi
A: Jilet
B: Epilasyon
Yok
1-30
A: 3/96
B: 2/110
Walia ve ark,.
2021
Hindista
n
Genel
Cerrahi
A: Jilet
B: Epilasyon
Yok
7-14
A: 9/50
B: 4/50
Woraya ve ark.
2013
Tayland
Meme
Cerrahisi
A: Jilet
B: Epilasyon
Yok
1-30
A: 3/66
B: 2/70
153
          

  
           
Dakshinamoorthy, 2018; Grober ve ark., 2013; Jacop ve ark,. 2018; Kovavisarach ve ark,. 2005;


             

             
         
        
         
          

            


2021; Okoli ve ark,. 2020; Omolabake ve Ozoila, 2020; Suvera ve ark,. 2013; Taylor & Tanner,



erinin

Yazar
Tarih

Ameliyat


Takip
Edilen


Adeleye &
Olowookere
2011
Nijerya
Genel
Cerrahi
A: Jilet
B

Krem
7-21-30
A: 11/86
B: 2/79
Dakshinamo
orthy
2018
Hindistan
Genel
Cerrahi
A: Jilet
B
3-15
A: 5/50
B: 1/50
Grober ve
ark,.
2013
Kanada

Cerrahi
A: Jilet
B
30-60
A: 2/108
B: 2/107
Jacob ve
ark,.
2018
Hindistan
Timpanopl
asti
A: Jilet
B
14
A: 2/33
B: 0/31
Kovavisarac
h ve ark,.
2005
Tayland

A: Jilet
B: 
14 21
A: 24/231
B: 16/227
154
Li
2011

Ortopedik
Cerrahi
A: Jilet
B: 

Krem
1-30
A: 3/130
B: 5/130
Mahanth ve
ark,.
2017
Hindistan
Genel
Cerrahi
A: Jilet
B

Krem
C
7-14-
30
A: 9/74
B: 4/82
C: 2/71
Marul &

2005


Cerrahi
A: Jilet
B
15
A: 15/78
B: 13/78
Okoli ve
ark,.
2020
Nijerya

Abdomina
l Cerrahi
A: Jilet
B

Krem
30
A: 11/50
B: 6/50
Omolabake
& Ozoila
2020
Nijerya
Genel
Cerrahi
A: Jilet
B
Net

A: 7/76
B: 2/65
Suvera ve
ark,.
2013
Hindistan
Genel
Cerrahi
A: Jilet
B

Krem
7-14-30
A:15/112
B: 3/103
Taylor &
Tanner
2005


Cerrahi
A: Jilet
B
15
A: 15/78
B: 13/78

         

          
        
 



Ame
           

            

155

Adeleye, A. O., & Olowookere, K. G. (2008). Nonshaved cranial surgery in black Africans: a
short-term prospective preliminary study. Surgical Neurology, 69(1), 69-72.
Adisa, A. O., Lawal, O. O., & Adejuyigbe, O. (2011). Evaluation of two methods of
preoperative hair removal and their relationship to postoperative wound infection. The Journal
of Infection in Developing Countries, 5(10), 717-722.
Alexander, J. W., Fischer, J. E., Boyajian, M., Palmquist, J., & Morris, M. J. (1983). The
influence of hair-removal methods on wound infections. Archives of Surgery, 118(3), 347-352.
-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene,
L., & Kaye, K. S. (2014). Strategies to prevent surgical site infections in acute care hospitals:
2014 update. Infection Control & Hospital Epidemiology, 35(S2), S66-S88.
AORN, (2019); Guideline for preoperative patient skin antisepsis. In: Guidelines for
Perioperative Practice. Denver, CO: AORN, Inc; 2019:
--Casares, C., &
Balibrea, J. M. (2020). Surgical site infection prevention measures in General Surgery: Position
statement by the Surgical Infections Division of the Spanish Association of Surgery. Cirugía
Española (English Edition), 98(4), 187-203.
Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., & Duane, T.
M. (2017). American College of Surgeons and Surgical Infection Society: surgical site infection
guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59-74.

hair on infection after cranial surgery. Acta Neurochirurgica, 143, 533-537.
Calvet, G., Aguiar, R. S., Melo, A. S., Sampaio, S. A., De Filippis, I., Fabri, A., & de Filippis,
A. M. (2016). Detection and sequencing of Zika virus from amniotic fluid of fetuses with
microcephaly in Brazil: a case study. The Lancet İnfectious Diseases, 16(6), 653-660.
CDC, Surgical Site Infection Event (SSI) January 2023
https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf

spinal surgery? Spine, 32: 1575-1577.
Dakshinamoorthy, K. (2018). A clinical study on surgical site infections in Government Mohan
Kumaramangalam Medical College, Salem (Doctoral dissertation, Government Mohan
Kumaramangalam Medical College, Salem).
Dhamnaskar, S., Mandal, S., Koranne, M., & Patil, P. (2022). Preoperative Surgical Site Hair
Removal for Elective Abdominal Surgery: Does It Have Impact on Surgical Site Infection. The
Surgery Journal, 8(03), e179-e186.
Faheem, M., Zafar, M. R., & Othman, H. (2011). Cranial access procedures without shaving
scalp hair. Pan Arab Journal of Neurosurgery, 15(2), 1.
156
Grober, E. D., Domes, T., Fanipour, M., & Copp, J. E. (2013). Preoperative hair removal on
the male genitalia: clippers vs. razors. The Journal of Sexual Medicine, 10(2), 589-594.
Hallstrom, R., & Beck, S. L. (1993). Implementation of the AORN skin shaving standard.
Evaluation of a planned change. AORN Journal, 58(3), 498-506.
Huguenin, P, I switched to a single blade razor. Here's what happened
https://www.menshealth.com/style/a19526899/single-blade-razor-shave/, 2017 (accessed
13.03.2023).
Iwami, K. I., Takagi, T., Arima, T., & Takayasu, M. (2006). Cranial surgery without shaving:
practice and results in our hospital. No Shinkei geka. Neurological Surgery, 34(9), 901-905.
Jacob, K. R., Markose, A., Mathew, A., & Jacob, C. E. (2018). A randomised controlled trial
to compare the effects of two methods of preoperative hair removal on surgical site infections
in patients undergoing elective tympanoplasty. Journal of Evolution of Medical and Dental
Sciences, 7(37), 4895-4902.
Kattipattanapong, W., & Isaradisaikul, S. (2012). Surgical site infections in ear surgery: hair
removal effect. OtolaryngologyHead and Neck Surgery, 147(S2), P222-P222.
Kattipattanapong, W., Isaradisaikul, S., & Hanprasertpong, C. (2013). Surgical site infections
in ear surgery: hair removal effect; a preliminary, randomized trial study. Otolaryngology--
Head and Neck Surgery, 148(3), 469-474.
   ical site infectionsreview of current knowledge, methods of
prevention. Polish Journal of Surgery, 91(4), 41-47.
Kothari, S. N., Borgert, A. J., & Kowalski, T. J. (2016). Impact of Clipping vs No Hair
Removal on Surgical Site Infections: A Prospective, Randomized Trial. Journal of the
American College of Surgeons, 223(4), e19-e20.
Kovavisarach, E., & Jirasettasiri, P. (2005). Randomised controlled trial of perineal shaving
versus hair cutting in parturients on admission in labor. Journal-Medıcal Assocıatıon Of
Thaıland, 88(9), 1167.
Kusachi, S., Kashimura, N., Konishi, T., Shimizu, J., Kusunoki, M., Oka, M., & Sumiyama,
Y. (2012). Length of stay and cost for surgical site infection after abdominal and cardiac surgery
in Japanese hospitals: multi-center surveillance. Surgical İnfections, 13(4), 257-265.
Lefebvre, A., Saliou, P., Lucet, J. C., Mimoz, O., Keita-Perse, O., Grandbastien, B., & Aho-
            -
analysis of randomized controlled trials. Journal of Hospital Infection, 91(2), 100-108.
Li, XF. (2011) A study to compare the effect of two methods of preoperative skin preparation
in orthopedic patientsD(Chinese)
Liu, SL., Yu, LH., Huang, DQ., & Peng, SL. (2008)Comparison between infection rates of
incisional wound in patients perfomed different skin preparation methods before operation.
Chin J Infect Control 7(4), 262-263.
Lu, XY., Zhao, JJ., Zhou, Y., Cao, J., & Qin, SH. (2002)Influence of hair removal on
postoperative wound infection in thoracic surgery. Nursing Journal of Chinese People's
Liberation Army (Chinese)19 (6), 12-13.
157
, Thompson, D. L., Dumyati, G., Nadle, J., & Edwards,
J. R. (2018). Changes in prevalence of health careassociated infections in US hospitals. New
England Journal of Medicine, 379(18), 1732-1744.
Mahanth, H. M., Chetty, Y. N., & Rudresh, H. K. (2017). Evaluation of Depilatory Cream,
Razor and Clipping Method of Hair Removal in Pre-operative Skin Preparation and Its Effects
on Surgical Site Infection. IJSS Journal of Surgery, 3(3), 57-63.
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., Jarvis, W. R., & Hospital Infection
Control Practices Advisory Committee. (1999). Guideline for prevention of surgical site
infection, 1999. Infection Control & Hospital Epidemiology, 20(4), 247-280.
Different Hair Removal Methods
Prior to Surgery on Surgical Site Infections. GMJ, 32, 364-370.
McIntyre, F. J., & McCloy, R. (1994). Shaving patients before operation: a dangerous
myth?. Annals of the Royal College of Surgeons of England, 76(1), 3.
Mehdi, A., Nasim, S., Mehrdad, H., Mehrdad, B., & Armin, R. (2009)Effect of hair on surgical
wound infection after cranial surgery: a 3-armed randomized clinical trial. Surg Neurol 71, 261-
262
bias, C., Paz Cruz, L. D.,

   Actas Urológicas
Españolas, 28(10), 761-765.
Miller, J. J., Weber, P. C., Patel, S., & Ramey, J. (2001). Intracranial surgery: to shave or not
to shave?. Otology & neurotology, 22(6), 908-911.
Okoli, C. C., Anyanwu, S. N., Emegoakor, C. D., Chianakwana, G. U., Ihekwoaba, E.,
Ughasoro, M. D., & Nzeako, H. (2020). Does preoperative chemical depilation make any
difference in postoperative wound infection?. Nigerian Journal of Clinical Practice, 23(9),
1318-1323.
Ratanalert, S., Musikawat, P., Oearsakul, T., Saeheng, S., & Chowchuvech, V. (2005).
Nonshaved ventriculoperitoneal shunt in Thailand. Journal of Clinical Neuroscience, 12(2),
147-149.
Suat, EC., & Ayhan, K. (2007) Does shaving the incision site increase the infection rate after
spinal surgery? Spine 32, 1575-1577.
Sun, J., & Kou, JL,. (2014) Two methods of skin preparation before laparoscopic
cholecystectomy. Chin J Mod Nurs 20(13), 1559-1561.
Suvera, M., Vyas, P., Patel, M., Varghese, V., Ahmed, A., Kashyap, R., & Nair, D. (2013).
Two methods of pre-operative hair removal and their effect on post-operative period.
International Journal of Medical Science and Public Health, 2(4), 885-8.
T.C. S      
https://www.saglikaktuel.com/d/file/guvenli_cerrahi_uygulama_rehberi_1_15.07.2015.pdf/ ,
2015, (accessed 22.01.2023).
Taylor, T., & Tanner, J. (2005). Razors versus clippers: a randomised controlled trial. British
Journal of Perioperative Nursing (United Kingdom), 15(12), 518-523.
158
Walia, D. S., Saini, J. R. S., Mohi, R. S., Singh, S., & Kaur, R. Shaving before Surgery-Merits
& Pitfalls. Annals of International Medical and Dental Research, 7(1), 24.
Wangensteen, O. H., Wangensteen, S. D., & Freshwater, M. F. (1980). The Rise of Surgery:
From Empiric Craft to Scientific Discipline. Plastic and Reconstructive Surgery, 65(4), 530.
159


Investigation of the Effect of Tele Nursing Practices on the Care of Individuals with
Chronic Diseases
1
1
guldenatan@yyu.edu.tr , Orcid: 0000-0001-8816-9537

           
         

           
          


     

           
         

         
    
  -
       
uygulam
-
-l, klinik, psikolojik
         
        
        


Anahtar Kelimeler: 
ABSTRACT
The World Health Organization (WHO) defines chronic diseases as non-communicable
diseases that tend to be long-lasting, progress slowly, and result from a combination of
genetic, physiological, environmental and behavioral factors. Chronic diseases cause the
death of 41 million people every year, which corresponds to 71% of all deaths in the world.
Major types of chronic diseases; cardiovascular diseases (such as heart attack and stroke),
cancers, chronic respiratory diseases (such as COPD and asthma), and diabetes. Chronic
disease management refers to the ongoing care and support provided to individuals living
160
with a chronic illness. Nurses have the opportunity to spend more time and communicate
with patients due to the nature of their practices, their primary duty is to provide care in line
with the individual's needs, and they have a key role in the treatment and adaptation to daily
life of patients and in the management of chronic disease. Nurses plan their care in line with
the needs of the individual with a chronic disease, and guide the patients in the management
of chronic disease by making individual-specific training plans. Tele-nursing has the
capacity to facilitate patients' access to these services. Tele-nursing is a technology-based
nursing service created to facilitate healthcare services for patients. The concept of tele-
nursing focuses on using computers, internet, telephone, remote monitoring devices and
digital assessment tools while planning, maintaining, applying and evaluating the results of
nursing care practices. In studies conducted to examine the effects of tele-nursing in chronic
diseases, it has been reported that tele-nursing is an effective method in educational, clinical,
psychological and economic nursing practices, facilitates symptom control in patients, and
helps to improve individuals' mental health and personal care behaviors. The aim of this
study is to evaluate the chronic diseases in which tele-nursing is used and the results of tele-
nursing in these diseases.
Key words: Tele-Nursing, Chronic Disease, Patient Care, Nursing.


          

         
             

          


kronik solu
          
dir. Bu

         


         
           

         
         


           
           
161
           
         
        


        
     
-


   
           
          

(6).

    -       
  
         
           


         
          

-

 


        






 


.
3.Bulgular
162
-
         


  

    - 
   
         

 -         


Kronik obstrüktif akciğer hastalığı (KOAH):     
         
          

         
anksiyeteyi etkileyip etkile


57 ol
          
        e

Alkole bağlı olmayan karaciğer yağlanması (Non-Alcoholic Fatty Liver Disease: NAFLD):
        
e tele-       

ndan telefonla

          
          
   
         
           

Hipertansiyon:         
        
       
         

ortal            
          

163
Epilepsi: Epilepsi, kendi ke


et         

     


     
          
          
        

Diabetes Mellitus: 
 Glikolize Hemoglobin olarak bilinen HbA1c
    
    


          
         


Kronik Böbrek Yetmezliği (KBY):    
   
          
Hemodiyaliz ile te  

          
-


Parkinson:        
         

   


         
        

          
     -   


164
Kronik h  

Bu nedenle tele-    - 
h

        
ziya         edilmesi, tele-
        
 
KAYNAKLAR
1. WHO, World Health Organization; Noncommunicable Diseases. https://www.who.int/news-
room/fact-sheets/detail/noncommunicablediseases
           

-106.

       -2020.
https://hsgm.saglik.gov.tr/depo/birimler/kronik-hastaliklar
4. Grover A, Joshi A. An Overview of Chronic Disease Models: A Systematic Literature
Review. Glob J Health Sci. 2014 Oct 29;7(2).
           
Management. Disease Management & Health Outcomes. 2003;11(8):47788.
6.Nield, M., & Hoo, G. W. S. (2012). Real-time telehealth for COPD self management using
-619.
          
       
Bilimleri Dergisi, 12(4), 607-615.

-201.
9.Li R, Liang N, Bu F, Hesketh T. (2020). The effectiveness of self-management of
hypertension in adults using mobile health: Systematic review and metaanalysis. JMIR Mhealth
And Uhealth, 8(3), 1776-1792.
         
-14.
11.Asimakopoulou E. (2020). Telenursing in clinical practise and education. International
Journal of Caring Sciences, (13)2, 781-782

-35
165
   -management strategies and the role of
nurses in the management of chronic diseases. Eurasian Journal of Health Sciences, 4(1), 9-13.

Dergisi, 11(1), 1-4.
           
perception and Knowledge among University Students of Nursing in Poland. Telemedicine and
e-Health, 19(7), 523529. doi:10.1089/tmj.2012.0217.
16. Souza-Junior, V. D., Mendes, I. A. C., Mazzo, A. ve Godoy, S. (2016). Application 56 of
telenursing in nursing practice: An integrative literature review. Applied Nursing Research, 29,
254260. doi:10.1016/j.apnr.2015.05.005.
17.MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P. ve Bond, C.
A. (2005). Assessing medication adherence in the elderly: Which tools to use in 63 clinical
practice? Drugs and Aging, 22(3), 231255. doi:10.2165/00002512-200522030- 00005
    -        
- 
severe COPD: the PROMETE study. Respiratory medicine, 108(3), 453-462.
19. Ghodsbin, F., Javanmardifard, S., Kaviani, M. J., & Jahanbin, I. (2018). Effect of tele-
nursing in the improving of the ultrasound findings in patients with nonalcoholic fatty liver
diseases: A Randomized Clinical Trial study. Investigacion y educacion en enfermeria, 36(3),
8. doi: 10.17533/udea.iee.v36n3e09.
20. Kazem, S., Shahriari, M., & Eghbali, M. (2016). Comparing the effects of two methods of
self-monitoring and telenursing on the blood pressure of patients with hypertension. J Res
Health Sci, 5, 213-22.
21. Arab, M., & Bagheri, E. (2016). Comparison of the effect of educational intervention based
on adult learning theory and telenursing on selfmanagement among epileptic patients. Journal
of Research and Health, 6 (5), 522-529.
22. Borhani, F., Lashkari, T., Sabzevari, S., & Abbaszadeh, A. (2013). Effect of telenursing
(telephone follow-up) on glycemic control and body mass index (BMI) of type 2 diabetes
patients. Iranian journal of nursing and midwifery research, 18(6), 451.
23. Jahromi, M. K., Javadpour, S., Taheri, L., & Poorgholami, F. (2016). Effect of nurse-led
telephone follow ups (tele-nursing) on depression, anxiety and stress in hemodialysis patients.
Global Journal of Health Science, 8(3), 168.
24. Mancini, F., van Halteren, A. D., Carta, T., Thomas, S., Bloem, B. R., & Darweesh, S. K.
(2020). Personalized care management for persons with Parkinson's disease: A telenursing
solution. Clinical parkinsonism & related disorders, 3, 100070.

    (3), s.613- 632. DOI:https://www.doi.org/
10.25279/sak.939169.
166


Comparison of Risk Assessment Methods in Spice Processing Plants
and Evaluation in Terms of Occupational Safety
1,23
1    
91210000278@ogrenci.ege.edu.tr, 0000-0002-0263-9110
2     hasan.ates@kavram.edu.tr, 0000-0002-
0263-9110
2     omer.kemal.kemahlioglu@ege.edu.tr,
0000-0002-8125-6563
 Baharatlar, ken        
         
     
       
       
         
paketlenmesi ve depol

-Kinney risk

Anahtar Kelimeler**: 5x5 L Matris, Fine-
ABSTRACT
Spices are widely used for various purposes in households as well as in the pharmaceutical,
cosmetic and food industries due to their unique flavor properties. Phytochemicals in spices are
bioactive plant compounds that can be used as antimicrobial, antibacterial, anticancer agents.
Studies have reported that phytochemicals prevent cancer, cardiovascular and inflammatory
diseases. Occupational health and safety rules must be complied with during processes such as
processing, packaging and storage of spices, which have such important properties. In this
study, it is aimed to analyze the hazards and risks that may occur in a spice processing plant in
the determined regions and to compare and evaluate them according to the 5x5 L Matrix and
Fine-Kinney Risk Assessment Methods.
Keywords**: 5x5 L Matrix, Fine-Kinney, Risk Assessment, Spices
167
 VE 
1. Bitkiler ve Baharatlar
Baharatlar, eski zamanlardan beri insan beslenmesinde mutfak malzemeleri olarak
         
          

-inflamatuar,
antimikrobiyal, anti- -, nefron- ve hepatoprotektif aktiviteye, anti-
romatizmal, anti-kanser, anti-mutajenik ve anti-









     
         

 
           
            



         
          

         



Baharatlar

siyah ve beyaz biberler,
zencefil
Hafif baharatlar

Aromatik baharatlar


 cevizi (nutmeg)
Bitkiler

kekik
Aromatik sebzeler

  -
168
organik       

         hassas



2. 
        

 
          
          

             

    


i insani ve ekonomik faydalar sunar
   




         
         -
-

1. L-Matris 
L-       

       -    
           
 





169
Tablo 2. L-
OLASILIK
 
 Durumlarda
 
 
 
Tablo 3. L-

1:  
 
 
 
 :Felaket
Tablo 4. L-


5
4
3
2
1

Ciddi
Orta
Hafif

5

25
20
15
10
5
4

20
16
12
8
4
3
Orta
15
12
9
6
3
2

10
8
6
4
2
1

5
4
3
2
1
Tablo 5. L-

Eylem (faaliyet)
15,16,20,25
Kabul Edilemez


8,9,10,12



1,2,3,4,5,6
Kabul Edilebilir Risk
Acil eylem gerekli olmayabilir
2. Fine-
Fine-
  
potansiyel olarak tehlikeli 
           
        
dene
-
ar Tablo 6., Tablo

170
Tablo 6. Fine-


Beklenebilir
10

6

3

1

0.5

0.2

0.1
Tablo 7. Fine-
Frekans


10

6

3

2

1

0,5
Tablo 8. Fine-



100

40

15

7

3


1
Tablo 9. Fine-
Toplam

me
Risk
Seviyesi

0.1-20

Edilebili
r

21-70




gereklidir.
71-200
Orta




201-400




171
400


n Derece



Tablo 10. Fine-

Risk durumu
>400

200 - 400

70 - 200

20 - 70

<20
Risk; bir ihtimal kabul edilebilir
BULGULAR
        
            
 -Matris hem
de Fine-
nleyici

 -Matris ve Fine-     


        -Tipi matris risk


         
 

        -Kinney risk

            

erden


172
ike ve risklerin L-



L-Matris ve Fine-
L-Matris ve Fine-Kinney 

No
Faaliyet

Faaliyet

Tespit Edilen Tehlike

(Risk)


Frekans
Risk
Riskin


Tedbirler





Frekans
Risk
Riskin

1
Baharat

Baharat 2


  



4
5
20
Kabul
Edilemez
Risk
   
    
tertip edilmelidir.



2
5
10

Risk
6
15
6
540


risk
1
15
6
90

risk
2
Baharat



  

Duyma

4
4
16
Kabul
Edilemez
Risk
   
     
     
    




M
SORUMLUSU/

2
4
8

Risk
6
3
6
108

risk
1
3
6
18
Kabul
Edilebilir
Risk
3
Baharat

Sortexin
Silosunun



 
 
Sonucu Personelin




3
5
15
Kabul
Edilemez
Risk
     
belirlenmeli  
 
verilmelidir.




SORUMLUSU/

2
5
10

Risk
3
15
6
270

Risk
1
15
6
90

Risk
4
Baharat

Sortexin
Silosunun



 
  
Emniyet Kemeri, Baret
 




3
5
15
Kabul
Edilemez
Risk
   

    




2
5
10

Risk
3
15
6
270

Risk
0,5
15
6
45

5
Baharat

Baharat 2


 
 
 
Emniyet Switchlerinin

Uzuv

Yaralanma
3
5
15
Kabul
Edilemez
Risk
 
   
  








2
5
10

Risk
6
7
6
252

Risk
0,5
7
6
21

173
6
Baharat

3.

Makinalar
(Baharat 2



Makine- 




Yaralanma

3
5
15
Kabul
Edilemez
Risk
Makine-   kullanma
    
   





SORUMLUSU
1
5
5
Kabul
Edilebilir
Risk
6
15
6
540

Risk
1
15
6
90

Risk
174
-



L-Matris ve Fine-
L-Matris ve Fine-
7
Baharat


Kullanma
  

Trafik

3
5
15
Kabul
Edilemez
Risk
     
belirtilmelidir.   





SORUMLUSU
1
5
5
Kabul
Edilebilir
Risk
6
40
6
1440


Risk
0,5
40
6
120

Risk
8
Baharat

Baharat 2


 

Meslek

Gaz- Toz
Birikim
Sonucu
Patlama,

3
5
15
Kabul
Edilemez
Risk
  
leri
   




2
5
10

Risk
3
100
6
1800


Risk
0,2
100
6
120

Risk
9
Baharat

Baharat 1


Sarsak Eleklerin Elektrik
  

Elektrik



3
5
15
Kabul
Edilemez
Risk
    





BAKIM

2
5
10

Risk
3
15
6
270

Risk
0,5
15
6
45

10
Baharat

Baharat 2


 
  

Elektrik


Sonucu
Yaralanma


3
5
15
Kabul
Edilemez
Risk

   
    





2
5
10

Risk
6
15
6
540


Risk
1
15
6
90

Risk
11
Baharat

3.

Elektrik
Prizleri,
Elektrik

Kablolarda, Priz Ve
 

Elektrik


3
5
15
Kabul
Edilemez
Risk
    
   
   





ONARIM

2
5
10

Risk
6
15
6
540


Risk
1
15
6
90

Risk
12
Baharat




Malzeme

3
5
15
Kabul
Edilemez
Risk
    
   
  



1
5
5
Kabul
Edilebilir
Risk
175


6
15
6
540


Risk
engellemeyecek ve    
  
  
   


SORUMLUSU
0,5
15
6
45

176
Tablo 12.      L-    

L-

Faaliyetlerden Sonra
Eylem (faaliyet)
Adet
Adet
Kabul Edilemez
12
0

0
9
Kabul Edilebilir Risk
0
3
Tablo 13.  Fine-
Fine-
Risk durumu
Adet
Adet

6
0

5
0

1
7

0
4
Kabul Edilebilir Risk
0
1
 VE 
L-Tipi Matris ve Fine-      
         -Kinney
 -         
    -Tipi Matris riskin
-Kinn

Bu durumda bize Fine-
n sonra L--Kinney


         
 -Matris, Fine-  

         
          

         
          
yenilenmesi ve persone

177

Modupalli, N., Naik, M., Sunil, C. K., & Natarajan, V. (2021). Emerging non-
destructive methods for quality and safety monitoring of spices. Trends in Food Science
& Technology, 108, 133147.
Lim, T. K. (2016). Edible medicinal and non-medicinal plants, In Edible
medicinal and non-medicinal plants (Vol. 10). https://doi.org/10.1007/978-94-017-7276-
1 Sasikumar, B. (2019). Advances in adulteration and authenticity testing of
turmeric (Curcuma longa L.). Journal of Spices and Aromatic Crops, 96105.
https://doi.org/10.25081/josac.2019.v28.i2.6072
Bhagya, H. P., Raveendra, Y. C., & Lalithya, K. A. (2017). Mulibenificial uses
of spices: A brief review. Acta Scientific Nutritional Health, 1(1), 36.
https://actascientific.com/ASNH/pdf/ASNH-01-0002.pdf
Guldiken, B., Ozkan, G., Catalkaya, G., Ceylan, F. D., Ekin Yalcinkaya, I., &
Capanoglu, E. (2018). Phytochemicals of herbs and spices: Health versus toxicological
effects. Food and Chemical Toxicology, 119, 3749.
https://doi.org/10.1016/j.fct.2018.05.050
Sagoo, S. K., Little, C. L., Greenwood, M., Mithani, V., Grant, K. A.,
McLauchlin, J., Pinna, E. de, & Threlfall, E. J. (2009). Assessment of the microbiological
safety of dried spices and herbs from production and retail premises in the United
Kingdom. Food Microbiology, 26, 3943.
McKee, L. H. (1995). Microbial contamination of spices and herbs: A review.
Lebensm, Wiss. Technol., 28, 111.
Peter, K. V. (2004). Handbook of herbs and spices (Vol. 2). Woodhead Publishing
Limited, Cambridge England.
FAO. (2011). FAOSTAT Agricultural Production and Trade Data.
http://faostat.fao.org [accessed March 2012]
Dhanya, K., Syamkumar, S., Siju, S., & Sasikumar, B. (2011). SCAR markers for
adulterant detection in ground chilli. British Food Journal, 113(5), 656668.
https://doi.org/10.1108/00070701111131755
Oliveira, M. M., Cruz-Tirado, J. P., & Barbin, D. F. (2019). Nontargeted
analytical methods as a powerful tool for the authentication of spices and herbs: A
review. Comprehensive Reviews in Food Science and Food Safety, 18(3), 670689.
https://doi.org/10.1111/1541-4337.12436
Peter, K. V. (2012). Handbook of herbs and spices (2nd ed., Vol. 1). Woodhead
Publishing Series in Food Science, Technology, and Nutrition: Number 227.
Alli, B. O. (2008). Fundamental Principles of Occupational Health and Safety
(2nd ed.). International Labour Office, Geneva.
178

Virtual Applicability of Occupational Health and Safety in Search and Rescue Activities
12
1   Bayburt,  fmehmetates@bayburt.edu.tr, ORCID:
0000-0002-7497-2211
2           
ORCID: 0000-0002-8199-3336

          

-
Bu            
 -      



       -kurtarma faaliyetlerinin sanal

    -   

          

         
arama-    

Bulgular: Afetle

 tehlikelere ve



          
-kurtarma

-
Anahtar Kelimeler: -kurtarma, 
ABSTRACT
Purpose: An ideal disaster management should be applied in order to eliminate the
negative effects of disasters that can cause loss of life and property in human life. People, who are
the main members in disaster management, play an important role in search and rescue teams. The
ability of these team members to be ready for disasters depends on having sufficient knowledge
and skills. Different methods can be used to maximize the learning capacity of search and rescue
team members. Virtual reality applications, one of the methods used in active learning, are
179
becoming widespread nowadays. With virtual reality applications, a real disaster-like situation is
created, allowing the user to make more applications than in the real environment. In this study,
the contribution of the virtual reality applications of the search and rescue activities to the
personnel vocational training was examined.
Method: Personnel who will be involved in search and rescue activities when exposed to
disasters should have a certain knowledge and skill about what to do during disaster response. In
order for the teams to work safely in disaster areas, they must have the maximum level of
knowledge and equipment. The use of innovative methods in addition to traditional education and
training methods in reaching these vocational qualifications will make positive contributions to
the search and rescue personnel's reaching their competencies more quickly. Especially virtual
reality applications were examined.
Results: Hazards, risks and precautions that employees and volunteers may be exposed to
during response to disasters should be determined and the most appropriate risk analysis should
be made according to the type of disaster. After the risk analysis is carried out, both precautions
should be taken and exercises and trainings should be carried out in order to reduce the exposure
of those who will take part in disasters to these hazards and risks. In these trainings, permanent
learning can be created by using virtual reality applications.
Conclusion and Suggestions: The capacity of learning the disaster awareness of search
and rescue members will be maximized through virtual reality applications of the activities to be
carried out in disaster areas that have high similarities with real life. Thus, it will be possible to
have search and rescue team members with high disaster awareness and competence.
Keywords: Disaster management, search and rescue, virtual reality, occupational health and
safety

  

           
         

            
makine, eki

ken bazen de afet olarak
          
           



           

 


           
          

180
        e; belirlenen



    -     



      
         

       

         

      -  
    
          le


      
- 


-

De          -kurtarma

Arama-
    zel ekiplerce arama, bulma ve kurtarma faaliyetlerini ifade etmektedir.
 
     -   
mal          

        Kuvvetleri,

          

Arama-       

      -      
          
          
-kurtarma faaliyetleri
boy    -kurtarma ekipleri, arama- 
           

181

         
          



    
          
         
kaydedilmesinde uygulama       
   

          
         
( 
          


          


        
 
         
    
          
         



    
arama-      in bilgi ve becerilerini
     -kurtarma personelinin afetlerdeki

        
 

de benzer etkiyi ya    -  


Bulgular
 
    
kullanacak olan arama-          
gerekmektedir-

182
       

Arama-
arama-       
etmelidir.
Arama-kurtarma eki        
    




           
tatbikatlar
-kurtarma personelleri daha




            

          
-kurtarma ekiplerin-kurtarma
   -     

Arama-
        

        

   -   
-


         



--95.

Educational Technology, 9(4):15-24.
Bloch T., Sacks R., Rabinovitch O., (2016). Interior Models of Earthquake Damaged
Buildings for Search and Rescue, Advanced Engineering Informatics, 30(1), 65-76.
Bruner, J. (1966). Toward a Theory of Instruction. Cambridge: Belknap Press.
Dale, E. (1969). Audio-Visual Methods in Teaching.(3rd ed).New York: The Dryden
Press.
183
     
-63.
            (2012). Afet
-123.

-38.
Klein, L. R. (2003). Creating Virtual Product Experiences: The Role of Telepresence.
Journal of Interactive Marketing, 7(1), 41-55.
Ochoa S.F., Santo R., (2015). Human-     
h and Rescue Activities, Information Fusion, 22, 71-
84.
         
Psikolojisi (s. 304-
Peleg K., Bodas M., Shenhar G., Adini B., (2018). Wisdom of (Using) The Crowds:
Enhancing Disasters Preparedness Through Public Training in Light Search and Rescue,
International Journal of Disaster Risk Reduction, 31, 750-757.
Philippe, H., Scheuren, J.M., Below, R., GuhaSapir, D. (2007). Annual Disaster Statistical
Review: Numbers and Trends. Jacoffset Printers, Melin: Brussels.
           
Progress for Open and Equal Access for Learning. Open and Equal Access for Learning in School
Management (s.117-143).
Suh, K.-S., & Eun Lee, Y. (2005). The Effects of Virtual Reality on Consumer Learning:
An Empirical Investigation The Effects of Virtual Reality on Consumer Learning: An Empirical
Investigation1. Source: MIS Quarterly MIS Quarterly, 29(4), 673-697.

   
6(1): 196-208.
184

Virtual The Impact of Stressful Working Life on Our
Health
Meryem Buket Yarar1, Seda 2, Fatih Mehmet 3
1 Avrasya       ve    Trabzon, 
22121050003@avrasya.edu.tr
2 Avrasya        
,Trabzon,  seda.fandakli@avrasya.edu.tr
3  fmehmetates@bayburt.edu.tr

 Stres,   belirli biyolojik, fiziksel ve  

 olan
kronik stresle; kan  artma, i  sistemde bozulma, 
 tekrar  ya
da stres  damarlarda hasara yol  Bu durumda hipertansiyon, kalp krizi veya
  da stresin 
etkileri 
 ve Bulgular: Soyut  stres bir   uyum  iken somut 

         
        
 dikkate     ile   sonucu 

          
organizasyonun  organizasyonel stresin sebeplerinden  ifade edilebilir. Bu
 
      
   

stres de       performans  maliyetlerin
 ve     Bu  ile stresin  ve
 
          
           
        
         
    olarak nitelendirilen stres ve stres  maruz
 analiz 
Anahtar Kelimeler: Stres, stresin nedenleri, organizasyonel stres, stres  fabrika

185
ABSTRACT
Objective: Stress refers to the situation that occurs in conditions that trigger the
development of certain biological, physical and cognitive reactions in the body, and that expose
the person to a momentary threat or a problem that requires struggle. With chronic stress, which
is among the causes of stress; increase in blood pressure, deterioration in the immune system,
problems in fertility, heart diseases and intestinal problems may develop. If acute stress is
experienced repeatedly or if the stress becomes chronic, it can cause damage to the vessels. In
this case, hypertension increases the risk of heart attack or stroke and irritable bowel syndrome.
In this study, the effects of stress on health were examined.
Methods and Findings: In abstract terms, stress is a kind of adaptation to change, while
in concrete terms it is both a physical and physiologically based life experience that occurs at
the personal level. The basis of the organization in a workplace is established by the individuals
working in this workplace. Of course, it is not surprising that every single employee that makes
up the organization is taken into account in the study of organizational stress. Organizational
stress resulting from the relationship between the employee and the environment; It can be
expressed as a reaction to the excessive psychological or physical demand demanded from the
employee. Relationships between employees, physical conditions, organizational policies and
structure of the organization; It can be stated that it is one of the causes of organizational stress.
As a result of these reasons, employees face many problems. The first of these problems is the
decrease in the performance of the employees. Situations such as centralized behaviors in the
organization, excessive expertise, excessive workload, low promotion and development
opportunities, and bureaucratic inhibitions can cause stress. Organizational stress also causes
alienation from work, absenteeism, work accidents, decrease in performance, increase in costs
and increase in employee turnover. In this study, the sources and consequences of stress were
examined.
Conclusion and Suggestions: In stress management, reducing the increased adrenaline
level, body relaxation exercises, sports activities, proper nutrition, the body spends less energy
and enters the resting position, starting the process of managing stress. In this study, considering
the variability of stress in different sectors, the analysis of factory workers who are exposed to
stress and stress factors, which is described as the plague of business life, was carried out.
Keywords: Stress, causes of stress, organizational stress, stress management, factory workers


  rutin faaliyetlerini ve hayat kalitesini etkilemektedir. Bunun  strese
uzun  maruz kalmak, bireyde    ortaya  yol
         
     
186
2008; Schneiderman vd., 2005).  her yerinde maruz  stres;  herhangi
bir zorluk veya tehdit   hallere    bir tepki veya 
           




           
 Bu    strese yol   belirlemek ve strese neden olan
 irdeleyerek, stres       (Siqueira vd.,
2000; Simmons vd, 2009).
 

          
stres; bireyle   dengenin  durumunda, bireyin yeniden dengeyi tesis
(Butcher
vd., 2013). Richlin-

    
         
maruz kalan    gastrointestinal problemler, tansiyon  nefes almada
zorlanma,  terleme vb. fiziksel belirtilerin    gerginlik, keyifsizlik,
        vb.
psikolojik ve    2008).
BULGULAR
          
       

 genellikle fizyolojik ve psikolojik semptom  
 Fizyolojik semptomlar; insan bedenindeki fiziki  kimi zaman maruz
 


yeme, kilo  kronik yorgunluk, halsizlik, uykusuzluk,  veya  uyku,  

duygu durum     sigara veya alkol kullan enerji  terleme,

     
   stresin bu prosesi   ilgilidir. Stresli halde psikolojik
semptomlar;     ifade etmesi ve  kendini

187

Normal bir    bir    

 isterse evde  istenmeyen durumla   fabrika
   
        
   
 bir problemdir. Temelde stres bir tepki halidir.  bir durumun,  ya
          
          
       
   
 tespit edilebilmesi  anket  ger durum tespiti
  zamanda   

  (2008).   stres. (3.  Ankara: Pegem Akademi 
 A. ve  Z. (2008). Stres ve    (24.   Remzi
Kitabevi.



 incelenmesi,   Dergisi, 20(1), 133-150.
 K. (2019). Stres, Ruh  Ve   Bir  
Akademik   Hakemli Sosyal Bilimler Dergisi, (73), 63-81.


-263.
Schneiderman, N., Ironson, G., Siegel, S. D. (2005). Stress and health: psychological,
behavioral, and biological determinants. Annual Review of Clinical Psychology, 1, 607- 628.
Siqueira, L., Diab, M., Bodian, C., and Rolnitzky, L. (2000). Adolescents becoming
smokers: The roles of stress and coping methods. Journal of Adolescent Health, 27, 399-408.
Simmons, L. A., Havens, J. R., Whiting, J. B., Holz, J. L., and Bada, H. (2009). Illicit
drug use among women with children in the United States: 2002-2003. Annals of
Epidemiology, 19(3), 187-193
188

Hacettepe    6(6), 175-189.
 H. (2014).   Ve Stres  Durumsal Bir  Manas
Sosyal -131.
189

1Adem Keskin2 Recai Aci3
1          
muratari60@gmail.com, 0000-0002-1504-7050
2 ademkeskin78@gmail.com, 0000-0003-
1921-2583
3 recaiaci35@gmail.com, 0000-0002-3332-6619

           
mikroorganizma bulunur. Probiyotikler de bu iyi etkileri olan mikroorganizmalar grubuna


           

         
  

             
probiyotik L


Anahtar Kelimeler: Probiyotikler, Antioksidanlar, Oksidatif stres, Laktik Asit Bakterileri
ANTIOXIDANT EFFECTS OF PROBIOTICS
Abstract
In terms of their effects on the human body, there are many microorganisms that have
good and bad effects. Probiotics are also included in this group of microorganisms with good
effects. Due to their numerous health benefits, some of which seem to be connected to their
antioxidant characteristics, lactic acid bacteria (LAB) are the most commonly utilized
probiotics in fermented foods and beverages as well as as food supplements for people or
animals.
LAB may help enhance the flavor and quality of food while preventing a wide range of illnesses
brought on by oxidation in the host. In this review, we discuss about probiotic LAB's ability to
withstand oxidative stress, its antioxidant capacity, and the underlying mechanisms and
signaling pathways that it uses. The antioxidant properties and potential mechanisms of action
of probiotics and postbiotics are also revealed and in vitro-in vivo studies in the literature are
widely included. In addition, we discuss appropriate methods used to evaluate the antioxidant
capacity of probiotic LAB.
190
The purpose of the current study is to give a broad overview of the status of the research
associated with the oxidative stress tolerance and antioxidant capacity of LAB.
Key Words: Probiotics, Antioxidants, Oxidative stress, Lactic Acid Bacteria


    
  
         r (1).
         
 6  

        
        
 

  

          l

         
 

          

Probiyotiklerin s


         
Hipoksi, oksijen ko        

         
radyas           

f stres prensibi ile

          
     
ateroskleroz, artrit, diya

-  eler

191
Probiyotikler ve Antioksidan Rolleri
       
          


         
       

            

  
(20).
Probiyotik LAB

 
lur ve organizmaya zarar verir. Oksidatif stres,
        
           
  

          
kapasites

        
        rek

        
        

        


ROS ve reakt        

2  Bu
     
2 ve H2O2
etkiye sahiptir (27).
192

Antioksidatif enzim      

(28). Fe2+ ve Cu2+          2+,
Fenton        2+  
       2+ hem de Cu2+    


LAB kendi antioksidan enzimat
O2 ve H2O2       
           


       

       





         

idasyonunun
       




         
        

         

          
        
         
 idobacterium

          
193
        


erkek albino wistar farelerine Lactob    
          

   

 






Referanslar
1. Lee, K.Y., 2009. Definitions. In: Lee, Y.K., Salminen, S. (eds.) Handbook of Probiotics and
Prebiotics, 3, Wiley Inc.
, Mistry V.V., Shah, N.P., 2007. Production
and maintenance of viability of probiotic microorganisms in dairy products. In: Tamime, A.Y.
(ed.) Probiotic Dairy Products, 39-72, Blackwell Publishing.
3. Kaur, P. and Satyanarayana, T., 2004. Probiotics. A beneficial health option. Everyman’s
Science 4: 224-229.
4. Parvez, S., Malik, K.A., Ah Kang, S., Kim, H.Y., 2006. Probiotics and their fermented food
products are beneficial for health. Journal of Applied Microbiology 100: 1171-1185.
5. Wang Y, Wu Y, Wang Y, Xu H, Mei X, Yu D, Wang Y, Li W., 2017. Antioxidant properties
of probiotic bacteria. Nutrients, 9:521. doi:10.3390/nu9050521.
194
6. Kailasapathy, K., Chin, J., 2000. Survival and therapeutic potential of probiotic organisms
with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell
Biology 78: 80-88.
7. Halliwell, B.; Cross, C.E., 1994. Oxygen-derived species: Their relation to human disease
and environmental stress. Environ. Health Perspect. 102: 5.
8. Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord, J.M.,
Harman, D., 1987. Oxygen radicals and human disease. Ann. Int. Med. 107, 526545.

Adnan Menderes -74.
10. Unluguzel Ustun G, Keskin A, Aci R., Arslanbek Erdem, M., Ari, M., 2021. Association
between Hb A1c and severity of COVID-19 patients. Hemoglobin, 45: 124128.
11. Keskin, A., Karul. AB., 2022. The effect of niacin and melatonin supplementation on the
antioxidant system and lipid peroxidation in exercised rats. Meandros Med Dental J. 23(1):60-
6. doi: 10.4274/meandros.galenos.2021.27048.
12. Eftekharzadeh, B., Maghsoudi, N., Khodagholi, F., 2010. Stabilization of transcription
factor Nrf2 by tBHQ prevents oxidative stress-
Biochemie, 92: 245253.
13. Mishra, V., Shah, C., Mokashe, N., Chavan, R., Yadav, H., Prajapati, J., 2015. Probiotics
as potential antioxidants: A systematic review. J. Agric. Food Chem. 63, 36153626.
14. Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., Van-Hylckama Vlieg,
J.E., Strissel, K., Zhao, L., Obin, M.; et al. Modulation of gut microbiota during probiotic-
mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 2015, 9, 115.
15. Rad, A.H., Sahhaf, F., Hassanalilou, T., Ejtahed, H.S., Motayagheni, N., Soroush, A.R.,
Javadi, M., Mortazavian, A.M., Khalili, L., 2016. Diabetes management by probiotics: Current
knowledge and future perspectives. Curr. Diabetes Rev.
16. Gomes, A.C., Bueno, A.A., de Souza, R.G., Mota, J.F., 2014. Gut microbiota, probiotics
and diabetes. Nutr. J. 13, 60.
17. Holzapfel, W.H., Schillinger, U., 2002. Introduction to pre-and probiotics. Food Res. Int.
2002, 35, 109116.
18. Zocco, M.A., Dal Verme, L.Z., Cremonini, F., Piscaglia, A.C., Nista, E.C., Candelli, M.,
Novi, M., Rigante, D., Cazzato, I.A., Ojetti, V., et al. 2006. Efficacy of Lactobacillus GG in
maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 23: 15671574.
19. Liu, Y.W.; Su, Y.W.; Ong, W.K.; Cheng, T.H.; Tsai, Y.C. Oral administration of
Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via
the anti-inflammatory and immunomodulatory activities. Int. Immunopharmacol. 2011, 11,
21592166.
20. Rad, A.H., Sahhaf, F., Hassanalilou, T., Ejtahed, H.S., Motayagheni, N., Soroush, A.R.,
Javadi, M., Mortazavian, A.M.;-, Khalili, L. 2016. Diabetes management by probiotics: Current
knowledge and future perspectives. Curr. Diabetes Rev.
21 Grajek, W., Olejnik, A., Sip ,A., 2005. Probiotics, prebiotics and antioxidants as functional
foods. Acta Biochim Pol. 52: 665671.
195
22. Vasquez, E.C., Pereira, T.M.C., Peotta, V.A., Baldo, M.P, Campos-Toimil, M., 2019.
Probiotics as beneficial dietary supplements to prevent and treat cardiovascular diseases:
uncovering their impact on oxidative stress. Oxid Med Cell Longev. 2019:3086270.
23. Song, P., Zhang, R., Wang, X., He, P., Tan, L., Ma, X., 2011. Dietary grape-seed
procyanidins decreased postweaning diarrhea by modulating intestinal permeability and
suppressing oxidative stress in rats. J Agric Food Chem. 59:62276232.
24. Qian,Y., Zhang, J., Zhou, X., Yi, R., Mu, J., Long, X., Pan, Y., Zhao, X., Liu, W., 2018.
Lactobacillus plantarum CQPC11 isolated from Sichuan pickled cabbages antagonizes d-
galactose-induced oxidation and aging in mice. Molecules. 23:3026.
25. Wang, Y., Guo, Y., Chen, H., Wei, H., Wan, C., 2018. Potential of Lactobacillus plantarum
ZDY2013 and Bifidobacterium bifidum WBIN03 in relieving colitis by gut microbiota,
immune, and anti-oxidative stress. Can J Microbiol. 64:327337.
26. Wang, Y., Wu, Y., Wang, Y., Xu, H., Mei, X., Yu, D., Wang, Y., Li, W., 2017. Antioxidant
properties of probiotic bacteria. Nutrients. 9:521.
27. Feng, T.; Wang, J. 2010. Oxidative stress tolerance and antioxidant capacity of lactic acid
bacteria as probiotic: A systematic review. Gut Microbes,12.
       -Espinosa, R.M., 2019. Haloarchaeal
Carotenoids: Healthy Novel Compounds from Extreme Environments. Mar. Drugs.17, 524.
29. Rodrigo-       - -Espinosa, R.M.,
2015. Carotenoids from Haloarchaea and Their Potential in Biotechnology. Mar. Drugs, 13:
55085532.
30. Newton, G.L., Javor, B., 1985. gamma-Glutamylcysteine and thiosulfate are the major low-
molecular-weight thiols in halobacteria. J. Bacteriol. 161: 438441.
31. Sarcinelli, C., Fiorentino, G., Pizzo, E., Bartolucci, S., Limauro, D., 2016. Discovering
Antioxidant Molecules in the Archaea Domain: Peroxiredoxin Bcp1 from Sulfolobus
solfataricus Protects H9c2 Cardiomyoblasts from Oxidative Stress. Archaea, 110.
32. Lin, S.M., Baek, C.Y., Jung, J.-H., Kim, W.S., Song, H.-Y., Lee, J.H., Ji, H.J., Zhi, Y.,
Kang, B.S., Bahn, Y.S., et al., 2020. Antioxidant Activities of an Exopolysaccharide (DeinoPol)
Produced by the Extreme Radiation-Resistant Bacterium Deinococcus radiodurans. Sci. Rep.
10: 111.
33. Aarti, C., Khusro, A., Varghese, R., Arasu, M.V., Agastian, P., Al-Dhabi, N.A., Ilavenil,
S., Choi, K.C., 2017. In vitro studies on probiotic and antioxidant properties of Lactobacillus
brevis strain LAP2 isolated from Hentak, a fermented fish product of North-East India. LWT.
86: 438446.
34. Amaretti, A., Di Nunzio, M., Pompei, A., Raimondi, S., Rossi, M., Bordoni, A., 2013.
Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl
Microbiol Biotechnol 97: 809-17.
35. Lin, M.Y., Chang, F.J., 2000. Antioxidative effect of intestinal bacteria Bifidobacterium
longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci. 45: 1617-22.
36. Kullisaar, T., Zilmer, M., Mikelsaar, M., 2002. Two antioxidative lactobacilli strains as
promising probiotics. Int J Food Microbiol 72: 215-24.
196
37. Wang, A.N., Yi, XW., Yu, HF., Dong, B., Qiao, SY., 2009. Free radical scavenging activity
of Lactobacillus fermentumin vitro Arkadiu
12 Arch Med Sci and its antioxidative effect on growing-finishing pigs. J Appl Microbiol, 107:
1140-8. 41.
38. Shen, X., Yi, D., Ni, X., et al., 2014. Effects of Lactobacillus plantarum on production
performance, immune characteristics, antioxidant status and intestinal microflora
of bursinimmunized broilers. Can J Microbiol, 60: 193-202. 42.
39. Rajpal, S., Kansal, V.K., 2009. Probiotic Dahi containing Lactobacillus acidophilus and
Bifidobacterium bifidum stimulates antioxidant enzyme pathways in rats. Milchwissenschaft,
64: 287-90.
40. Yadav, H., Jain, S., Sinha, P.R., 2008. Oral administration of dahi containing probiotic
Lactobacillus acidophilus and Lactobacillus casei delayed the progression
of streptozotocininduced diabetes in rats. J Dairy Res. 75: 18.
41. Kapila, S., Kapila, R., Reddi, S., Sinha, P.R., 2014. Oral administration of probiotic
Lactobacillus casei spp. casei ameliorates oxidative stress in rats. Int J Curr Microbiol App Sci
3: 670-84. 48.
42. Sun, J., Hu, XL., Le, G.W., Shi, Y.H., 2013. Inhibition of Fe-induced colon oxidative stress
by lactobacilli in mice. World J Microbiol Biotechnol 29: 209-16.
43. Hoffmann, A., Kleniewska, P., Pawliczak, R., 2019. Antioxidative activity of probiotics.
Arch. Med. Sci. 17: 792804.
197


1
1fatmacakir@nevsehir.edu.tr, 0000-0002-7225-9172

-6
   
         
   
          


          
        

           
        
        

Anahtar Kelimeler:  


SUMMARY
The aim of this study is to determine the methods and levels of child development students to
convey earthquake and earthquake awareness to 3-6 year old children in the early childhood
education period. In the study, in which the simple descriptive research method with
quantitative content was used, the easily accessible sampling method was used. Data were
collected with 148 students studying in the child development department of a university
              
expressed in numbers and percentages. As a result of the research, the rate of transferring
earthquake awareness of child development students was found to be low. On the other hand,
it can be said that child development students have a good level of awareness about how and
with which methods and techniques the earthquake issue should be explained to children. It
was determined that the rate of having earthquake awareness of children, families and
individuals around them was low. In this context, it can be suggested that various information
trainings and seminars be given to increase the awareness and experience of child development
students on these issues so that vital issues such as earthquakes can be transferred to children
at a young age.
Keywords: Child development students, earthquake, early childhood
198



         n, 1993).
       

          rkan, 2010;


           

            
   
        
         
        


          


         
   
 

         

           
        
          
           
         
        
.




199
        




         


 

          
 


BULGULAR
Tablo 1. mografik Bilgileri.

Kategoriler
N
%

18-
21-
26-

97
47
2
2
65,5
31,8
1,4
1,4
Cinsiyet

Erkek
139
9
93,9
6,1
200



88
60
88
60
Medeni Hal
Evli

3
145
2,0
98,0

Evet

103
45
69,6
30,4


Evet

82
66
55,4
44,6
---30
            

 
   

r.
Tablo 2.        

MADDELER
N
%
1. 

64
43,2
Orta
80
54,1

4
2,7
2. 
Evet
53
35,8

95
64,2
3.        
     

201

49
33,1
Orta
91
61,5

8
5,4
4. Sizce      

Evet
144
97,3

4
2,7
5. 
konusunda 
Evet
144
97,3

4
2,7


Evet
2
1,2

77
52,
Biraz
69
46,6
7. 

Evet
5
3,4

101
68,2
Biraz
42
28,4
8.       

Evet
85
57,4

63
42,6
      

a) 
141
95,3
b) 
7
4,7
       
verilmeli mi?
Evet
147
99,3

1
0,7
       
202
      

Evet
148
100

0
0
       
 
Evet
147
99,3

1
0,7
       
musunuz?
Evet
20
13,5

128
86,5

Evet
46
31,1

102
68,9

Evet
54
36,5

94
63,5

Evet
60
40,5

88
59,5

Evet
45
30,4

103
69,6


14
9,5
Orta
82
55,4

52
35,1
       
verilmeli midir?
203
Evet
140
94,6

8
5,4
      

Evet
39
26,4

37
25,0
Biraz
72
48,6
         

        
           

         
        
       
      
        
         
          
         
       
        
       

         
 
       
         
verilmesi ger
        
          
        
       

belir
       
        bulup
       
       
nde


        

         
204
          
        
         
        
        
         

 

        
       
          






 
            la zorlu yollardan
         
 -          
me ve rehberlik edilme
epremin
          

           

0
20
40
60
80
100
120
Fot. Mat. Film Uyg. Hikaye Gezi Uzman Oyun
Yöntem Kişi
205
konusunu anlatabilmek        
        
   

         
         
 leyecektir (
2019).        

   
        


       
         
           
       
          Tuncer vd.,
2021).    
        
     
beceri 
-
         
        
       
        
 

 

          
        


        
         
   
       

         
       
         
    
      

206

Alkan, N.U. (1999). 1995 Dinar Depremi. Türk Psikoloji Bülteni, 5 (14), 59-60.

http://ayhanaltas.blogcu.com/dogal-afetlerin-insanlar-uzerindeki-psikolojik
etkileri/4722749
Akcanbas M.(2009) “Çocuklar ve Gençlerde Afet Psikososyolojisi El Kitabı I
http://mertakcanbas.blogcu.com/cocuklar-vegenclerde-afet-psikososyolojisi-el-kitabi
i/6232106
Doğal afetlerin afetzedeler üzerine psikolojik etkileri: Trabzon ili
örneği. 

   
-Türk Psikoloji Bülteni, 5 (14), 78-88.

    Bir durum çalışması. Doğu Coğrafya
Dergisi, 22(37), 113-134.

   lnternational Journal of Geography and
Geography Education, (39), 83-94.
, D. (2021). Views on disasters and biologic disasters during
Covid-19. International Journal of Geography and Geography Education (IGGE), 44,
338-358.
        -  
Türk Eğitim Bilimleri Dergisi, 3, 443-466.
Eğitim Kuram ve Uygulama Araştırmaları Dergisi 2019, Cilt 5, Sayı 1, 113-123
 -
 -  International Journal Of Social
Science, 48, 319-332.
   
       Tezi, Marmara

         
     Pamukkale
Üniversitesi Eğitim Fakültesi Dergisi, Sayı 28, s.56-62
Erso
in Istanbul, Turkey. Geomatics, Natural Hazards and Risk, 7(4), 1307-1336.
           
d-


ucational Sciences, 2(1), 1-17.
207
           
standardizasyonu. Deprem Sempozyumu
   Toplumda Afet Bilincini Artırma Yöntemleri” Afet Zararlarını
Azaltmanın Temel İlkeleri Kitabı, 
Kaya, E. (2012). Şehre Tanıklık Edenler Erzincan Sözlü Tarih Çalışması-Cilt I, Pasifik Ofset,

Afetlerin Çocuk Sağlığı Üzerindeki Etkileri” TAF Preventive
Medicine Bullet-460.

surrounding natural disasters: An investigation of year 5 students, Wellington, New
Zealand. Australasian Journal of Disaster and Trauma Studies, (1), 17 26.
            
            
137.


637-655.

 Batı Anadolu Eğitim Bilimleri
Dergisi, 2(3), 89-108.
 Afet ve
Risk Dergisi, 4(2), 331-350. https://doi.org/10.35341/ afet.975939
   Çocuk ve Afet: Felaketlerin Çocuklar Üzerindeki Psikolojik Etkileri
http://www.tavsiyeediyorum.com/makale_921.html
-143.

-
604. https://doi.org/10.7827/TurkishStudies.9761.
       Language, Speech And Hearıng
Services İn Schools, 20, 153-169.
92). Posttraumatic stres disorder: The impact of life stres
events on adjustment. Integrative Psychiatry, 7, 209-217
      Türkiye Coğrafyası Araştırma ve
Uygulama Merkezi Dergisi, 2, 53-68.
Rubonis, A. V., ve Bickman, L. (1991). Psychological impairmentin the wake of disaster: The
disaster-psychopathology relationship. Psychological Bulletin, 109, 384-39
          Ondokuz
Mayis University Journal of Education Faculty, 38(1), 283-295.
     
Doğal Afet ve Afet Yönetimi Sempozyumu. 2-
208
             
 Medeniyet Araştırmaları Dergisi, 3(6), 149-159.
Resilience,
1(1), 1-9. https://doi.org/10.32569/resilience.344784
İnsan Bilimleri Dergisi, 10-14.
         
         

209


1 2
1 aksungur4617@gmail.com, 0000-0003-3257-5717
2fatmacakir@nevsehir.edu..tr, 0000-0002-7225-9172



ve 

          

          


         
           
            
       -   
    .     
r. Deprem ile ilgili
     

Anahtar Kelimeler: 

Development
SUMMARY
Human beings may encounter earthquakes throughout their lives. It is necessary for individuals of all
ages to obtain information about what to do in the face of this inevitable natural disaster. In particular,
children's acquiring this information at an early age and period will help them reduce their fears. The
devastating consequences of earthquakes affect all people, and one of the most affected segments is
children. The fact that children have little life experiences and experiences and insufficient knowledge
cause them to perceive the event completely differently and increase the dimensions of the trauma they
experience in these misperceptions. The only way that can help children, who have to live their lives
during and after the earthquake, erase the traces of the events they experienced more easily and cling
to life in a healthy way, is through the education and professional support they receive in these areas.
Especially after the earthquake, it is the healthy social and emotional development processes that enable
children to hold on to life. In this context, it is very important to give all necessary information and
education about earthquakes in a timely manner starting from early childhood. In this review study, the
literature review was conducted by examining the studies on the social-emotional development of
children after the earthquake. The aim of the study includes what should be done and approaches for
210
the social and emotional development of children after the earthquake. The importance of education
and information about earthquakes in terms of social and emotional development of children in early
childhood and what families will do in this process are mentioned.
Keywords: Earthquake education, early childhood, social and emotional development




          

r (Kaya, 2012; Depremlerde


          
 



       aile bireylerinin
   
           
        

 



         
            
         



       
   
        
           
         
         

          

211

.

-
-
-
-
-

          

           
anlam 

         
         
         
Bebeklik Dönemi (0-1 yaş)
İlk Çocukluk Dönemi (2-5 yaş)
Son Çocukluk Dönemi (6-11 Yaş
Ergenlik Dönemi (12-17 Yaş)
212
          


Ebeveynl
         


         
becerilerde gerilemeler olabilir.

009; Brook & Siegel, 1996).
-
2 - 
          

          
me
   







Uykuda 


 

          

-
         

          
hassasiyet du

           
213
           
         

          
          

     

okul personeli ve ebeveynler dikkat etmelidir.
         











         

-
 
 

         



            
        
         


         





214





          
          
at

 
        
        
           

         

      -     
-
depremin olma nedenine daha g

        
 

         
        
         

kekemelik ve kendini ifade etme probl
Stone & LeViness, 2001).
     


litera        

         &
Bickman, 1991).


İÇE KAPANIKLIK
215
         
(


           nlu
          
          
          


psikolojik sorunlara da neden olabilmektedir (Cheng vd. 201


(Karabulut & Bekler, 2019;        

  
    -   
         

20
DEPREM SONRASI
ÇOCUKLARDA
GÖZLEMLENEN
DUYGUSAL VE
DAVRANIŞSAL SORUNLAR
DUYGUSAL
YÖNELİM
ANKİSİYETE
SALDIRGAN
DAVRANIŞLAR
DİKKAT
SORUNLARI
SOMATİK
SORUNLAR
216
          
ebilmektedir.
 

    
Atmaca 2018; Sarman 2012).
      

           


        



        



         




      



S
  -      
         
ha fazla tedirginlik

         

          -
          
          
          
        

217
KAYNA
Alkan, N.U. (1999). 1995 Dinar depremi. Türk Psikoloji Bülteni, 5 (14), 59-60.
Çocuklarda ve gençlerde afet psikososyolojisi el kitabı (I),
http://mertakcanbas.blogcu.com/cocuklar-vegenclerde-afet-psikososyolojisi-el-kitabi
i/6232106.
   “Doğal afetlerin insanlar üzerindeki psikolojik etkileri
http://ayhanaltas.blogcu.com/dogal-afetlerin-insanlar-uzerindeki-psikolojik
etkileri/4722749.
 Son çocukluk dönemi dini gelişiminde sevgi ve korku motiflerinin
etkisi (Doctoral dissertation, Marmara Universitesi (Turkey)).
           
    International Conference on Trends in Advanced
Research (Vol. 1, pp. 20-25).
Gelişim ve öğrenme psikolojisi. 
  Depremden etkilenen çocuklarınıza nasıl
yardımcı olabilirsiniz? Anne-baba el kitabı.  78-88.
Brooks, B. & Siegel, P. (1996). The scared child: helping kids overcome traumatic events,

Can, G., (2004). Kişilik gelişimi, editör: binnur yeşilyaprak, gelişim ve öğrenme psikolojisi. 6.

Cheng J., Liang Y., Fu L., Liu Z., (2018), Posttraumatic stress and depressive symptoms in
children after the Wenchuan earthquake, European Journal of Psychotraumatology,
9(1):1472992, 1- 12.
             
 Selçuk İletişim, 15(2), 737-766.
           
travma tepkileri ve psiko-    Türk Psikoloji Yazıları, 12(24),
1- 13.
       Çocuklar ve ergenlerde travmatik yaşantılar ve
başetme, 
-141.
      a psikolojik tepkiler ve bunlara yaklaşımlar. Türk
Psikoloji Bülteni, Deprem Özel Sayısı, 5, 14.
Ekici S., Tuncel G., (2015). Göç ve İnsan, Birey ve Toplum, 5(9), 9-22.
Felix E., Hernandez L.A., Bravo M., Ramirez R., Cabiya J., Canino G., (2011), Natural
disaster and risk of psychiatric disorders in puerto rican children, Journal of
Abnormal Child Psychol, 39(4), 589-600.
   International Conference on
Scientific and Academic Research (Vol. 1, pp. 379-383).
Abant İzzet
Baysal Üniversitesi, Eğitim Fakültesi Dergisi, 1(2), 80-104.
Karabulut, D., & Bekler, T. (2019). Doğal afetlerin çocuklar ve ergenler üzerindeki etkileri.
-376.
218
         
problemler, Uluslararası Sosyal ve Eğitim Bilimleri Dergisi, 2(4), 216-229.
Kaya, E. (2012).   Erzincan: sözlü tarih çalışması II.
          
     
http://www.ibb.gov.tr/sites/akom/documents/dogal_afetler.
 Doğal afetlerde kriz yönetimi 

  stres disorder: The impact of life stres
events on adjustment. Integrative Psychiatry, 7, 209-217.
      Türkiye Coğrafyası Araştırma ve
Uygulama Merkezi Dergisi, 2, 53-68.
Pfefferbaum B., Houston J.B., North C.S
       Prev. Res. Author Manuscript, 15(3):
3-6.
Pataki, G. E, Stone, J. M. ve LeViness, J. (2001). Crisis counseling guide to children and
families in disaster. New York, USA, 11-13.
Rubonis, A. V., ve Bickman, L. (1991). Psychological impairmentin the wake of disaster: The
disaster-psychopathology relationship. Psychological Bulletin, 109, 384-399
Sarman A., (2012). Elazığ ili karakoçan ilçesinde yaşanan yıkıcı deprem sonrasında, depremi
yaşayan ilköğretim çağı çocuklarda kaygı düzeyi, depresyon belirtileri ve etkileyen
faktörler,  
             
       International Journal of
Educational Spectrum, 3(1), 1-27.
İnsan Bilimleri Dergisi, 10-14.
Yavuz, E. (1939). Erzincan Depremi Ve Depremin Etkileri.
219


SIKLIKLARI
1
1fatmacakir@nevsehir.edu..tr, 0000-0002-7225-9172

m 
        
        


         
edile         
        
        
         
        

   



 

Anahtar Kelimeler:        

-School

The aim of this study is to determine the frequency of child development program students'
preparation of learning centers for children in the fields of application in pre-school education
institutions. In the quantitative type, descriptive research method was used. In the study, the
easily accessible sampling method was used to save time. 113 students studying in a child
             
indicated by numbers and percentages in the SPSS program. As a result of the analysis of the
data obtained from the research, it was determined that the rate of organizing learning centers
in pre-school education institutions of child development students is moderate. It can be said
that the student group organizing learning centers is at a good level when the frequency of
organizing learning centers is examined. On the other hand, when the type and number of
learning centers in institutions and the material proficiency levels in learning centers are
examined, it has been concluded that it is not at a sufficient level. In this context, it can be
suggested to include more subjects and courses covering learning centers in the curriculum of
child development students in universities, and to carry out activities that will raise awareness
about learning centers in the practice areas of child development students. On the other hand,
220
informative in-service courses and seminars can be recommended for educators and institution
managers in order to ensure that the learning centers in pre-school education institutions are
in sufficient number and variety.
Keywords: Child development students, learning centers, preschool education institutions

         
       
      i   
      


            
alanlara dikkatlerini to        

tirilmeli,
y          

nme merkezleri

        

          

         
merkezi, dramatik oyun merkezi, sanat merkezi, kitap merkezi, fen ve matematik merkezi,


MEB, 2013).
         
n        
an, 2007; Aral ve Can
          
          
    lan  da kendilerini,
         
           

        
          

          
         
       
(Ze          


  
221

.

         
 incelemektir.





        
l
 
    
   

    



tir.
BULGULAR


Kategoriler
N
%

18-
59
52,2
26-
54
47,8
Cinsiyet

109
96,5
Erkek
4
3,5


29
25,7

84
74,3
-25 -

222


         
    
%        

Tablo 2.
        



0
10
20
30
40
50
60
Ö.M.Hazırlayan Ö.M.Hazırlamayan
0
5
10
15
20
25
30
35
40
HaftadaBir İkiHaftadaBir AydaBir DönemdeBir YıldaBir
223

      z  
Akabinde iki haftada bir (%20,1) ve ayda bir (19,5) 
MADDELER
Kriterler
N
%
    
merkezlerini ?
Haftada Bir
44
38,9

23
20,4
Ayda Bir
22
19,5

15
13,3

9
0,8
  
merkezlerinin  yeterli midir?
Yeterli
24
21,2
Yetersiz
23
20,4

66
58,4
  
merkezlerinin  yeterli midir?
Yeterli
25
22,1
Yetersiz
30
26,5

58
51,3
  
merkezlerindeki materyaller ve
oyuncaklar yeterli midir?
Yeterli
31
27,4
Yetersiz
25
22,1

57
50,4
Tablo 1      a 
     58, 
         ise
       
   n     


matery


          
        
       a
         
        
         
        
          
         yetersiz
          



         
    gelman & Karakuzu, 2016; Ramazan vd.,
2018).
224
        

       

          


          
ort        

         enlenerek,

KAYNAKLAR
Allen, D. & Fraser, B. (2007). Parent and student perceptions of classroom learning
environment and its association with student outcomes. Learning Environment
Research, 10, 67-82.
Okul öncesi eğitim 1. -.
-72 Aylık çocuklar için eğitim programı. okul öncesi eğitim
programları-112 Ankara: Hed.
         Okul öncesi eğitim ve okul öncesi eğitim
programı öğretmen rehber kitabı. -
   Okul öncesi öğretmenlerini okul öncesi eğitim programına yönelik
değerlendirmeleri,         

 
 incelenmesi. Kastamonu Eğitim Dergisi 24, 2561-257.

K. (2012). Improving the school environment from a student perspective: Tension
and Opportunities, Education Inquiry 3 (1), 19-35.
          
  Kastamonu Eğitim Dergisi, 24(5),
2561-2574.
Cowling, T. (2015). Setting up Preschool Learning Centers: A Guide for Teachers (Ed.: J.
  http://www.brighthubeducation.com/teaching-preschool/77877
setting-uplearning-centers-ideas-and-organization/, 2015).
  ). Okul öncesinde ilgi köşelerinin düzenlenmesinin ve kullanılmasının
öğretmen görüşlerine göre değerlendirilmesi    

   Milli Eğitim Bakanlığına bağlı anaokulu ve anasınıflarında görev yapan
öğretmenlerin uygulanan eğitim programına ve programın kullanımına ilişkin
görüşlerinin incelenmesi.      

             
behaviors of preschool children. Children’s Geographies, 11 (3), 263-280.
225
Ekinci (Palut), B. (2012). Erken çocukluk döneminde gelişim ve öğrenmenin
değerlendirilmesi ve desteklenmesi

   Okul öncesi öğretmenlerinin okul öncesi eğitim programındaki değerler
eğitimine ilişkin görüşlerinin değerlendirilmesi Tezi).

       Kastamonu Üniversitesi Eğitim Fakültesi
Dergisi, 15(2):501-510.
Li, Y.L. (2006). Classroom organization: Understanding the context in which children are
expected to learn. Early Childhood Education Journal, 34 (1), 37-43.
Okul Öncesi Eğitim Programı. www.meb.gov.tr.
        Okul Öncesi Eğitim
Programı. 
            
       
Kırıkkale Üniversitesi Sosyal Bilimler Dergisi, 6(2), 73-98.
         
merkezlerinin incelenmesi. Kastamonu Eğitim Dergisi, 25(2), 733-746.

       Ahi Evran Üniversitesi
Kırşehir Eğitim Fakültesi Dergisi, 15(1), 313- 331.

      Karabük Üniversitesi Sosyal
Bilimler Enstitüsü Dergisi, 5(2), 125-138.
Prescott, E., 1987, The environment as organizer of intent in child-care settings, In C. S.
Robinson, E. & Fraser    
of science classroom environments: Achievment and Attitudes. Learning Environment
Research, 16, 151-167.
            
merkezlerinin durumunun belirlenmesi ve   
   Erken Çocukluk Çalışmaları Dergisi, 2(2), 213
233.
           
science classroom environments: Achievment and Attitudes. Learning Environment
Research, 16, 151-167.
   Okul öncesi eğitimi programında planlama ve etkinlikler. okul öncesi
eğitimde özel öğretim yöntemleri    :25-62. Ankara:

Zembat, R. (2005). Okul öncesi eğitimde güncel konular, içinde: okul öncesi eğitimde
nitelik 
Zembat, R. (2007). Okul öncesi eğitimde nitelik. okul öncesi eğitimde güncel konular. Edt.:
n. s:25-
Weinstein, C.S. & David, T.G., 1987, Spaces for Children: The Built Environment and Child
Development, Plenum Press, New York.
226


1 ,2
1aksungur4617@gmail.com, 0000-0003-3257-5717
2fatmacakir@nevsehir.edu..tr, 0000-0002-7225-9172

          
       
       
        
 2022-m-
        

       
 -    allerinin analizi sonucunda
         
         
        
et
          
niklerinin  
        
          
tedir.

Storytelling Techniques Materials Produced By Child Development Students:
Document Analysis
This study was carried out to examine the storytelling techniques materials developed within
the scope of the educational equipment development course of child development students. In
the conduct of the study, the document analysis method, one of the qualitative research
designs, was used. Within the scope of the study, 50 materials prepared within the scope of
the department course in the spring term of the 2022-2023 academic year by the students
studying in the child development program at a university in Central Anatolia in Turkey were
evaluated. educational materials; It has been examined within the framework of a form that
includes general characteristics, subjects and types. In order to carry out the research, the
necessary permissions were obtained from the institutions and verbal and written consent was
obtained from the participants. As a result of the analysis of the training materials, it was seen
that the materials were prepared on the subjects of 24 animals, 20 planets, 16 submarines, 16
seasons, 12 time, 8 fruits, 4 numbers. Of the educational materials, 22 were puppets, 15 were
flannel boards, 8 were story aprons, and 3 were story cubes. Of the 22 puppet materials, 5 are
sock puppets, 8 are club puppets, 6 are puppets that move joints, and 3 are string puppets. As
a result of the research, it was seen that the students of the child development program prepared
functional and creative materials suitable for the qualities of storytelling techniques. In line
with these results; In the field of child development, it can be recommended to conduct studies
227
in which new and different methods related to material development education are developed.
Keywords: Storytelling Techniques, Document Analysis, Child Development



          
            

          
      l z  
        
         

ki 
        

ecerilerini ve
       


          
        

 
  
e anlat  
anlat  anlat  

   

           
         
        
          
Geree  teknikleri materyallerinin
        







228
         
         
evrenini, 2022-         
       
, 
         
 nciler 2022-        

ir.

       
t
matery


        
-
        
         

ifade ed
        
        
vd., 2006).



 

BULGULAR
            



       

Tablo 1.

*

%
Hayvanlar
24
24
Gezegenler
20
20

16
16
Mevsiler
16
16
Zaman
12
12
Meyveler
8
8

4
4

229
Pazen Tahta
15
30

8
16

5
10
Kukla
22
44
*Eklemleri Hareket Eden Kukla
6
12

8
16

5
10

3
6

50
100

       

  


Grafik 1. 


0,3
0,16
0,1
0,44
1. Pazen Tahta 2. Hikâye Önlüğü 3. Hikâye Küpü 4. Kukla
230
Grafik 2.  
Kukla materyallerinden 
 (Grafik 2).
Tablo 2.



%

45
90

38
76

35
70

50
100

40
80

amaca




de       
          
      

          

aha fazla tercih

           
           
            


1. Eklemleri Hareket Eden Kukla 2. Çomak Kukla 0,16 3. Çorap Kukla 0,10 4.İpli Kukla
231


        

         


         

           

          


       




 -       
       
        

hem uygulamalarda kul   

         
o        
         


232
233
KAYNAKLAR
      Okulöncesi eğitim  -

     Kuklalar okul öncesi çocuklar için kukla yapımı ve
kullanımı. Ankara: YA-.
   Okul öncesi öğretmenlerinin Türkçe etkinliklerinde kullandıkları hikaye
anlatım yöntemlerinin incelenmesi: Kara

Eğitim psikolojisi
yer alan okul
   
incelenmesi. 1. Çocuk Gelişimi ve Nörolojisi Sempozyumu.
Çocuk edebiyatı. .
Öğretici hikayeler yoluyla düşünce ve duygu eğitimi tanımlar ve yöntemler.

234
   Anne-baba ve öğretmenlerin okul öncesi çocuk kitaplarını
değerlendirmesi.       

   Resimli çocuk kitaplarının benlik kavramıyla ilgili konuları içermesi
yönünden incelenmesi      

            
Avrasya Sosyal ve Ekonomi Araştırmaları
Dergisi, 6(3), 517-533.
Nas, R. (2002). Örneklerle çocuk edebiyatı

incelenmesi, Mehmet Akif Ersoy Üniversitesi Eğitim Fakültesi Dergisi, 36, 34-46.
Kayahan, Z. (2010). İlköğretim I. kademe 5. sınıf görsel sanatlar eğitimi dersinde hikaye
anlatım yönteminin yaratıcılığa etkileri     

i
Ege Üniversitesi Hemşirelik Yüksekokulu Dergisi, 19, 115-126.
 Okul öncesi kurumlarında ana dili etkinlikleri,   

   Milli Eğitim Bakanlığı Kız Teknik Öğretim Genel Müdürlüğü,
METGE, Mesleki Ve Teknik Eğitimi Geliştirme Projesi,   


Türk Eğitim Bilimleri Dergisi, 2(4), 495-509.
   Okul öncesi çocuklarına yönelik kitapların dil gelişimi ve anlambilim
açısından değerlendirilmesi.      

Ural, S. (2013). Okul öncesi çocuk kitaplarının tanıtımı. Çocuk Edebiyatı
(pp.33- 

 
incelenmesi, Kuram ve Uygulamada Eğitim Yönetimi, 45,129-148.
             
2005-  kavramsal,
Eurasian Education & Literature Journal,
Volume:6, s. 9-23.
235
Okul öncesi dönemde yaratıcılık eğitimi ve yaratıcı
etkinliklerde kullanmak için materyal hazırlama I-II 

Okul öncesi eğitimde araç geliştirme 

Zembat, R         ohbet ve hikaye
etkinliklerinde     Kuram ve
Uygulamada Eğitim Bilimleri Dergisi. 6(2), s. 587-608.
236

Gases Used In the Health Sector and Occupational Safety Management
1, 2,
1         
gkaratas@agri.edu.tr, 0000-0003-1858-2013
2         
seda.fandakli@avrasya.edu.tr, 0000-0002-8199-3336



         

 
           


ABSTRACT
Various gases are used in works such as medical interventions, sterilization activities, building
maintenance and repair in the health sector. Individuals encounter dangerous situations in the
activities of storing and using these gases. In addition, occupational accidents occur and
undesirable consequences arise. All employees must comply with the Occupational Safety rules
in order to avoid such situations. In this study, the gases used in the health sector, possible
dangers and occupational safety precautions that should be taken within the scope of social
policies are included.
Key Words: Health Sector, Medical Gases, Social Policy, Occupational Safety

   
          




          



   

237

           


 kaynak incelemeleri sonucunda s 
Oksijen, Hidrojen, Azot Protoksit, Etilen Oksit, Helyum, Argon, Asetilen, Karbondioksit, Kuru
de, sterilizasyon
 [1,

Oksijen;    



           
           

Azot Protoksit;         


           


ok

[9].
Etilen Oksit;         
       


Hidrojen; s        

          n
         

Helyum;         
       

Argon;        
          
           

238
Asetilen;        
         


Karbondioksit; 
       

 

  -        rda donma

 

].
         

           


          




      

Tehlikeli kabul edileni daha az tehlikeli veya tehlikesiz olarak kabul

 

           
           

  


          


        
dan
         
239

 



         


 

        
        


 

          
         


1. 

2.       


3. 
        
-178.
4.       
     

5. Marwah, V., Peter, D. K., & Choudhary, R. Medical Compressed Gas
Cylinder: Handling and Use.
6. Hendryani, A., Nurdinawati, V., & Dharma, N. Design of Manifold with
Pressure Controller for Automatic Exchange of Oxygen Gas Cylinders
in Hospital. TEKNIK, 42(1), 45-51.
7. http://www.hastane.hacettepe.edu.tr/medikal-gaz-unitesi_969.html.

8. https://www.tinsagaz.com
9. https://www.seralgaz.com
10. 
240
11.    
pplied Tourism Research, 2(2), 169-176.
12. 
 TAF Preventive Medicine Bulletin, 8(1).
13. https://www.mevzuat.gov.tr/mevzuat?
  
04.04.2023].
14. European Commission, (2011). Socio-economics of cost of accident at
workandwork relatedilhealth. http:// ec.europa.eu/social/publications.

15. https://www.mevzuat.gov.tr/File/GeneratePdf?mevzuatNo=18709&me
vzuatTur=KurumVeKurulusYonetmeligi&mevzuatTertip=5 
tarihi: 04.04.2023].
16. 
  
265-281.
241
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
İnsanlık 18. yüzyılda tarihsel bir kırılma noktası olarak ele alınabilecek bir dönemi geride bırakmıştır. Bu dönem literatürde Sanayi Devrimi olarak adlandırılmaktadır. Sanayi Devrimi'yle birlikteki işyeri mekân anlamında ciddi bir ayrıma tabi tutulmuş ve iş-ev arasına kalın duvarlar örülmüştür. Yine bu dönem işgücünün profilinin ciddi anlamda değiştiği bir süreç olarak bilinmektedir. Özellikle zanaatkârların yeni dönemde kurulan fabrikalarda işçi olması bu durumun en temel göstergelerindendir. Tarımsal hayattan kopuşla işin sadece fabrika olarak adlandırılan bir ortamda yapılmaya başlanmasıyla birlikte çalışma hayatına ve sorunlarına yönelik olarak adlandırılan tüm parametrelerin yeniden tanımlanması ihtiyacı ortaya çıkmıştır. Dolayısıyla tarım hayatından farklı olarak sanayileşmeyle birlikte çalışanların problemlerinde ve bu problemlere dönük olarak ortaya atılan çözüm önerilerinde de değişiklikler meydana gelmiştir. Ayrıca bu dönemde kendi emeğini başkalarının tekeline bırakan işçi, çalışma sürelerinin uzamasına paralel olarak iş konusunda beklentilerini karşılayamamış tam aksine hayal kırıklığına uğramıştır. Kısacası, sanayileşmeyle birlikte işçiler, psikolojik anlamda her gün çalışma hayatının vebası olarak nitelendirilebilecek stres ve stres faktörlerine maruz kalmış; sonuç olarak da işçi devir hızı, işten ayrılma gibi tepkisel davranışlar ortaya koymaya başlamışlardır. Tüm bunlardan hareketle çalışmanın temel amacı işgörenlerin çalışma hayatında karşılaştıkları ve işten ayrılmalarıyla son bulan stres kavramını sebep ve sonuçlarıyla birlikte detaylı bir analize tabi tutmaktadır.
Article
Full-text available
Introduction Postoperative surgical site infection (SSI) forms the major burden of nosocomial infections in surgical patients. There is prevalent practice of surgical site hair shaving as a part of preoperative preparation. There is uncertainty regarding the benefit versus harm of shaving for SSIs. Hairs at surgical sites are removed prior to surgery most often by shaving. We performed this study to look for what impact preoperative hair removal by shaving has on postoperative SSI. Methods We performed prospective comparative cohort study in patients undergoing elective abdominal surgeries. We included clean and clean-contaminated surgeries in immunocompetent patients of which half were shaved and other half not shaved prior to surgery. Other confounding factors like skin cleaning, aseptic technique of surgery, antibiotic prophylaxis and treatment, and postoperative wound care were as per care. Patients were assessed for presence and grade of SSI postoperatively on day 7, 14, and 30. Results were analyzed statistically using chi-square and Fischer's exact tests for significance in entire sample as well as in demographic subgroups. Results Overall SSI rate was 11.42%. There was no statistically significant difference in SSI rates between patients who underwent preoperative surgical site hair removal by shaving (232) and who did not have shaving (232) on all the three different assessment timelines in postoperative period, namely, day 7, 14, and 30. Although the absolute number of patients who had SSI was more in those who underwent preoperative surgical site hair removal by shaving, the difference was not statistically significant ( p > 0.05). But on subgroup analysis patients with clean-contaminated surgeries ( p = 0.037) and patients with surgeries lasting for less than 2 hours (Fischer's exact = 0.034) had significantly higher SSI in the shaved group compared with unshaved on day 14. Conclusion As per our results, preoperative shaving did not significantly increase overall SSI except in subgroup of clean-contaminated surgeries and in surgeries of less than 2 hours' duration. So especially in these patients avoiding preoperative surgical site hair shaving may be used as one of the infection control measures.
Chapter
Full-text available
Medical gas cylinders have been used for the treatment of millions of patients at healthcare centers and at homes. They comprise oxygen, nitrous oxide, carbon dioxide, air, entonox, and helium. These are compressed and stored in cylinders in liquid or gaseous form. These gases are predominantly used in medical procedures, some for inducing anesthesia and others for driving devices like ventilators, cryoprobe, etc. Improper storage, handling, and use of gas cylinders can pose a physical and chemical threat to both staff and patients. Many patients with diseases like chronic obstructive pulmonary disease with respiratory failure were already on domiciliary oxygen. The recent COVID-19 pandemic left many patients fighting for their lives and in those who survived, the residual pulmonary damage led to increased prescription of domiciliary oxygen therapy. Reckless use of cylinders is associated with high chances of accidents. We must be aware and also impart knowledge regarding the handling of cylinders to our patients. In this chapter, the basics of medical gas cylinders will be dealt with and we will also learn how to store these cylinders safely at hospitals and home.
Article
Full-text available
Kesitsel olarak yapılan bu çalışmada, vajinal doğum yapan kadınların doğum sürecine uyumlarının ve ilişkili faktörlerin değerlendirilmesi amaçlanmıştır. Çalışmanın örneklemini bu kamu hastanesinde 01.06.2018-31.09.2018 tarihler arasında normal vajinal doğum yapan, araştırmaya dahil edilme kriterlerine uyan ve araştırmacıların doğumun tüm evrelerinde katılımcı-gözlemci olduğu 146 gebe oluşturmuştur. Gebelerin sözlü onamları alındıktan sonra “Tanıtıcı Anket Formu” uygulanmıştır. Ardından kadının doğum sürecine uyumu, doğum eylemi süresince doğumhanede bulunan araştırmacı ebeler tarafından değerlendirme ölçütleri kullanılanarak “Gösterdi (Evet)” “Göstermedi (Hayır)” şeklinde gözlem yöntemi ile değerlendirilmiştir. Veriler frekans ve yüzdelik dağılımı ve kikare analizi ile değerlendirilmiştir. Kadınların %51,4’ünün 25-34 yaş aralığında, %54,8’inin ilköğretim mezunu, %74,7’sinin multipar olduğu, %90,4’ünün doğuma hazırlık sınıfına katılmadığı, %89,7’sinin gebeliğine ilişkin olumlu düşüncelere sahip olduğu bulunmuştur. Ayrıca kadınların %66,4’ünün bu süreçte aktif kararlara katıldığı, %91,8’inin ebenin yönlendirmelerine uyum sağladığı, %64,4’ünün sakinliğini koruyup kontrolü elinde tuttuğu, %54,8’inin doğum dalgaları sırasında solunum egzersizlerini kullandığı, %54,8’inin gevşeme yöntemlerini kullandığı belirlenmiştir. Çalışmamızda kadınların normal doğum sürecindeki bazı ölçütlere uyumlandıkları, bu durumu kadının eğitiminin, doğum hakkında bilgi alma durumunun, normal doğumu isteme durumunun, gebeliğini planlanmasının, gebeliği ve normal doğum hakkındaki olumlu düşüncelerinin, indüksiyon ve epizyotomi gibi intrapartum müdahalelerin etkilediği bulunmuştur.
Article
Full-text available
Objective We conducted a systematic review and meta-analysis to clarify the effects of different exercise modes (resistance training [RT], whole body vibration training [WBVT], and mixed training [MT, resistance training combined with other exercises such as balance, endurance and aerobic training]) on muscle strength (knee extension strength [KES]) and physical performance (Timed Up and Go [TUG], gait speed [GS] and the Chair Stand [CS]) in older people with sarcopenia. Method All studies published from January 2010 to March 2021 on the effects of exercise training in older people with sarcopenia were retrieved from 6 electronic databases: Pubmed, Cochrane Library, Embase, Web of Science, the China National Knowledge Infrastructure (CNKI), and Wanfang Database. Two researchers independently extracted and evaluated studies that met inclusion and exclusion criteria. Pooled analyses for pre- and post- outcome measurements were performed using Review Manager 5.4 with standardized mean differences (SMDs) and fixed-effect models. Result Twenty-six studies (25 randomized controlled trails [RCTs] and one non-randomized controlled trail) were included in this study with 1191 older people with sarcopenia (mean age 60.6 ± 2.3 to 89.5 ± 4.4). Compared with a control group, RT and MT significantly improved KES (RT, SMD = 1.36, 95% confidence intervals [95% CI]: 0.71 to 2.02, p < 0.0001, I ² = 72%; MT, SMD = 0.62, 95% CI: 0.29 to 0.95, p = 0.0002, I ² = 56%) and GS (RT, SMD = 2.01, 95% CI: 1.04 to 2.97, p < 0.0001, I ² = 84%; MT, SMD = 0.69, 95% CI: 0.29 to 1.09, p = 0.008, I ² = 81%). WBVT showed no changes in KES (SMD = 0.65, 95% CI: − 0.02 to 1.31, p = 0.06, I ² = 80%) or GS (SMD = 0.12, 95% CI: − 0.15 to 0.39, p = 0.38, I ² = 0%). TUG times were significantly improved with all exercise training modes (SMD = -0.66, 95% CI: − 0.94 to − 0.38, p < 0.00001, I ² = 60%). There were no changes in CS times with any of the exercise training modes (SMD = 0.11, 95% CI: − 0.36 to 0.57, p = 0.65, I ² = 87%). Conclusions In older people with sarcopenia, KES and GS can be improved by RT and MT, but not by WBVT. All three training modes improved TUG times, but not improved CS times.
Article
Full-text available
Background: The aim of this study is to determine the SSI rate in preoperative shaving versus non shaving of hair prior to surgical procedure and to determine if shaving is necessary or not. Methods: The study was carried out on 100 patients of age group 20 to 60 years admitted in. Patients was divided at random into two equal groups of 50 cases each. Study group A: Hair was not shaved before operation. Study group B: The operation site was shaved a night before surgery. Results: Out of 50 pts in group A(non-shaving) 4 pts developed SSIs. Out of 50 pts in group B(shaving) 9 pts developed SSIs. P-value is significant. Conclusion: It was concluded that shaving of the operative site has no role in prevention of postoperative wound infection even in cases/areas with heavy growth of hair at the operative site, the infection rate was not influenced by preoperative shaving preparation. Moreover, we did not experience any mechanical hindrance in making the incision. Care was, however, taken at the time of closure of wound to prevent hair being entangled in the sutures.
Article
Full-text available
İnsanlar yaşadıkları coğrafyaya ilişkin edinmiş oldukları bilgi ve deneyimleri ile kendi yaşamsal hafızlarını, afet bilinçlerini, toplumsal afet kültürünü ve coğrafyanın da tarihçesini oluştururlar. Bu çalışmanın amacı, yetişkinlerin yaşadıkları coğrafyadaki afetlere ilişkin yaşamsal hafızalarında oluşturdukları bilgi ve deneyimlerini ortaya koymaktır. Çalışma nitel araştırma desenlerinden biri olan temel nitel araştırma deseni kullanılarak gerçekleştirilmiştir. Çalışma grubu bir devlet üniversitesinde 2019-2020 yılında öğrenim gören Sosyal Bilgiler Eğitimi Anabilim Dalı öğrencilerinin ebeveynlerinden biri olmak şartıyla 154 katılımcıdan oluşmaktadır. Çalışmanın verileri afet öncesi, afet anı ve afet sonrasını kapsayan açık uçlu sorulardan oluşan anket ile toplanmıştır. Katılımcılardan elde edilen veriler içerik analizi ile çözümlenmiş ve 6 farklı kategori altında sınıflandırılmıştır. Çalışma sonucunda katılımcıların yaşadıkları coğrafya ilişkin en çok bildikleri ile en çok yaşadıkları afetlerin deprem, sel ve heyelan olduğu belirlenmiştir. Katılımcıların afet anında dışarı çıktıkları, çok korktukları ve duygularını kontrol edemedikleri sonucuna varılmıştır. Katılımcılar afet sonrasında ise daha çok bir şey yapamadıklarını ifade etmişlerdir. Afet konusundaki önerilerinde ise afet bilincine sahip bireylerin yetiştirilmesini için eğitime vurgu yaptıkları sonucuna ulaşılmıştır.